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ABSTRACT 
This thesis outlines the proposed attributes of healthcare which can define its 
quality and reviews existing research in this area. Specifically, the limitations of 
existing research into the volume-outcome relationship within surgery are 
highlighted, thereby addressing the ‘health outcome’ dimension of quality of care. 
The principles and existing application of funnel plots within surgery are reviewed 
alongside their ability to overcome the limitations, risks and implications of 
contemporary ranking of surgical performance. Methods by which future research 
should be conducted are proposed as a conceptual model. This model, along with 
the proposed ‘quality’ attributes, identifies the research themes of the empirical 
studies.  
The application of a validated methodological scoring system formally explores 
the limitations of existing volume-outcome research within the uro-oncological 
field. A cross-sectional analysis of administrative data assesses the volume-
outcome relationship for radical cystectomy in England, using an improved 
methodology that incorporates a multilevel model to account for the relationship 
and influence of both the surgeon and institution and adjustment for institutional 
structural and process of care confounders. Subsequently, risk-adjusted funnel plot 
methodology is applied to the dataset to further explore provider performance. A 
longitudinal analysis assesses compliance with healthcare policy for radical pelvic 
surgery in England by exploring the patterns of service provision, in response to 
the existing understanding of the volume-outcome relationship for uro-oncology.  
This thesis demonstrates the limitations with existing volume-outcome 
methodology and the need for improved methodology for both the interpretation 
and presentation of volume-outcome research. Appropriate handling of the data in 
volume-outcome analysis, which recognises the hierarchical nature, is important 
to adequately inform future service reconfiguration. Volume-outcome research is 
just one component of a quality framework that will help align healthcare with 
quality improvement programmes and must incorporate a multidimensional 
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approach to measuring and presenting both the clinical and patient-orientated 
measures of quality of care. 
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SUMMARY OF KEY POINTS ARISING FROM 
THIS THESIS 
 
1. It is possible to describe the structured approach of a quality framework 
which is required to appraise the quality of care in surgery in order to 
enhance future quality improvement programmes (Chapter 1), published as: 
Mayer EK, Chow A, Vale JA, Athanasiou T. Appraising the Quality of Care in 
Surgery. World J Surg. 2009;33(8):1584-93. 
2. Development of multilevel modelling based on a methodological 
framework is needed to direct future research and the clinical translation of 
evidence for volume-outcome relationship (Chapter 1), published as: Mayer E, 
Chow A, Darzi A, Athanasiou T. How can we assess Quality of Care in Surgery? 
In: T. Athanasiou (eds.), Key Topics in Surgical Research and Methodology, 
Springer-Verlag Berlin Heidelberg 2010. 
3. Funnel plots should play an increasingly important role as a quality 
control tool in future surgical performance assessment and will help to 
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performance (Chapter 1), published as: Mayer EK, Bottle A, Rao C, Darzi AW, 
Athanasiou T. Funnel plots and their emerging application in surgery. Ann Surg. 
2009;249(3):376-83. 
4. The methodological quality of existing volume-outcome research as applied 
to cystectomy, prostatectomy and nephrectomy is only modest at best. Pooled 
analysis confirms a higher volume, lower mortality relationship for 
cystectomy and nephrectomy (Chapter 2), published as: Mayer EK, Purkayastha 
S, Athanasiou T, Darzi A, Vale JA. Assessing the quality of the volume-outcome 
relationship in uro-oncology. BJU Int. 2009;103(3):341-9. 
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5. Appropriate interpretation of the volume-mortality relationship was only 
possible after adjusting for institutional and surgeon volume effects and also 
structural and process of care confounders (Chapter 3), published as: Mayer 
EK, Bottle A, Darzi AW, Athanasiou T, Vale JA. The volume-mortality relation 
for radical cystectomy in England: retrospective analysis of hospital episode 
statistics. BMJ 2010 Mar 19;340:c1128. doi: 10.1136/bmj.c1128. 
6. A volume-outcome relationship for re-intervention after radical 
cystectomy existed at the institutional and surgeon level (Chapter 4). 
Submitted as: Mayer EK, Bottle A, Aylin P, Darzi AW, Athanasiou T, Vale JA. 
The volume-outcome relationship for radical cystectomy in England: An analysis 
of outcomes other than mortality. 2010. 
7. In the risk-adjusted funnel plot, using the final complex statistical model, 
no English NHS Trust demonstrated a truly divergent higher rate of 
mortality or re-intervention within 30 days following radical cystectomy 
(Chapter 5). Submitted as: Mayer EK, Bottle A, Aylin P, Darzi AW, Vale JA, 
Athanasiou T. What is the role of risk-adjusted funnel plots in the analysis of 
radical cystectomy volume-outcome relationships? 2010. 
8. Four years after the introduction of Improving Outcomes Guidance for 
radical pelvic surgery, only a third of English NHS Trusts achieved the 
minimum standard of 50 procedures (Chapter 6), published as: Mayer EK, 
Bottle A, Darzi AW, Athanasiou T, Vale JA. Provision of radical pelvic 
urological surgery in England, and compliance with improving outcomes 
guidance. BJU Int. 2009;104(10):1446-51. 
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1.1 Appraising the quality of care in surgery 
There is a growing global movement towards quality and safety in healthcare and 
quality improvement initiatives in surgery 
1
. Quality of care can be defined in 
many different ways and in order to measure it, there must be consensus as to 
what it comprises. Broadly, it can represent an overall impression of delivery of 
healthcare, but equally it can be defined in more specific terms such as treatment 
process or outcomes achieved. Patients are more likely to relate to the former, 
whilst clinicians may be more concerned with the latter. The nature of health and 
healthcare delivery is also changing with a greater emphasis on prevention, and 
novel treatments and technologies which may allow treatment of greater numbers 
of patients, perhaps with more co-morbidity, to a higher standard. Measures of 
healthcare productivity must be able to reflect this ‘health inflation’.  
The provision of high quality care is the universal aim of any healthcare system 
and those that work within it. When the health service is working at its best, it can 
provide excellent care to our patients, and it is well recognised that high quality 
care can lead to high quality results. However this is not always achieved. There 
exist wide variations in the quality of surgical care provision. This variation 
occurs between countries, regions, hospitals, departments, and surgeons. The 
delicate interaction of multiple factors at numerous stages of a patient’s care 
pathway means that any single suboptimal episode can result in a cascade effect 
on the overall quality of care, to the detriment of the person who matters most, the 
patient. 
This introduction forms a narrative review which describes why we need to 
measure quality of care and what tools we have currently. The requirement for a 
more structured approach to assess several multi-dimensional aspects of quality of 
care is also presented along with the components that would be included in such a 
quality framework. Particular focus is given to describing the volume-outcome 
relationship, its existing limitations and future potential direction for 
improvement. Finally the importance of appropriate statistical methodology and 
data presentation are discussed. 
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1.1.1 The need to measure quality of care 
There is evidence that measuring and reporting quality of care drives 
improvement. Berwick et al. described two pathways by which this occurs 
2
. The 
“change pathway” describes how the very act of measuring and benchmarking 
standards itself drives continuing improvement and innovation. Further to this the 
“selection pathway” describes how publicly released performance data is 
compared, and better-performing providers are rewarded by ‘selection’ of that 
provider.  This selection pathway appears to carry more motivational drive than 
the change pathway. A third pathway, the “reputational pathway” was proposed 
by Hibbard 3. This describes a provider’s concern for public image or reputation. 
Public reporting of performance data appears to stimulate quality improvement 
activity at the hospital level, although it is unclear if this translates into improved 
effectiveness, safety, and patient-centeredness 4. Transparency of performance and 
outcomes reporting, and therefore public accountability, is a way of empowering 
the patient to inform choice; choice is becoming a legal requirement through the 
patient constitution 5 and is a common aspect of the patient’s perception of quality 
of care6. 
Beyond public accountability, performance reporting has also been linked with 
financial incentives in pay-for-performance schemes 7 8. Five key dimensions have 
been suggested as the most important influencing determinants of pay for 
performance programmes:  
• Selecting high-impact performance measures  
• Making payment reward all high-quality care  
• Prioritizing quality improvement for under-served populations 
• Appropriate financial rewards 
• Choosing when to incentivise individuals or institutions 
9
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Financial incentives have been shown to modestly increase improvements in 
quality among hospitals already engaged in public reporting 
10
. 
1.1.2 Defining quality of care 
The Institute of Medicine (IOM) in the US defines quality of care as: 
“..the degree to which health services for individuals and populations increase the 
likelihood of desired health outcomes and are consistent with current professional 
knowledge”  11 
The American Medical Association defines high quality care as: 
“[that] which consistently contributes to the improvement or maintenance of 
quality and/or duration of life” 12.   
Or the definition can incorporate a patient-orientated emphasis such as that of 
BUPA Hospitals UK 
13
: 
“…ability to provide the service you want and need - resulting in medical 
treatment you can rely on and personal care you'll appreciate” 
It is clear from these definitions that the term ‘quality care’ may imply different 
things to both clinicians and patients. From the clinician point of view, high 
quality care means up-to-date, evidence based patient care that results in improved 
clinical outcomes. Although this is also important to the patient, they may be 
more concerned with aspects of care such as availability, flexibility, reliability and 
personal touches such as politeness and empathy of medical staff.  
The term ‘quality of care’ can therefore be broadly defined to represent an overall 
impression of delivery of healthcare, but equally requires some very specific and 
agreed measures of the treatment process or outcomes achieved. This makes it a 
complex entity to encompass, requiring an ordered approach.  
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1.1.3 Assessing quality of care and previous attempts at quality appraisal  
Although current definitions of quality of care are applicable, they are deliberately 
vague and therefore of limited use in defining the assessment of quality of care. 
Although it can be obvious when high quality care is being provided, providing 
objective proof of this can be more challenging. The inherent flexibility of 
healthcare provision must also be considered; with innovation in medical 
technology and treatments, optimum care standards and therefore the markers of 
quality of care evolve. It is therefore easy to see why standardising the assessment 
of quality of care even at a procedural level can be problematic. 
Quality of care assessment should include every aspect of a patient’s journey 
through their healthcare system. This would encompass community care, 
screening where applicable, referral to a specialist, and processes of investigation, 
diagnosis and treatment. Also needed are details of post-operative management, 
and follow-up both in the hospital and in the community. In other words, the 
assessment of quality should be multi-factorial. It is clear that there are countless 
variables which could be measured. How then to either measure all of them or 
identify the most pertinent ones? 
The principles of using a conceptual framework for organising measures of 
healthcare quality have been previously recognised. In 1966 Donabedian divided 
quality of care into three tangible parts; structure, process and outcome 14 ( Figure 
1.1). Structure is concerned with the actual infrastructure of the healthcare system. 
This includes aspects such as the availability of equipment, availability and 
qualifications of staff, and administration. Process looks at the actual details of 
care including aspects from diagnostic tests, through to interventions such as 
surgery and continuity of care. Outcome looks at the end result of medical care, 
traditionally in the form of survival, and restoration of function. 
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Figure 1.1 As defined by Donabedian, quality of care can be perceived as an interaction of 
three key elements 
 
Figure 1.2 Multi-dimensional ‘quality’ measures need to include both clinical pathway and 
patient-reported measures. 
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A fourth element can be proposed for this conceptual model; healthcare 
economics or its dependent measure productivity. In modern medicine, the 
availability of financial resources and any resulting financial constraints can 
impact upon the accessibility and delivery of healthcare services and potentially 
therefore the provision of high quality care. This is particularly true of publicly 
funded systems, such as the NHS. The ability of a healthcare provider to deliver a 
quality of care operating within financial or resource restrictions is an important 
factor that must be considered. The notion of cost being associated with quality of 
care is not novel however; Donabedian described several attributes of healthcare 
which define its quality, the ‘seven pillars of quality’. One of these, ‘efficiency’, 
related to the “ability to obtain the greatest health improvement at the lowest cost” 
15. Although Donabedian introduces the concept of cost within his quality 
attributes, the organisation of a contemporary healthcare service is so influenced 
by business planning that it directly shapes it. For this reason a strong argument 
can be made for healthcare economics to be included in a conceptual model of 
quality of care. It could also be argued that healthcare economics forms part of 
structure and therefore does not require special attention. 
Over the years Donabedian built up a framework for defining quality, starting 
with his structure-process-outcome paradigm, then the seven pillars of quality and 
finally the 11 buttresses of quality assurance ( Table 1.1) which are essential for 
the design, operation and effectiveness of care 16. Quality assurance itself can be 
seen as a combination of system design which results in rough adjustments in 
performance and quality monitoring, which is responsible for fine tuning of 
performance. 
More recently the IOM 
17
 and the Institute for Healthcare Improvement (IHI) 
18
 
have also set specific aims for quality measurement ( Table 1.2). A review of the 
NHS has also recognised the need for a greater focus on appraising quality in 
healthcare 5. The need for a strong evidence base to support quality improvement 
initiatives is implicit 19 20 and conceptual frameworks have been proposed to 
facilitate the translation of published evidence into policy and managerial 
decisions for improving quality 21. 
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The equality of healthcare provision is a vital part of high quality care. It has been 
suggested that quality assessment tools have failed to address adequately 
healthcare inequality across socio-economic groups 22 and few have looked at the 
impact of healthcare access (a component of healthcare delivery) on health 
inequality 
23
.  
1.1.4 Benchmarking quality of care 
1.1.4.1 Recent initiatives 
The need for maintenance of high standards and the improvement of quality of 
care is well recognised. There are a number of existing programmes dedicated to 
the improvement of quality of care. The majority of these base their work on 
performance benchmarking. 
Performance benchmarking is a tool that allows organisations to evaluate their 
practice as compared to accepted best practice. If any deficiencies exist, 
adjustments can be made with the aim of improving the overall performance. This 
process must be continuous as healthcare is a continually evolving entity. 
Currently, healthcare institutions are either benchmarked against national targets 
or each other as a means of comparison. This approach identifies ‘good’ and ‘bad’ 
outliers and a cohort of ‘average’ performers. It also serves to identify inequalities 
that exist, which can then be addressed. This method of benchmarking does help 
to maintain a nationwide drive to continuously improve services, although there 
are critics of any system that arbitrarily ‘ranks’ performance without due 
consideration for underlying causative factors. 
The Healthcare Commission was an independent body that promoted 
improvements in quality of care in both the NHS and independent health sectors 
in England and Wales. Its role was to assess and report upon the performance of 
healthcare organisations to ensure high standards of care. It evaluated 
performance against targets set by the Department of Health. The Healthcare 
Commission also looked at clinical and financial efficiency, giving annual 
performance ratings for each NHS Trust. The areas assessed were generalised, and 
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included categories such as patient safety, clinical and cost effectiveness, 
governance, and waiting times. In April 2008 the Care Quality Commission 
became the independent regulator of health and adult social care services in 
England and took on the responsibilities of the Healthcare Commission.  
The UK QIP (UK Quality Indicator Project) 
24
 is part of an international 
programme (IQIP: International Quality Indicator Project) that was started in the 
USA in 1985. UK QIP is a voluntary exercise based upon the anonymous 
feedback of comparative data to encourage internal improvement within 
healthcare organisations. There is no system for publication of results or external 
judgement of data. By using performance indicators, the aim of the project is not 
to directly measure quality but to identify areas that require further attention and 
investigation. Examples of surgical performance indicators include rates of 
hospital-acquired infections, surgical site infections, in-patient mortality and 
readmission rates. 
A similar project exists in the US alone called the NSQIP: National Surgical 
Quality Improvement Programme 
25
.  This nationwide programme was started by 
the department of Veterans Affairs (VA) to monitor and improve the standards of 
surgical care across all VA hospitals, and has been slowly introduced into the 
private sector since 1999 ( Figure 1.3). 
International benchmarking of healthcare systems has the opportunity to globally 
improve the quality of healthcare. Sharing of best practice can be beneficial in a 
supportive network of participating organisations. Such projects include the 
World Health Organisation’s Performance Assessment Tool for Quality 
Improvement in Hospitals (PATH) project 26 and the Organization for Economic 
Cooperation and Development (OECD) healthcare quality indicators project 
27
. 
None has been designed specifically for surgery, but some do include surgical 
performance indicators, such as surgical wound infection and surgical 
prophylaxis, perioperative mortality and unplanned returns to the operating theatre 
24. An international review of projects on hospital performance assessment 
concluded that there was “common methodology for the design and selection of 
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indicators; however, major differences exist with regard to the philosophy, scope 
and coverage of the projects” 
29
. 
Performance benchmarking is a useful exercise for ensuring that the minimum 
standard of care that can be expected is attained, but is far too vague and 
imprecise to inform us if we are delivering high quality care. This is the same 
problem that any generalisable quality assessment tool will experience, as it also 
will be unable to appreciate the intricacies of disease-specific high quality 
healthcare. 
1.1.4.2 Pay for Performance Strategies 
Pay-for-performance (P4P) programmes use financial reimbursements for clinical 
providers as a ‘reward’ for a positive change in performance measures. It is 
thought that this will help drive further improvements in quality of care. These 
programmes have gained popularity in recent years with new initiatives in the 
USA 10 30, UK 7, Australia 31, and Canada 32, being based in both hospital and 
primary care. P4P programmes typically focus upon process measures as these 
can detect suboptimal care in a timely manner, whilst being directly under control 
of the clinician.   
There are a multitude of variations of P4P programmes, with incentives being paid 
either to individual clinicians, clinician groups, clinics, hospitals, or multi-hospital 
collaborations. Similarly, the amount of incentive required per measure can vary 
from $2 to $10,000, with incentives received either for reaching absolute 
thresholds of care, relative thresholds (such as a 30% increase in performance) or 
even a pay-per-case arrangement.   
Although studies have shown that P4P programmes can have positive effects on 
quality measures, these gains may be only modest 10 33. Cost-effectiveness is also 
unclear with some studies showing massive savings 
34
, and others showing gross 
overspending 35.  
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Perhaps the most worrying aspect of P4P programmes is the unintended adverse 
consequences that can result. Examples of these include ‘gaming’ strategies where 
clinicians avoid sick or challenging patients, or reclassify patient conditions, or 
even claim their incentive when care has not been provided. Similarly patients 
may receive substantial ‘over-treatment’ of their medical conditions. In fact, the 
NHS P4P programme in the UK found that the strongest predictor of 
improvement in achievement was the exclusion of patients from the programme 7. 
On the other hand, clinicians and hospitals serving the more disadvantaged 
populations may see their income fall as targets and thresholds are difficult to 
reach.  
Although P4P programmes have been shown to improve performance in key 
clinical areas they can potentially have multiple problems if not subject to careful 
design and regular evaluation. In order to be successful these programmes must be 
implemented with the involvement of clinicians from the very start to prevent 
unintended harm coming to the patient.  
1.1.5 The need for a contemporary quality framework in surgery 
Despite all of the universally accepted benefits to measuring quality of care in 
surgery there is currently no universally accepted and/or validated measurement 
system. An example of how an evidence-based quality framework can be used to 
improve healthcare has been seen with improvements in stroke services in the 
NHS. The Department of Health in England recognised the need to improve 
stroke services by implementing the National Service Framework (NSF) for older 
people in 2001. This in particular concentrated upon the structure of stroke 
services as well as the process of care for patients suffering stroke. The Biannual 
Sentinel Stroke Audit for 2008 has recently been published 36, and demonstrates a 
continued significant improvement in stroke services. In terms of healthcare 
structure, 96% of hospitals in the UK now offer specialist stroke services, with an 
increasing number of specialist stroke unit beds. 98% of hospitals employ a 
physician with a specialist interest in stroke. There have also been improvements 
in process of care measures including the uptake of thrombolysis services and 
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secondary prevention measures. A similar initiative has been beneficial for 
coronary heart disease 
37
 and more recently broadly applied to cancer 
38
.  
Quality assessment inevitably includes the measurement of output or outcomes of 
care. Much of the disagreement with current quality measurement programmes 
comes from the potential inaccuracy of the benchmarking data or the limited 
ability of the ‘outcome’ measure to truly reflect the quality of a healthcare 
encounter. Traditionally mortality and morbidity have been used as outcome 
measures and therefore as proxy measures of overall quality of care. Their use has 
come about in part by the ease with which they can be measured and because they 
document a definitive end point to interventional treatment. Mortality, however, 
has a limited ability to discern differences in performance for operations where 
the mortality rate is low, such as appendicectomy or mastectomy. Even for 
operations where it is a more appropriate proxy measure for outcome, e.g. 
coronary artery bypass surgery, changes in the mortality rates over time mean that 
the ‘strength’ of mortality as an outcome measure will change accordingly and 
likewise the weight attributed to other measures of quality will change 
39
. A 
quality framework will therefore need to attribute a ‘weight’ to a number of 
different quality measures and this will need to be adaptable over time. 
A quality framework would therefore need to move away from the traditional 
approach of using predominantly outcome measures as a proxy of the overall 
episode of care and incorporate a number of ‘quality’ measures that are truly 
reflective of several dimensions of care within the entire treatment episode. These 
can be broadly defined as clinical pathway measures, using Donabedian’s 
structure-process-outcome classification 14 and adding the fourth element 
healthcare economics, and patient-reported measures as outlined in  Figure 1.2. 
1.1.6 Measuring quality of care 
1.1.6.1 Structural variables 
The structure of surgical care can be thought of as the “bare bricks” or 
infrastructure of care. It is involved with details such as equipment, number of 
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beds, nurse-to-patient ratios, qualifications of medical staff, and administrative 
structure. It is thought that if surgery occurs in a high quality setting, then surely 
high quality care should follow. An advantage of measuring structural variables is 
that the information required is usually fairly reliable and used frequently at a 
hospital managerial board level. It is however infrequently used in a more clinical 
and or public domain to help inform the environment in which surgical care is 
delivered. Logically we need to be certain what correlation exists between these 
structural variables and quality of care, and this is not well established. Brook et 
al. have assessed the relationship between patient, physician, and hospital 
characteristics and the appropriateness of intervention for carotid endarterectomy, 
coronary angiography, upper gastrointestinal endoscopy.40 They concluded that 
the appropriateness of care could not be reliably predicted from standard, easily 
obtainable data about the patient, the physician, or hospital structural variables. 
However, coronary angiography and carotid endarterectomy was significantly 
more likely to be carried out for medically appropriate reasons if performed in a 
teaching hospital. Hospital teaching status and other associated hospital variables 
such as size or for-profit status did not however translate into lower postoperative 
complication or death rates following carotid endarterectomy.41  
A structural variable that has received more attention than most is the institutional 
or surgeon volume: the volume-outcome relationship. In this scenario, the volume 
of patients treated is used as a proxy for the quality of care and then the 
correlation to important clinical outcome measures determined. On the basis of a 
large number of studies that show better outcomes for patients treated at high-
volume institutions and or by high-volume surgeons, we are seeing a trend of 
preferential patient referral to high-volume institutions. Promoters of this 
centralisation of services in the US argue that it is important to help advance the 
quality of healthcare, e.g. the Leapfrog group 42. Similarly in the UK, 
centralisation of oncological services is identified in the Department of Health’s 
Improving Outcomes Guidance framework 43. Institutional and surgeon volume 
either independently or in combination are nevertheless rather broad proxy 
measures for quality of care. Indeed some low-volume providers have excellent 
outcomes and some high-volume providers’ poor outcomes. As a result, research 
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in this area has started to improve its understanding of the core factors that 
determine whether or not the institution or surgeon produces better outcomes. 
 Figure 1.4 illustrates potential structural variables for which volume acts as proxy 
measure and may therefore better inform us of quality of care. 
In order to determine which structural variables potentially have the most 
influence on the quality of care, we first need to determine if correlation exists 
between them and some dependent end-point; research to date has used clinical 
outcome measures. Elixhauser et al 44  demonstrated the importance of the ratio of 
doctors and nurses per bed number, irrespective of the institutional volume, on the 
mortality rates for paediatric heart surgery. A systematic review published by 
Pronovost et al 45 also showed that high-intensity intensive care unit (ICU) 
physician staffing was associated with reduced hospital and ICU length of stay 
and mortality. Treggiari et al 46 demonstrated in a multicentre study that ICUs that 
were run by, or associated with, a specialised intensivist had significantly lower 
mortality rates in patients with acute lung injury (odds ratio = 0.68, 95% CI 0.52-
0.89). This association was independent of severity of illness, and consultation by 
a respiratory physician. 
As we better understand the core structural variables that correlate with markers 
of outcome, it will enable us to assess the degree to which they also influence 
overall quality of care. It is not unrealistic to imagine that integration of the 
structural variables, demonstrated to improve quality of care, into institutions 
irrespective of their caseload volume could further our aim of achieving equality 
of outcomes for all patients. 
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Figure 1.4 Examples of potential structural variables which could influence quality of care 
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1.1.6.2 Process measures 
In surgery, process of care can be thought of as the pre-operative, intra-operative, 
and post-operative management of a patient.  It looks at what is actually done for, 
and to, the patient.  For example, it can look at the availability of screening 
programmes, the appropriate use of diagnostic tests, waiting times to operation, 
discharge processes, post-operative follow-up and availability of and willingness 
to give adjuvant treatments.  However the measured processes are only useful if 
there is evidence to prove that they translate into improved patient care. There is 
little point, for instance, in ensuring that all patients prior to laparoscopic 
cholecystectomy have an MRI, when no clinical benefit will be gained. Malin et 
al. 47 assessed the quality of care for breast and colorectal cancer in the US. They 
reviewed existing quality indicators, guidelines, review articles, and peer 
reviewed clinical trials to produce a list of explicit quality measures evaluating the 
management of newly diagnosed breast and colorectal cancer patients. These were 
then checked for validity by a panel of experts, and included areas such as 
diagnostic evaluation, surgery, adjuvant therapy, management of treatment 
toxicity, and post treatment surveillance. Data was extracted from the patients’ 
notes and via patient questionnaires. Overall adherence to 36 and 25 quality 
measures specific to the process of care was 86% (95% CI 86-86%) for breast 
cancer, and 78% (95% CI 77-79%) for colorectal cancer patients respectively. The 
unique element in this approach was that the group was not trying to correlate 
process with outcomes, but simply looking at process measures that were agreed, 
in this instance by evidence base and expert review, to reflect quality of care.  
There are a number of potential benefits to the measurement of process as 
opposed to outcomes in assessing the quality of care. Lilford et al. 48 describe 
these in detail, but in brief; process measures are less susceptible to, although not 
exempt from, case-mix bias; their assessment and subsequent improvement will 
positively reflect on the entire evaluated institutional patient population as 
opposed to a few outliers with poor outcomes; deficiencies in processes of care 
are less likely to be seen as a label of poor performance, but instead indicate when 
and how improvement can be made; and process measures are reflective of the 
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current state of care, as opposed to the time-delay which is experienced with some 
outcome measures. 
Process measurement is not easy.  It is difficult to standardise measurements for 
process of care in surgery, as this process varies depending upon the surgical 
pathology. Creating a standard quality measure for all surgery may be impossible.  
It is more feasible to create measures of process of care for specific pathologies.  
Examples of where best practice has been defined include diseases with published 
national guidelines such as those produced by the National Institute for Health and 
Clinical Excellence (NICE) for cancer of the breast and lung. In the absence of 
agreed national guidelines, ongoing clinically based research will help us to define 
evidence-based processes that improve quality of care.  
The appropriate use of surgical services is an important process measure in that it 
not only acts as a very good measure of the quality of care that a patient receives, 
but also has repercussion on the use of healthcare resources and the economics of 
healthcare. For a surgical intervention to be appropriate, it must ‘have a health 
benefit that exceeds its health risk by a sufficiently large margin to make the 
intervention worth doing’. The RAND Corporation has published extensively on 
the topics of overuse and underuse of healthcare services.  One of their largest 
studies examined the appropriateness of coronary angiographies, carotid 
endarterectomy, and upper gastrointestinal endoscopy across multiple regions of 
the US 49.  It found that 17%, 32%, and 17% of these procedures respectively 
were performed for inappropriate clinical reasons (i.e. overuse).  Extrapolation 
from the literature may indicate that one quarter of hospital days, one quarter of 
surgical procedures, and two fifths of medications are inappropriately overused 50. 
Measuring the process of care can however be incredibly labour and time 
intensive and will require significant clinical knowledge. There will be a 
multitude of measurement which can either be obtained prospectively, or gleaned 
retrospectively, from patient notes. The introduction of electronic coding of 
patient records may make this an easier task in the future. A recent Cochrane 
review did find that process measurements in the form of audit are effective in 
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improving clinical practice 51. However the costs of measuring process will 
ultimately have to be weighed against the patient benefit that is gained from any 
actions taken as a result of those measurements.   
In summary there is no doubt that for the majority of surgical conditions, 
measuring the process of care will provide us with contemporary indicators of 
quality of care which will be directly influenced by the functionality of a 
healthcare provider. 
1.1.6.3 Outcome measures 
Traditionally, quality of care has been judged on outcome measures using 
endpoints such as mortality and morbidity. They are used because they are easy to 
measure and recorded with regularity. For an outcome measure to be a valid test 
of quality it must be linked to and correlate with known processes that when 
changed will accordingly alter that outcome measure. For example, knowing the 
number of patients who present with metastases within six months of diagnosis 
with inoperable liver cancer is an important prognostic outcome. However, it is 
not a compelling measure of quality, as our ability to influence it is limited.  
There are many advantages to using outcomes as a measure of quality of care. 
Outcomes are well established as an important feature of quality. They can be 
viewed as the overall effect of care on a patient. Few would doubt the validity of 
outcomes such as mortality in judging surgical care. Statistics such as mortality 
rates are understandable at face value, including to the lay person. Consequently 
there is a natural tendency to rank hospitals according to outcome measures such 
as mortality rates, with an implied association with quality of care. Examples of 
organisations that produce rankings according to outcome measures such as 
mortality rates include the Leapfrog group 30 and the US News “America’s Best 
Hospitals” in the US 
52
, as well as Dr Foster Intelligence which produces the 
“Good Hospital Guide” 53, and the Healthcare Commission, now the care Quality 
Commission, in the UK 54. 
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The use, however, of outcome measures as the sole indicator of quality of care can 
be gravely misleading and inappropriate as outcomes are the ‘end result’ of an 
entire patient pathway and thus reliant on numerous other variables. The outcome 
measure itself may not therefore directly correlate with the quality of care. For 
example, if a patient, who has undergone an operation to remove a colorectal 
cancer, dies one year after surgery, can we say that he has had poor quality of 
care?  He or she may have received all the best treatments available as guided by 
the latest evidence based medicine and despite all of this, died. Should their death 
be assumed to indicate a poor quality of care from the surgical team and allied 
healthcare professionals? Sometimes the best quality of care in surgery may still 
result in mortality through circumstances beyond our control. Equally though, the 
patient may have received the best quality of care throughout their hospital 
admission, but poor follow-up surveillance and delays in adjuvant treatments may 
have impacted on the final outcome. Other factors such as the natural history of 
the disease, the patient’s age and co-morbidities often have much larger influences 
on outcome than surgical care. The method of risk adjustment attempts to 
compensate for the difference in case-mix between surgical centres. However, the 
effect of case-mix can never be completely eradicated. Firstly, risk adjustment can 
not allow for variables that are unmeasured, or not known.  Neither can it adjust 
for the effects of varying definitions (such as the definitions of a surgical site 
infection) between centres. Risk adjustment can cause increased bias if the risk of 
that measured factor is not uniform across the compared populations. 
This is why, even after adjusting mortality rates for risk, the relationship between 
quality of care and outcomes such as mortality is inconsistent. Pitches et al. 
looked at the relationship between risk-adjusted hospital mortality rates and 
quality or processes of care 55.  They found that a positive correlation between 
better quality of care and risk-adjusted mortality was found in under half of the 
papers examined, whilst the others showed either no correlation or a paradoxical 
correlation. Similarly, Hofer 56 found that the sensitivity for detecting poor quality 
hospitals based upon their risk-adjusted mortality rates was low at only 35%, 
whilst the positive predictive value was only 52%.  This work has been 
corroborated with similar models by Zalkind 57 and Thomas 58.  
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Traditional outcome measures fail to appreciate important patient-specific 
measures such as quality of life. Recently, NICE has taken the quality adjusted 
life year into account against a negative financial outlay when deciding to 
recommend the use of novel oncological medications such as herceptin 59. There 
has also been increasing interest in measuring national Patient Reported Outcome 
Measures (PROMS), as a way of measuring healthcare performance 60. Successful 
pilot studies for PROMS data collection were completed in the UK and this has 
led onto a more formal national programme for PROMS within surgery 61.  
Outcomes remain an important method of quality assessment despite their 
significant limitations around risk adjustment. The use of outcome measures in 
isolation is clearly inappropriate and in order to improve the use of outcomes as a 
measure of quality, a multidimensional approach including traditional measures 
such as mortality and morbidity, but also including more patient reported 
outcomes such as quality of life, pain scores and so forth, should be encouraged. 
This will help us to include more patient-centred measures into a currently 
clinically dominated quality of care assessment.  
1.1.6.4 Healthcare Economics 
High quality care needs to meet the “productivity challenge” of modern healthcare 
5. A limitation on available resources or financial constraint can be an inhibitor to 
producing the highest quality of care. With new technologies usually having 
initial premium costs, and increasing levels of demand from a more educated and 
aging population, healthcare costs will continue to increase in the future. In the 
US healthcare expenditure is determined by private insurance companies whilst in 
the UK, policy has given control to regional strategic health authorities. This 
‘local’ budget control can, and has, led to geographical healthcare inequality. In 
the UK, this has been termed the ‘postcode lottery’: the treatments that you are 
eligible to receive can be dependent upon the area in which you live in accordance 
with the financial priorities of that area. Indeed the Department of Health has 
taken this one step further and begun to look at expenditure in a number of 
different areas of healthcare and correlated this to outcome data 62 ( Figure 1.5). 
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In economic terms, productivity is defined as the amount of output created per 
unit of input. Until recently, NHS productivity was determined using cost (input) 
and volume measures (output). Volumes of treatment measures such as GP 
appointments, ambulance journeys, and operations, taken from the National 
Accounts 
63
, were taken as clear indicators of how much work the NHS does. This 
is obviously an oversimplified approach, which ignores important aspects such as 
quality of care. Due to increasing costs, productivity has therefore been seen to 
fall in recent years between 0.6 and 1.3% per annum 63. However, if NHS output 
is adjusted to account for increased quality of care as well as the increasing value 
of health, NHS productivity actually demonstrates an increase in productivity 
from 0.9 to 1.6% per annum 63 64. Thus we can see how understanding quality of 
care can have economic benefits as well as increasing public satisfaction.  
Although new surgical technologies are usually associated with a higher cost, this 
cost can at times be counterbalanced by subsequent benefits. A good example of 
this is the advent of laparoscopic surgery. Given the higher price of laparoscopic 
equipment compared to standard equipment, along with the surgical learning 
curve and at times increased duration of procedures, you would be forgiven for 
thinking that laparoscopic procedures were invariably associated with a higher 
cost of treatment. However, as shown by Hayes et al. 
65
 although the initial cost of 
procedures such as laparoscopic colectomy can be higher, there are overall 
improvements in cost effectiveness due to savings in reduced recovery days and 
quality-adjusted life years. Similarly, introducing a dedicated clinical pathway for 
procedures such as laparoscopic cholecystectomy can provide further cost 
advantages 66. The decision-making of the individual surgeon is central to 
healthcare costs. Using Kissick’s decision-making model, Fisher et al have 
demonstrated that using faecal occult blood testing as a primary screening tool for 
colorectal cancer can give similar sensitivity to that of colonoscopy, whilst 
significantly improving access with huge cost savings 67.  
These examples show that improving the quality of care that a patient receives, by 
simply improving the efficiency of healthcare delivery or using evidence-based 
practice, can result in additional economic benefits. Providing high quality care 
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does not necessarily have to cost more and may also facilitate the alignment of 
financial and clinical incentives. 
1.1.6.5 Patient-reported treatment outcomes 
Patient-reported measures can be classified into patient-reported treatment 
outcomes, health-related quality of life and patient satisfaction. They are not 
mutually exclusive, but each provides us with a different dimension to quality 
assessment.  
Patient-reported treatment outcomes (PRTO) greatly enhance quality of care 
assessment by reflecting the patient’s viewpoints on treatment outcomes and 
typically provide information on symptoms and/or functional status. In an ideal 
system, PRTO should be integral to clinicians’ decision-making processes and the 
assessment and appropriateness of the care provided. PRTO are especially 
important within oncology where several different treatment options may exist, 
and where survival gains can be small with significant treatment side-effects 68. 
Numerous questionnaires, across various diseases and treatments, have been 
designed and clinically validated to record PRTO. The Patient Reported Outcomes 
& Quality of Life Instruments Database (PROQOLID) provides a comprehensive 
list of PRTO and quality of life measures 69. Similar resources will stimulate 
future benchmarking of PRTO and can be used as an international platform to 
develop metrics for assessing the quality of patient pathways. Several criteria can 
aid the selection of the most suitable PRTO measurement tool,  Table 1.3. 
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Table 1.3 As suggested by the Patient-Reported Outcomes Measurements Group at the 
University of Oxford, consideration needs to be given to eight necessary criteria to 
select the most suitable patient-reported outcome measures instrument(s). Adapted 
from online information available at http://phi.uhce.ox.ac.uk/inst_selcrit.php. 
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1.1.6.6 Health related Quality of Life 
Health-related quality of life (HRQOL) measures must include an evaluative 
component that assesses impact on general well-being; this can include impact of 
PRTO. HRQOL measures can either be unidimensional or reflect multiple 
domains of impact on well-being (multidimensional) and typically include 
physical, psychological and social components 
70
. HRQOL measures can be 
generic, disease-specific or treatment-specific. HRQOL assessment tools were 
developed over 20 years ago and initially focused on patients with cancer. The 
latest version of the Functional Assessment of Cancer Therapy-General (FACT-
G) has 27 general questions divided into four primary HRQOL domains: physical 
well-being, social/family well-being, emotional well-being, and functional well-
being 
71
. Other cancer-specific assessment tools include questions that relate 
directly to surgical intervention, such as social embarrassment of stomas (FACT-
C). Generic, non-disease specific, HRQOL measurement tools are available and 
include EQ-5D 72 and SF-36 73.  
The importance attributed to HRQOL measures has been highlighted by NICE by 
taking the quality adjusted life year into account against a negative financial 
outlay when deciding to recommend the use of novel oncological medications 
such as herceptin 59. As highlighted by Osoba 74 however, the “science of HRQOL 
assessment has not yet been adequately tested in clinical practice”. This is now 
feasible and, following a successful feasibility pilot in the UK, all English 
hospitals were required to collect HRQOL data for four surgical procedures, 
starting in 2009 
61
. 
1.1.6.7 Patient Satisfaction  
Similar to PRTO, the measurement of patient satisfaction is crucial in quality of 
care assessment as the patient’s viewpoints on treatment may be completely 
different from the viewpoints of a healthcare professional. Patient satisfaction can 
be divided into two areas; satisfaction determinants - patient variables that can 
affect overall satisfaction (patient expectations, patient characteristics and 
psychosocial determinants) - and satisfaction components which refer to a 
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measure of the patient’s perceptions of care actually received (e.g. interpersonal 
manner, accessibility and convenience, continuity of care and physical 
environment of care) 75. Satisfaction determinants naturally influence satisfaction 
components and for this reason, measurement of satisfaction needs to incorporate 
both.  
The measurement of patient satisfaction is far from simple. When designing 
satisfaction surveys, four parameters need to be considered that will influence the 
results; choice of population, timing, type of questionnaire, and the rating of 
satisfaction 76. 
1.1.7 Future direction 
The greatest advances in the area of quality assessment will be in the realm of 
measurement of process and overall performance. Inclusion of structural variables 
will also need to be considered. This should not be confused with set performance 
targets, or blindly following clinical guidelines. These newly developed 
assessment scores should allow us to implement changes that will not only 
improve that score, but more importantly improve the quality of care delivered to 
our patients. For example a performance measure that tells us a certain proportion 
of the population underwent a particular desired process is not enough. It does not 
give us any indication on how to improve quality. It is important to know why 
certain members of the population failed to achieve this goal. Was it through 
contra-indications to that process, lack of communication, lack of compliance or 
something else? This information can give further understanding of what changes 
are needed to improve the service that is provided. In short, knowing that 
improvement is needed is important, but more helpful is the knowledge of how to 
improve. 
Engagement in this process by institutions and clinicians is crucial. They have 
been reluctant to date as the public reporting of performance data has had a 
‘name-and-shame’ style by inappropriately ranking them against each other 
without duly considering institutional variations that cannot be adjusted for, but 
which result in explicable varying performance. Better methods of visually 
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presenting performance data that avoid arbitrarily ranking healthcare providers, 
that are interpretable at face value to the lay person, and which still continue to 
identify Trusts which need special attention, will help to engage all stakeholders 
in future performance benchmarking. 
1.1.8 Public health implications 
The assessment of quality of care is a public health issue which is becoming a 
dominant theme in structuring modern healthcare. The rigorous and accurate 
measurement of quality is an essential component for the improvement of public 
health services, and answering public accountability. The methods by which 
quality is assessed has the potential to dictate healthcare policy well into the 
future, and as practicing surgeons, we must all be well educated on this topic.  
Some examples of the current assessment of quality of care can be gathered from 
the internet sources listed in  Table 1.4. 
The field of cardiothoracic surgery has long been aware of the push towards 
quality improvement and public accountability. In the 1980’s, the Society of 
Thoracic Surgeons (STS) initiated one of the largest data collection operations in 
medicine, resulting in the STS National Adult Cardiac Surgery Database. It is now 
the largest and most comprehensive single specialty database in the world. It 
allows not only surgeons and Trusts to compare their results, but is also freely 
publicly available and patients can identify their own surgeon’s outcomes. With 
increasing emphasis placed upon quality and performance measurement, the STS 
set up the Quality Measurement Task Force (QMTF) to create a comprehensive 
quality measurement program for cardiothoracic surgery. The results of this 
program have been published 77 78 and represent the most up to date and rigorous 
methods by which quality assessment can be performed. 
Undoubtedly, with further investigation and reporting of the factors driving 
quality of care, inequality of healthcare provision will be uncovered.  No one 
doubts that all patients should have equity of quality of care and it can result in 
more lives saved. The Leapfrog group in the US now recommends that there is a 
certified critical care specialist available for their ICUs, and estimated that this 
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restructuring could save more than 54,000 lives in the US per year 79. But can the 
current healthcare infrastructure manage geographical fluxes in demand that may 
result from patients mobilising their freedom of choice and seeking out ‘better 
care’? Often institutions that are currently able to provide higher quality 
healthcare can do so only under the constraints of their current patient population 
demand. Any reasonable increase in this demand can have a negative impact and 
subsequently lead to a worsening of the quality of their healthcare provision. 
1.1.9 How to design healthcare quality reforms 
Objectives to improve quality of care are well recognised, but the implementation 
of systems in order that these objectives are met, is far from straight forward. 
Translating research evidence into the everyday structure and processes of a 
healthcare system is feasible, but made difficult by the variation that exists across 
healthcare systems and between healthcare providers. Leatherman et al. 80 
describe a conceptual framework to facilitate the designing of health system 
reforms that consists of three aspects: 
• A taxonomy to organize the available evidence of potential quality 
enhancing interventions (known as the QEI project) 
• A multi-tiered approach to select and implement interventions in a health-
care system at four levels: national, regional, institutional and the patient–
clinician encounter 
• A model to guide the adoption of a balanced portfolio approach to quality 
improvement—recognizing the prudence of simultaneously employing 
professional, governmental and market levers for change. 
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Organisation URL: 
The Leapfrog Group http://www.leapfroggroup.org/ 
The National Surgical Quality 
Improvement Program (NSQIP) 
https://acsnsqip.org/login/default.as
px 
The International Quality Indicator 
Project (IQIP) 
http://www.internationalqip.com/ 
The Healthcare Commission 
http://2007ratings.healthcarecommi
ssion.org.uk/homepage.cfm 
The Institute for Healthcare 
Improvement (IHI) 
http://www.ihi.org/ihi 
Agency for Healthcare Research 
and Quality (AHRQ) 
http://www.ahrq.gov/qual/measurix.
htm 
The National Committee for Quality 
Assurance (NCQA) 
http://web.ncqa.org/ 
The Institute of Medicine (IOM) 
Health Care Quality Initiative 
http://www.iom.edu/CMS/8089.aspx 
The National Association for 
Healthcare Quality (NAHQ) 
http://www.nahq.org/ 
Quest for Quality and Improved 
Performance (QQUIP) 
www.health.org.uk/qquip 
 
Table 1.4 Internet Resources for Quality of Healthcare 
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The QEI project encompasses several aspects of quality improvement, such as 
effectiveness, equity, patient responsiveness and safety. It itself forms part of a 
wider initiative called the Quest for Quality and Improved Performance (QQUIP); 
a 5-year international collaborative research project between the University of 
North Carolina, School of Public Health, London School of Economics, 
University of York and University of Cambridge. The limitations of using 
evidence-base to bring about health reform are recognised, such as publication 
bias and difficulties in translating evidence from one healthcare system into 
another, but early results of the QEI project are generating some good examples of 
focused quality interventions. 
The integration of evidence-based interventions needs to occur across all levels of 
a healthcare system in order that predictable systemic improvement in quality 
arises. This “multi-tiered approach to building predictable systemic capacity for 
improvement” describes three key factors; ‘horizontal coherence’, the interaction 
of several different types of quality interventions; ‘vertical coherence’, the 
interaction of a quality improvement intervention across the multiple levels of the 
healthcare system; ‘coherence in accountability’, the balance between 
professionalism and professional accountability, centralised governmental control 
and market forces. Coherence in accountability forms the components for a 
“balanced portfolio approach to quality improvement” and recognises that 
individually professionalism, government or market factors cannot generate 
sustainable quality change. 
1.1.10 How to achieve healthcare quality improvement 
As highlighted by Glickman et al.81, there has been proportionally more attention 
directed towards the ‘process’ and ‘outcome’ components of Donabedian’s 
structure, process, outcome framework for quality. In today’s modern healthcare 
system, ‘structure’ consists of important organisational and managerial 
components that are the enablers for driving forward multidimensional quality 
improvement agendas. Glickman et al. describe these organisational 
characteristics from a management perspective; executive management, including 
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senior leadership and board responsibilities, culture, organisational design, 
incentive structures and information management and technology. 
The distinctive aspect to this work is the combination of business and medical 
viewpoints to provide a contemporary operational definition of structure that 
updates Donabedian’s ‘physical characteristics’ description. This framework 
engages managerial capabilities crucial to achieving healthcare quality 
improvement. 
1.1.11 Conclusions 
Assessing quality of care in surgery is an important and essential part of 
maintaining and improving patient care. The very act of measurement serves to 
determine current standards and provides a baseline against which improvement 
can be made locally and/or nationwide. Benchmarking between providers will 
assist in identifying inequalities at a provider or regional level. Further 
investigation of the causative factors will discover pockets of best practice and 
local innovation that can then be disseminated more widely. Although traditional 
assessments of quality have been heavily influenced by a number of clinical 
outcome measures, such as mortality and morbidity, we have shown that these are 
clearly inadequate in isolation and do not provide a reliable assessment of the 
quality of surgical service. 
As described by Donabedian some 40 years ago, quality of care can be explained 
by three key elements; structure, process and outcome. Treatment outcome 
measures will still form an important part of quality assessment as they are easily 
understandable to the clinician and patient alike, and outcomes such as 
postoperative mortality remain an important endpoint. We will see expansion of 
the use of patient reported outcomes such as quality of life, and current health 
status, in order to achieve a well rounded viewpoint on quality care.  
Measurement of structural and process of care variables must be used in 
combination with outcome measurements and have the significant advantage that 
they are less influenced by factors such as case-mix and patient co-morbidities. 
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This will help to overcome the methodological difficulties of producing suitable 
adjusted data. These structural variables and process measures are not, however, 
currently widely or routinely collected and it will require a labour-intensive 
undertaking, and undoubtedly require additional resources, in order for this to 
change. 
Healthcare economics is a further key element to assessing quality of care and has 
significant impact upon modern surgical care which is heavily influenced by 
continually evolving technological and biosurgical innovation. A lack of available 
finances will always act as an inhibitor to delivering the highest quality of care. 
The combination of surgical innovation, making more people eligible for 
treatment, with an aging and increasingly demanding public, means that financial 
constraints will remain a considerable factor for the foreseeable future.  
A quality of care assessment tool should be multi-factorial, taking into account the 
entire patient treatment episode. It should include up-to-date process 
measurements gleaned from evidence based medicine and national guidelines. It 
should consider patient-centred as well as disease-specific clinical outcome 
measures and incorporate structural variables indicating effective and efficient 
healthcare delivery. In this way we can be confident that we can obtain the most 
accurate and valid assessment of quality of care in surgery. 
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1.1.12 Key points for appraising the quality of care in surgery 
• The assessment of quality of care in surgery is an important and essential 
part of improving patient care. 
• Practising clinicians must be aware of the advances in quality of care 
assessment, as they have the potential to drive healthcare policy well into 
the future.  
• Three key determinants of quality of care have been defined; structure, 
process and outcome. 
• Traditional measures of quality have concentrated mostly on outcome 
measures such as morbidity and mortality figures. However outcome 
measures alone are inadequate to accurately assess quality of care. 
• Process of care measures are fast becoming a major method of assessment 
of quality care, as they can provide up-to-date assessments that are 
founded in evidence based surgery.  
• There are already established programmes using process of care measures 
to benchmark standards and reduce inequality in surgical care. These 
programmes are generic and give us only an indication of minimum 
standards. 
• In the future, quality of care assessments should be pathology-specific, 
taking into account the structures, processes and outcomes of the whole 
patient episode of care, and combining them with patient-centred measures 
such as quality of life and patient satisfaction. 
• The translation of available research evidence into everyday healthcare 
provision can be the limiting factor to ‘frontline’ quality improvements. It 
can be facilitated by conceptual frameworks for designing health system 
reforms and engaging contemporary managerial capabilities. 
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1.2 The role of volume-outcome relationship in surgery 
It has long been postulated that improved outcomes in healthcare can result from 
treating greater numbers of patients and is explained by “practice makes perfect” 
82. Over the last 10 years, we have seen an acceleration of more formal research in 
this area and particularly within the surgical specialities as a result of their 
interventional nature. Numerous studies have reported on a higher volume, better 
outcome association with the implication that the quality of care that patients 
receive can be greatly influenced by this relationship. Despite the considerable 
evidence, many uncertainties remain about the true relationship. Some low-
volume surgeons and or institutions have excellent outcomes and some high 
volume surgeons and or institutions have poor outcomes. An alternative 
explanation for the volume-outcome relationship may therefore be that healthcare 
providers, either at an institutional level or surgeon level, that display better 
outcomes receive more referrals and as a result treat greater volumes of patients. 
This is known as the selective-referral hypothesis 82. Volume, therefore, does not 
automatically result in better outcomes for patients and as such is an inexact 
indicator of quality of care. On its own, volume is acting as a surrogate marker for 
the other numerous and complexly interacting factors within a patient’s treatment 
episode that combine to determine their outcome, favourable or not ( Figure 1.6). 
We are seeing an increasing trend towards more detailed performance monitoring 
of surgeons and surgical healthcare providers. More so, this collated data is not 
solely for ‘internal’ consumption, but is being made publicly available to allow 
the better informed patient to exercise a degree of choice as to where they receive 
their treatment. A number of organisations, including the Healthcare Commission 
previously and now the Care Quality Commission 83 and Center for Medical 
Consumers 84, produce data at a surgeon and institutional level which report on 
number of operations performed and outcomes of those operations, although a 
direct link between the two is not advertised. 
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Figure 1.6 Conceptual framework of how patient outcome following healthcare intervention is 
determined by interaction of several dependent components (Redrawn from reference 85) 
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There are vast implications to the patient and healthcare providers alike of acting 
upon the published evidence in this area. When clinicians are appraising the 
volume-outcome relationship literature, in order to practise evidence-based 
surgery, three fundamental questions need to be answered 86,  Table 1.5.  
This section of the introduction will discuss the methodological basis for 
assessing the volume-outcome relationship in surgery and some of the limitations 
that surround it. It will explore the commonly used outcome measurements with 
their possible alternatives and consider the interaction between the surgeon’s 
volume and institutional volume and their effect on patient outcome. Finally, the 
health policy implications of incorporating volume-outcome relationship research 
into health service provision will be explored. 
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Table 1.5 Three fundamental questions that need to be answered when appraising the volume 
outcome literature. 
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1.2.2 Methodological framework for assessing volume-outcome relationship 
1.2.2.1 Data sources & Data quality 
The majority of research exploring the volume-outcome relationship in surgery 
has relied on large administrative databases for its source data, as extracting 
information direct from patient charts would be too time consuming and 
expensive. The inferences that we make from this research are therefore solely 
reliant on the accuracy of these databases and it comes back to the old adage; 
‘what you put in, is what you get out’. The nature of healthcare funding in the US 
by provider reimbursement through private health insurance companies means 
that the size and comprehensiveness of the associated databases makes them the 
most exploitable for volume-outcome research and as such the majority of 
publications in this field originate from the US. The administrative databases such 
as The Medicare Provider Analysis and Review Files and the Healthcare Cost and 
Utilization Project Nationwide Inpatient Sample can be linked to epidemiological 
databases such as Surveillance, Epidemiology, and End Results (SEER) to 
improve the sophistication of the data extraction, although this use of 
administrative data as opposed to clinical data inhibits the degree of risk 
adjustment that can be performed. Equally some administrative databases derived 
from managed care plan enrolees, although encompassing thousands of patients, 
may not be representative of the general population by virtue of only including 
patients older than 65.  
In England and Wales, Hospital Episodes Statistics (HES) is a database routinely 
populated within the health service for administrative purposes and not 
specifically for clinical audit. It has contained admitted patient care data since its 
inception from 1986 onwards. Its use as a data source in health service research 
has been limited by worries over the completeness and accuracy of the data input 
at a patient coding level. However, over time the quality of the HES database has 
improved and particularly so since the introduction of the ‘payment by results’ 
initiative in 2002 as a means to provide a transparent, rules-based system for 
paying healthcare providers, which is linked to activity and adjusted for case-mix. 
As a result, it is being used more frequently as a more reliable source database for 
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exploring the volume-outcome relationship in surgery in England. Indeed there is 
now evidence to suggest that HES has similar discrimination to clinical databases 
when used in risk prediction models for death 87. 
The availability of centrally collated administrative databases should not distract 
from the usefulness of data originating from a single centre or close network of 
centres, which tend towards relatively smaller caseloads. The ability in these 
settings to more closely quality control the data acquisition and subsequent risk 
adjustment and analysis overcomes some of the issues of administrative 
databases.  
1.2.2.2 Data presentation 
Although studies have demonstrated a correlation between volume and outcome, 
it is unclear whether the relationship is continuous, step-wise, or has a single clear 
cut-off ( Figure 1.7). Until this has been determined, the optimal means of 
displaying data cannot be established. Handling volume as a continuous variable 
will improve the chance of detecting an outcome difference along the volume 
gradient and equally may reveal a cut-off volume after which there is no further 
change in outcomes achieved. Presenting volume as a continuous variable is 
typically done by scatter graph. Although methodologically superior, visual 
difficulties can occur when apparent correlations are seen, but are not statistically 
proven because of a large number of low volume providers with a zero outcome, 
that are not visually obvious 88. Volume is often therefore analysed and displayed 
as a categorical variable. Under these circumstances, it should be handled as a 
minimum of three volume groups, of approximately equal size, which should be 
determined prior to analysis. Display is then in the form of histogram and 
importantly with confidence intervals displayed. 
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Figure 1.7 Possible relationships between volume and outcome. Reproduced from reference 88 
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Funnel plots have been used extensively to assess the quality of aggregated data in 
meta-analysis. This requires plotting a measure of study precision against 
treatment effects. They are therefore ideal for making an initial assessment of 
volume of cases (measure of precision) against outcome. The most public 
example of this in England surrounded the independent Bristol Royal Infirmary 
Inquiry into paediatric cardiac deaths. By plotting the mortality rates in under 1s 
for paediatric cardiac surgery against caseload undertaken for each of 12 English 
Hospitals, it becomes evident that there is an appreciable decrease in mortality 
rate as the total number of operations performed increases, ( Figure 1.14). A 
formal statistical test of the volume-outcome relationship can then be performed 
using regression analysis with an appropriate error structure. This is described in 
more detail by Spiegelhalter 89. The basic structure of a funnel plot is no more 
than a scatter graph. Unique is the construction of control limits as a function of 
the measure of precision which do not depend on the data being plotted. They are 
formed by calculated confidence intervals and typically represent 2 and 3 standard 
deviations. As the volume of cases (denominator) increases, the confidence 
interval narrows and a ‘funnel’ shape forms. Any plotted data point that lies 
within the control limits is said to be acting under common cause variation and as 
such its performance is within acceptable normal variation. Any data point lying 
outside of the control limits (see  Figure 1.9) is acting under special cause variation 
and as such is a ‘true’ outlier. The implications of this are that such outliers need 
to be carefully considered before inclusion in volume-outcome correlations as 
they will inevitably have a significant impact, which may only be the result of 
extenuating circumstances (e.g. methodological errors). The application of funnel 
plots in surgery is further discussed later in the introduction.  
1.2.2.3 Methodological limitations 
The quality of the data and methods used to analyse it will necessarily affect the 
results and substance of any conclusions. The quality of commonly used data sets 
has already been discussed and is generally well recognised in the literature. More 
recently there has been a growing awareness of the methodological limitations of 
data handling and presentation. The majority of studies exploring the volume-
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outcome relationship in surgery support an inverse relationship, such that the 
greater number of cases performed by a healthcare provider improves the patient 
related outcome, typically reported as mortality. The magnitude and degree of 
statistical significance of the reported correlation between studies does however 
vary considerably and much of this variation can be attributed to heterogeneous 
study design. The IOM held a workshop in 2000 to review the current 
understanding of the relationship between volume of health services and health-
related outcomes 90. As part of this, Halm et al created a quantitative method of 
assessing the research design of volume-outcome studies, such that higher scores 
would reflect increasing likelihood of the study’s ability to discern generalisable 
conclusions about the nature and magnitude of the relationship between volume 
and outcome. The designed scoring system assessed 10 integral methodological 
criteria including representativeness of the dataset, risk adjustment, clinical 
processes of care assessment and methods of volume analysis 85, ( Figure 1.8). 
The authors then scored 88 studies extracted by systematic review of the 
literature. Possible total quality scores ranged from 0 to 18. The mean total quality 
score was 7.8 ± 1.9, with a median score of 8 (interquartile range 6 to 9). Only 
18% of studies achieved a score greater than 10. A similar process was 
subsequently repeated for studies assessing volume-outcome relationships for 
oncological operations between 1984 and 2004 91. Again no study scored greater 
than 11 out of a possible 18 with the vast majority scoring between 7 and 10. The 
implication of this finding, that at best existing study design is only modest, limits 
the transferability of the reported correlations to clinical practice. It also raises the 
question whether much of the volume-outcome relationship will be voided by 
more methodologically robust research? 
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Figure 1.8 Scoring system for rating the quality of research on volume-outcome relationship. 
Adapted from reference 85 
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Volume, being easily measured, is used as a proxy for the expertise of a surgeon 
or institution. It is assumed that any volume categorised differences in outcome 
are the result of better surgical practices resulting from undertaking more cases 
and so improving expertise. Many studies use standard statistical methods that 
assume patients to be independent observations, whereas the outcomes of patients 
treated by the same provider (irrespective of volume treated) are likely to be 
similar. Indeed the potential for this phenomenon, known as clustering, to occur is 
greater the smaller the provider caseload. Similarly, standard statistical methods 
do not consider that outcomes between providers with similar volumes can vary 
considerably. These factors will serve to falsely accentuate any derived volume-
outcome relationship. An example of this was published by Panageas et al. 92 who 
performed a reanalysis of three previously published volume-outcome studies 
using statistical methods for analysing clustered data; a random-effects model and 
generalized estimating equations. They demonstrated that for colectomies, 
prostatectomies and rectal cancer surgery attenuation of the volume-outcome 
relationship occurred, depending on the outcome measured, when adjustment was 
made for clustering in addition to case-mix and volume of operations performed. 
The demonstration of clustering on its own is an important entity and the authors 
provide an example of a simple but plausible explanation “Some colon cancer 
surgeons are more likely to perform colostomies (thereby potentially avoiding 
anastomotic leaks and postoperative infections), while others are substantially 
more likely to attempt primary re-anastomosis. This variation in surgical practice 
leads directly to observed variation in these outcomes when analyzed on a 
surgeon-by-surgeon basis”. Consideration of the presence of clustering is 
therefore an important aspect to volume-outcome relationship assessment and will 
go some way to identifying unexplained variation in outcomes. It likely reflects 
important differences in processes of care that will provide opportunities for 
improving quality of care. 
The variability in the observed outcome will naturally be greater the fewer times it 
occurs, i.e. for low volume providers. For high volume providers the observed 
outcome, having occurred a sufficiently large number of times, (as determined by 
the underlying true rate of occurrence), is likely to be more representative of the 
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underlying true rate and thereby display less variability. So when analysing and 
presenting crude observed outcomes, there will be bias against low volume 
providers as the observed outcome will vary substantially from the true 
underlying outcome rate, often as the result of a few outliers. Some of this bias 
can be removed by considering the observed outcome as a rate of the expected 
outcome, a calculated estimate of the true outcome rate. As applied to mortality, 
this ratio of observed over expected mortality is known as the standardised 
mortality ratio. The calculated expected mortality rate can be adjusted for a 
number of confounding variables such as age, gender, race, co-morbidities, 
deprivation scores and volume and as such improve the robustness of any 
remaining volume-outcome relationship. 
1.2.2.4 Outcome measures 
Morbidity/Mortality/Length of Stay/Re-admission rates 
One of the most important aspects to researching the volume-outcome relationship 
is identifying the outcome to be assessed. Availability of measures recorded 
consistently and reliably in administrative databases has meant that mortality, 
either inpatient or 30-day, has predominated. Mortality is however not always the 
best outcome measure and indeed may result in the absence of any volume-
outcome relationship, when one exists for more procedure-specific outcomes 93. 
Mortality is unlikely to be useful as an outcome measure if the mortality rate for 
the operation of interest is too low to discern differences between high and low 
volume providers. This phenomenon likely explains why the volume-outcome 
(mortality) relationship appears strongest for complex operations such as 
oesophagectomy and pancreatectomy and weakest for operations such as 
colectomy and carotid endarterectomy, in the existing literature. Depending on the 
operation of interest and its associated mortality rate, procedure-specific 
morbidity could be a more appropriate outcome measure to detect a volume-
outcome relationship. Indeed there is evidence to suggest that among high-volume 
surgeons, those who performed well for one morbidity endpoint, performed well 
in others 94.  
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Mortality measured as long-term survival may overcome the problems described 
above for operations with low mortality rates. Needless to say it is reflecting very 
different quality components as compared to 30-day mortality. Long-term survival 
will be affected by surgical technique, e.g. positive margin rates for oncological 
procedures, follow-up diagnostics, availability and thresholds for giving adjuvant 
treatment, to name a few. As a result, operations which demonstrate no volume-
outcome relationship because of their low 30-day mortality can display volume-
outcome relationship for long-term survival 95. 
Hospital lengths of stay and 30-day re-admission rates are other important 
outcome measures that were infrequently assessed 96. In the last three to four years 
we are seeing them more frequently included 97. They act as important outcome 
measures reflecting the efficiency of post-operative care pathways and intensity of 
discharge planning. Besides the disadvantages to the patient, prolonged length of 
stay and high re-admission rates carry a significant financial burden and are 
therefore politically motivated. Emergency re-admission rates can be a clinically 
useful indicator, especially when the risk of death following surgery is negligible. 
This is particularly true in the day surgery setting, or the elective setting where the 
severity of a suitable condition of interest displays little variance. The studied 
populations, as a result, tend towards homogeneity and assessment of the re-
admission rate as an outcome measure allows comparison of like-with-like units 
of interest 98.  
1.2.3 Limitations of case-mix adjustment 
It is clearly advantageous to adjust outcome data for as many variables as possible 
thereby eliminating confounding explanations for demonstrated correlations. 
Limitations in data availability will naturally limit the degree of adjustment. 
Administrative databases as the main data source usually record data that allows 
adjustment for age, sex, ethnicity, socio-economic status, method of admission 
and hospital size (teaching status). Adjustment for patient co-morbidities is less 
readily available, albeit arguably the most important. It has been reasoned in terms 
of methodological quality that risk adjustment only from administrative databases 
is of relatively inferior quality and should originate from medical records or 
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prospectively designed clinical registries 85. The resources that would be required 
in order to fulfil this when dealing with thousands of administrative patient 
records in a retrospective fashion generally make this impractical. In order to 
circumnavigate this issue, much work has been done on manipulation of 
administratively recoded co-morbidity variables. Using predictive modelling 
incorporating the Charlson co-morbidity score, it has been shown that the UK 
based routinely collected HES administrative database can be used to predict risk 
of mortality following surgical intervention with similar discrimination to national 
speciality-specific clinical datasets. In this regard, performance suitably adjusted 
for patient case-mix can be determined 87. 
In addition to adjusting for patient orientated variables, the processes of care that a 
patient experiences as they progress through their treatment episode will clearly 
impact on the end outcomes. The variability that exists has been clearly 
demonstrated, using patient pathways for treatment of colorectal and breast cancer 
as example. The study analyses adherence to quality measures incorporating 
clinical domains representative of the entire patient episode: diagnostic 
evaluation, surgery, adjuvant therapy, management of treatment toxicity and post-
treatment surveillance. Further examination was made of eight components of 
care integral to these clinical domains: testing, pathology, documentation, referral,
 
timing, receipt of treatment, technical quality and respect for patient preferences. 
Although overall adherence to these quality measures was high, significant 
adherence variability was identified (13 to 97% for breast cancer and 50 to 93% 
for colorectal cancer) 47. 
As the quality of administrative databases improve both in terms of data 
acquisition and handling, so will our ability to adjust for a number of confounding 
variables. Statements concerning the existence of volume-outcome relationships 
will as a result be more robust in nature. 
1.2.4 Quality of life measures 
Outcome measures such as mortality, morbidity and length of stay are used 
frequently because of the ease with which they can be measured and the 
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abundance of data held in administrative databases. Studies have, where possible, 
assessed endpoints that directly affect a patient’s quality of life, such as long-term 
incontinence following radical prostatectomy 93. There is, however, a paucity of 
studies which use validated health surveys incorporating patient values using 
qualitative indicators (SF 36, EQ 5D). More recently, there is awareness that 
outcome measures which better assess the quality of life of patients following 
surgical intervention can add an important aspect to any outcome assessment tool. 
The Department of Health initiative for all English hospitals to collect Patient 
Reported Outcome Measures across four surgical procedures 61, signifies an 
important shift away from centrally collating and reporting ‘pure’ clinical 
outcome measures, to ones that encompass patient-orientated experiences of their 
treatment.  
1.2.5 The influence of the Surgeon and/or Institution 
Surgeons will care for their patients in ways that they feel appropriate. Although 
this will be affected by the institution’s structure in which they work, they may 
have had the opportunity to partially influence the structure themselves. The 
surgeon and institution could therefore be seen as a single influencing factor due 
to their integrated nature and yet they reflect very different influences on the 
patient’s final outcome. A surgeon’s volume may be indicative of his or her 
technical skill and case selection, whereas an institution’s volume will encompass 
the perioperative processes and multidisciplinary personnel that will all impact on 
a patient’s quality of care, some of which the surgeon will not be able to directly 
influence. This issue is at the very heart of volume-outcome research as it directly 
questions which is used as the independent variable, the surgeon or the institution.  
1.2.5.1 The role of the Surgeon 
A number of studies have shown a statistically significant relationship between 
surgeon volume and mortality across a variety of operations 
96
. The lack of 
adjustment for hospital volume in many cases, however, has resulted in much 
questioning of the true role of the surgeon’s caseload in surgical outcomes. Yet 
studies have shown that even when you adjust for the influence of hospital 
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volume on patients’ outcomes, the surgeon volume-outcome relationship persists. 
Indeed in some instances, the surgeon volume accounted for the entire apparent 
volume effect 99, and adjusting for surgeon volume can remove the hospital 
volume-outcome relationship 100. This clearly demonstrates the potential 
importance of the surgeon’s volume. However, even among high-volume 
surgeons, inter-surgeon differences in performance do result in significant 
variability in patient outcome 94. Independent of prior case volume, surgeons’ 
achieving better patient outcomes could attract greater numbers of referrals and so 
be rewarded with a higher volume of cases (the selective-referral hypothesis). 
Similarly, high volume hospitals might attract surgeons who are already achieving 
better outcomes, which will in part explain the hospital volume-outcome 
relationship. 
As the methodological quality of volume-outcome studies improves we may see 
that the surgeon and their caseload have a greater influence on outcomes for more 
technically complex operations. This does not mean to say that the hospital 
volume will cease to play a role, as the quality of intensive care services, ward 
nursing and physiotherapy remain integral to achieving the desired patient 
outcomes. 
1.2.5.2 The role of the Institution 
The institution in which a surgeon works will impact on the patient outcomes 
achieved. High volume hospitals are likely to be larger facilities and will provide 
a broader range of specialist and sub-specialist services. Associated academic and 
training programmes may result in higher staff to patient ratios, availability of 
innovative treatments & technologies and on-site multidisciplinary referral 
networks. The important question is ‘does this translate to improved outcomes for 
patients’? 
The importance of the structure and processes within an institution, aside from the 
surgeon’s technical expertise, is suggested from the studies assessing the 
outcomes of cancer patients managed non-surgically. Although confounded by 
differences in treatment regimens, lymphoma and testicular cancer patient 
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mortality appears to be lower for patients receiving their treatment at a 
comprehensive cancer centre 
101
. For colorectal resections, Harmon et al. 
102
 
demonstrated that in terms of inpatient mortality, medium volume surgeons could 
achieve results similar to high volume surgeons when operating in medium or 
high volume hospitals but not low volume hospitals. Similarly the outcomes 
achieved by low volume surgeons showed some improvement with increasing 
hospital volume, although they never equalled those of high volume surgeons. 
The relationship between hospital volume and mortality following colorectal 
surgery appears not only to affect inpatient mortality, but also 30-day, 2-year and 
overall mortality 103. This study corroborated the findings of Hillner et al. in 
showing that hospital volume was the greater predictor of each measure of 
mortality as compared to surgeon-specific mortality. Even when the authors used 
stoma formation rates as the outcome, which might be presumed to be almost 
solely determined by surgeon technique and preference, after adjusting for case-
mix, hospital volume was as an important independent predictor as surgeon-
specific volume. The exact reasons for this association have not been proven, but 
availability and quality of postoperative care available to a patient may well 
influence the surgeon in their choice of operation performed 103.  
It is now generally agreed that ongoing volume-outcome relationship research 
should focus at the institutional level and try and identify factors such as 
processes of care for which volume is acting as a proxy measure. The impact of 
surgeon volume should not however be disregarded as the surgeon and the 
institution in which he operates remain integrally linked.  
1.2.5.3 Immeasurable factors 
The direction of causality in the volume-outcome debate has not been proven, 
however the ‘practice makes perfect’ hypothesis alludes to factors which have 
been thought immeasurable, such as the surgeon’s skill. These factors have been 
implicated both at a surgeon level but also at an institutional level. While the 
majority of volume-outcome studies have used large administrative databases to 
investigate the relationship, in order that they identify small differences in 
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outcomes, access to clinical data extracted from medical records is likely to reveal 
differences in processes of care that were once considered immeasurable factors. 
This approach was used successfully by Thiemann et al. to investigate the 
association between hospital volume and survival after acute myocardial 
infarction in elderly patients 
104
. A third of the survival advantage associated with 
treatment at higher volume hospitals could be attributed to the use of aspirin, 
thrombolytic agents, beta-blockers, angiotensin-converting–enzyme inhibitors, 
and revascularization. While availability to technology for angioplasty and bypass 
surgery was greater in high volume centres; this was not independently associated 
with overall mortality. No predominant mechanism was identified to explain 
outcome differences between high and low volume institutions, but as alluded to 
by the authors, this is not surprising as the mechanisms and processes involved 
within a patient’s care pathway are multifactorial and interlinked. 
Variations in processes of care may go someway to explaining why even for a 
cohort of high volume institutions, there are good and bad performers and why 
volume per se does not always adequately reflect quality of care in terms of its 
process. If such relatively subtle differences in processes of care can be 
responsible for altering outcomes, then could low volume hospitals, which enforce 
clinical best practice throughout the patient treatment pathway, achieve outcomes 
approaching those of high volume hospitals? There is evidence to suggest that 
when low volume institutions have as many residents/interns and registered nurses 
per 100 beds as high volume institutions, overall mortality rates for paediatric 
heart surgery and heart transplants appear equivalent 44. 
Further volume-outcome research should focus on incorporating clinical data with 
administrative databases. This will identify important differences in the structure 
and processes between good and badly performing institutions that may or may 
not relate to caseload volume. Before we attribute outcome differences to 
immeasurable factors, we must first ensure that all measurable factors have been 
identified and considered.  
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1.2.6 Existing literature in urology 
The majority of volume-outcome research in urology, most of which has been 
published in the last 5-10 years, has focused on surgical urology and covers 
mainly cancer operations. Studies have included radical cystectomy 105-108, 
surgical repair of bladder exstrophy 109, radical prostatectomy 110-113, nephrectomy 
97 114-116
 and TURP 
117
. An important message comes from non-surgical urology, 
where comprehensive cancer centres appear to achieve lower mortality rates for 
testicular cancer patients. Although confounded by differences in treatment 
regimens, the importance of non-surgeon factors on patient outcomes is reinforced 
101. The majority of studies to date originate from the US and use administrative 
databases as their source data.  
Most studies have assessed the more complex procedures of cystectomy and 
prostatectomy, and the most commonly measured outcome is either 30-day 
mortality or in-hospital mortality. Studies suggest a higher volume-lower 
mortality relationship for both cystectomy and prostatectomy, when comparing 
low with high volume providers ( Table 1.6), although the relationship is not 
always statistically significant. Categorisation of volume means that the volume 
bands used to define low, medium and high providers etc. differ across studies, 
making direct comparison difficult. Other outcomes commonly measured include 
length of stay 97 and postoperative complications 118. 
Studies have assessed longer-term morbidity such as late urinary complications 
after radical prostatectomy (e.g. bladder neck obstruction, urethral stricture) and 
results indicate that the rate is reduced if performed by high-volume surgeons or 
in high-volume institutions 93. It is unclear if the same association is true for long-
term continence. No association between number of prostatectomies performed 
and overall (non-cancer specific) mortality rates was found.  
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Immediate oncological efficacy as indicated by positive surgical margin (PSM) 
rates has been assessed following radical prostatectomy. Two studies have 
assessed the relationship between the rate of PSM following radical prostatectomy 
and surgeon volume 111 119. Both studies were single centre and highlight the 
benefit of prospectively collected data in this regard as results were also adjusted 
for pathological variables. There is a suggestion that surgical volume does 
decrease PSM rates, although in both studies a single surgeon with very high 
volume (accounting for a third to half of the total dataset) biased the results 119. 
Similarly, patients treated at lower volume institutions are at increased risk of 
initiation of subsequent adjuvant therapy with radiation therapy, medical hormone 
ablation or orchiectomy following radical prostatectomy, indicating higher rates 
of failure of cancer control 110. 
Although there has been preference towards measuring institutional volume and 
outcomes, only one study has specifically looked at processes of care in the 
patient’s treatment pathway and their influence on institutional outcome 
variability 
107
. This study identified that there were many processes of care before, 
during, and after radical cystectomy that differ between high and low volume 
institutions. Adjusting for these process differences accounted for 23% of the 
volume-mortality effect. Similarly, adjusting for institutional structural variables 
has been shown to attenuate the institutional volume-mortality relationship by up 
to 59% following cystectomy 120. A patient treated in a low volume institution 
with a high registered nurse-to-patient ratio may have the same risk of mortality 
following cystectomy as a patient treated in a higher volume institution with a 
lower nurse-to-patient ratio 108. 
Across all outcomes, most studies assess the relationship of the institutional 
volume with outcome as opposed to the surgeon-outcome relationship. The exact 
reason for this is unclear, but may reflect the feeling that a change in institutional 
processes could bring about improvements in outcomes more readily than changes 
at the surgeon level. Only a minority of studies combined both surgeon and 
institutional volume, and only one incorporated a multilevel modelling approach. 
This study confirmed the importance of using this statistical technique by 
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demonstrating that, for mortality following cystectomy, the proportion of the 
effect of surgeon volume attributable to hospital volume and vice versa was 46% 
and 39% respectively 99. 
Only three published studies to date have looked at the UK’s volume-outcome 
relationship: one for cystectomy 
106
, one for prostatectomy 
121
 and one for 
nephrectomy 114. Using HES data, McCabe et al reported a significant inverse 
relationship between inpatient mortality rate and the mean number of 
cystectomies/year calculated over a five-year period at the institutional level. The 
study design is unfortunately limited by many methodological shortcomings and 
further conclusions cannot be made 106. Also using HES data, Judge et al. 
demonstrated that length of hospital stay and rates of some short- and long-term 
postoperative complications following radical prostatectomy were lower in high-
volume hospitals, although magnitudes of the effects were small 121. Davenport et 
al. reported on the data obtained from the BAUS UK national laparoscopic 
nephrectomy audit over a three year period. Although data submitted to the 
database increased over the audited period, the study was not sufficiently powered 
to be able to primarily assess the volume-outcome relationship. However, early 
results suggest lower mean conversion rates and mean transfusion rates for 
institutions performing more than one case per month. These higher-volume 
centres showed a lower rate of minor morbidity, but conversely a higher rate of 
major morbidity; this may reflect case-selection and case-mix factors 114. 
1.2.7 Public health implications 
1.2.7.1 Policy change and Healthcare restructuring 
Volume outcome research has enormous potential to impact on current and future 
policy initiatives. It is for this very reason that its validity must be assured. The 
Leapfrog Group is a coalition of America’s largest corporations and public 
agencies that buys healthcare on behalf of their employees, dependants, and 
retirees and was founded in November 2000. One aspect of their mission 
statement is to advance the safety, quality and affordability of healthcare. With 
this premise, they acted as early proponents for selective referral to high-volume 
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institutions for five surgical procedures. Although better understanding of the 
volume-outcome research has necessarily caused a redefinition of the ‘basket’ of 
operations suitable for regionalisation, the message has not wavered and indeed 
has gained momentum with a number of other organisations joining in. Surely 
whatever the underlying causative factors, centralisation of healthcare can only be 
beneficial for the patient? Opponents, however, describe a number of valid 
disadvantages to centralisation; long travel times for patients and family of 
patients particularly in rural areas, alterations of local referral patterns that could 
destabilise other non-centralised healthcare services, the potential for a two-tier 
healthcare system generating yet further health inequality, inhibiting continuity of 
care because of segmentation of preoperative, perioperative and postoperative 
care and the possible overburdening of high-volume centres which could 
negatively affect quality of care. 
Policy change is the ‘end result’ of health service research and acts as the initiator 
for healthcare restructuring. Restructuring and subsequent organisation of 
healthcare based on the centralisation model would implement a selective referral 
strategy. While the evidence might indicate probable or potential improvements 
for patients in terms of treatment outcomes, it is unable to incorporate the 
variability that exists in terms of disease incidence, patient demographics, existing 
healthcare resource and patient choice. In this regard, flexibility and adaptation 
needs to be exercised during any implementation process to reflect local 
requirements. 
Change can be accompanied by a period of instability and uncertainty. Potential 
barriers to implementing a selective referral process are summarised in  Table 1.7. 
Restructuring in order to facilitate the selective referral process is not the final 
step in ensuring improved outcomes for patients. As discussed, high volume per 
se is no guarantee of improved outcomes. The continued evaluation of processes 
and systems of care within existing or newly created high volume institutions will 
act as a quality control mechanism, but also continue to enhance our 
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understanding of the determinants of improved outcome thereby facilitating any 
future modifications.  
1.2.8 Research & Ethical implications 
The last five years has seen a great increase in health services research exploring 
the volume-outcome relationship within surgery, yet there remain many 
unanswered questions. At the turn of the century, the American Institute of 
Medicine outlined the feedback of participants of a workshop ‘Interpreting the 
Volume–Outcome Relationship in the Context of Health Care Quality’ and their 
proposals for future warranted research actions 
90
. Proposals broadly fell into four 
categories; Implementation of related research, new areas of research, 
methodological development and health services research data infrastructure. The 
improved quality of research since publication of this consensus has reflected in 
part some of the recommendations. Improvements have generally been seen in the 
field of methodological development, where authors have examined outcomes 
other than mortality, such as functional status, quality of life and longer term 
outcomes and better adjusted for confounding variables such as processes and 
systems of care. Outcomes and risk adjustment tools have also been tailored more 
towards being procedure specific as opposed to generic within surgery.  
As with all translational research, the implementation of health services research 
into directing future developments in service provision remains the end objective. 
With the potential for such important policy implications as described previously, 
we must be certain not only of our methodological rigour, but also that we have 
asked the correct question. Many groups have pursued defining a minimum 
annual caseload above which better outcomes can be assured. This relies solely on 
the basis that volume acts as a surrogate marker for factors resulting in better 
outcomes for patients. As our understanding of the volume-outcome relationship 
has developed, we know this is not always true. Should we therefore not focus 
more on exploring factors that can be shown to correlate with improved outcomes 
and then verify if they are independently reliant on volume of delivery and scales 
of economy? This approach would better identify local variations in service 
provision and better influence policy change. 
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A potential for decrements in quality of care at higher volume providers 
Patients’ preferences for care close to home 
Patients’ lack of resources to travel to hospitals that are far away 
Patients who need immediate treatment or are too unstable to transfer 
Loss of access in areas where low-volume services have been closed (e.g., 
cardiac surgery) 
Resistance from surgeons and hospitals to cooperate in quality monitoring 
efforts;  
Effects on marketplace structure and competition: 
Increased market power of high-volume hospitals (e.g., prices could rise) 
Barriers to entry of new competitors (e.g., it is difficult to start at high 
volume) 
Potential for medically inappropriate admissions to boost volumes to meet 
cut-offs. 
Table 1.7 Potential barriers to implementing a selective referral program based on a volume 
standard. Adapted from reference 90 
 
 83 
Not surprisingly, volume-outcome research is not spared of ethical considerations. 
Varying service provision demographics means that widespread and all-
encompassing service re-configuration based on volume-outcome research will 
have to overcome a number of challenges. It has been suggested that this may be 
particularly true in rural areas and as a result it has been suggested that “initial 
implementation efforts be focused in urban areas with dense concentrations of 
hospitals, where success is more likely” 90. During this implementation phase 
there is clearly the potential for a ‘two-tier’ healthcare system separating rural and 
urban populations.  
Policy change based on this research can only occur once we are certain of its 
validity and that validity must be confirmed by a number of stakeholders and in 
particular those who will not have commercial gain. This is not to say that we 
should discourage healthcare providers from carrying out volume-outcome 
research, but we need to be happy that the output is robust and demonstrates 
equity to all patient groups. 
1.2.9 Conclusion 
Research of the volume-outcome relationship in surgery will continue to thrive in 
the current healthcare environment and will help shape its future structure. As we 
have dissected apart the relationship, we have unveiled a complex interaction of 
numerous outcome, process and structural factors. Although the ‘practice makes 
perfect’ or ‘selective-referral’ hypotheses are not the sole determinants of the 
causal relationship, they will continue to form a part. Continuing research in this 
area should be conducted under the guidance of a methodological framework that 
incorporates many of the methodological limitations and ideals discussed within 
this chapter and equally emphasise, and account for, the importance of the 
hierarchical nature of patients’ outcomes within modern healthcare.  
Great strides have been made and our understanding today far surpasses that of 20 
years ago. This is however not the end and continued research will form an 
important component of society’s wish and the medical communities’ desire to 
improve the quality of care that patients receive.  
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1.2.10 Key points for volume-outcome relationship in surgery 
• We have seen an appreciable increase in research evaluating the volume-
outcome relationship in recent years 
• Existing explanations for the relationship have revolved around the 
‘practice makes perfect’ and/or ‘selective-referral’ hypotheses. 
• Most studies are restricted to using administrative databases as their source 
and are thereby limited by insufficient case-mix adjustment  
• A specifically designed rating system has demonstrated that the 
methodological quality of existing volume-outcome research is modest at 
best 
• Although the majority of studies have supported an inverse correlation 
between volume and outcome, appropriate refinement of the statistical 
methodology attenuates this relationship 
• Mortality has been most frequently used as an outcome measure; 
expansion to more procedure-specific and discriminatory outcomes would 
be appropriate and should include process, structural and quality of life 
measures 
• Development of multilevel modelling based on a methodological 
framework is needed to help direct future research and the clinical 
translation of evidence in this area 
• This health service research is crucial for ongoing advances in healthcare 
delivery and the subsequent quality of care that patients receive. 
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1.3 Funnel plots and their emerging application in surgery 
The concept of exploring, modelling and displaying the variation in performance 
is not new. Well over 80 years ago, the attempt to identify unacceptable variation 
in performance was first developed by Walter Shewhart, a physicist and engineer. 
He described two coexistent causes of variation, using a managerial setting: 
“common cause variation”, which is intrinsic to any stable process, and “special 
cause variation”, which signals the effects of external factors upon a process. The 
first step in reducing the effect of the factors causing the special cause variation is 
to acknowledge their existence. 
As highlighted recently, surgical outcomes are being more commonly measured as 
a facet of quality improvement initiatives 
122
. Although this occurs more 
intensively in private healthcare delivery, similar changes are evident in publicly 
funded systems such as the NHS. Increasing accountability within healthcare as 
part of governmental policy has meant that surgeons and surgical outcomes have 
lent themselves to inspection as a result of the interventional nature of their 
discipline. This has led to the reporting of data reflecting performance and quality 
of care for specific surgical specialities 
123
. Maximising productivity of healthcare 
output involves continuous quality assessment which is becoming increasingly 
important as health demands increase, although resources remain often finite. 
Healthcare institutions need to become more involved in the process of quality 
assessment, including the use of appropriate and practical quality control tools to 
measure and benchmark performance. In the setting of a value-based competitive 
healthcare delivery system, performance may have an impact on future 
development and fund allocation. 
Several quality control tools have been introduced and tested in healthcare but 
their use has been limited by the fact that their importance has been recognised 
within the managerial and statistical circles, but relatively ignored by clinicians. 
Graphical tools such as funnel plots that have been previously implemented 
within the industry setting were considered more practical, although their uptake 
within the healthcare setting has been relatively slow to follow. Subsequent to 
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their validation as a tool for assessing performance outcomes 124, we are now 
seeing increasing application in several aspects of healthcare assessment. As with 
other graphical tools such as control charts or CUSUM charts, funnel plots offer 
the opportunity to statistically define “control limits” around measurable 
outcomes. This allows for adjustment of unmeasured factors and makes them 
extremely useful for the monitoring of performance in surgery, either at a surgeon, 
institutional, regional or national level or indeed by means of qualifying 
aggregated data in reported literature. 
1.3.1 Principles of funnel plots 
1.3.1.1 Funnel plots versus ranking 
The ability to perceive variation in data is greater with graphical than tabular 
display. The method of presentation may however influence our interpretation of 
the results. Marshall et al. used a randomised controlled trial design to assess the 
effects of using two forms of data presentation on outlier identification by health 
service managers 125. Three different case studies of service provider mortality 
outcome data were displayed using either a ranked histogram (or league table – 
ranking of institutions’ performance from ‘worst’ to ‘best’, e.g. from highest to 
lowest mortality rate) or a control chart. They first simulated death rates consistent 
with common-cause variation so that labels like ‘good’ and ‘bad’ performance in 
the league table were spurious (and hence any investigation unnecessary, which 
the control chart avoided); in the second case study there were two units with 
genuinely high rates and in the third there were no such units. Although this study 
was limited by its low response rate (47%) and blinding of the authors to the 
characteristics of the participants, the league table group wanted to investigate a 
greater number of units than were actually out of control, whereas the control 
chart group wanted to investigate on average about the right number. The 
presentation of outcome data using control charts may therefore reduce the 
inappropriate labelling of service providers as outliers, which can occur with 
‘league table’ formats. 
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1.3.1.2 The control limits of a funnel plot 
The control chart as developed by Shewhart in the 1920s has been adapted to 
generate the funnel plot; both adhere to the basic theory of statistical process 
control 126. Constructing funnel plots involves plotting data on a scatter plot and 
then superimposing ‘control limits’ around the data points ( Figure 1.9). The 
control limits typically represent two and three standard deviations from the mean. 
The method of calculation of the standard deviation is affected by the data 
distribution which is typically binomial or Poisson ( Table 1.8). The smaller the 
sample size (denominator) the wider the control limits become, reflecting the 
greater the variability due to chance and the degree of uncertainty. Therefore, as 
the sample size (denominator) increases, the control limits converge and a ‘funnel 
shape’ forms. Data points lying within the control limits are said to be consistent 
with common cause variation, or natural variation inherent in any stable process. 
This can be a result of chance (random) variability or equally reflect marginal 
differences in external factors. For example, a degree of variation between 
hospitals for lengths of stay following complex elective surgery can result from 
factors such as postoperative care pathways, rehabilitation facilities, discharge 
facilitators, local socioeconomic deprivation, and availability of carers. It is 
accepted that common cause variation will compensate to a degree for differences 
in the data points as a result of unmeasured factors, but it should not be used to 
overcome basic inadequacies in data quality. 
Data points outside of the control limits are said to be consistent with special 
cause variation. The causes of this variation can be internal or external to a 
process, intentional or unintentional and transient or permanent. Mortality 
differences following emergency repair of ruptured aortic aneurysm between 
Trusts could result from decisive factors such as surgical error, availability of 
open or endoluminal repair techniques and availability of intensive care support. 
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1.3.1.3 The choice of axis in funnel plots 
Interpretability of a graphical tool is very much influenced by the choice of axis. 
When a funnel plot is used to detect publication bias, it is typical to plot a measure 
of the study size on the vertical axis and a measure of the treatment effect on the 
horizontal axis. As a result the “funnel” is in an ‘up-down’ direction ( Figure 1.10). 
The application of funnel plots in assessing outcomes in healthcare has generally 
seen a switching of the axis with the ‘health outcome’ plotted vertically against a 
measure of sample size horizontally as in  Figure 1.9. The funnel is therefore in a 
‘left-right’ direction. There is no apparent statistical reason for this change, 
although as a result data points will fall above or below an overall ‘mean line’, 
potentially visually representing under or over achievement. This effect is 
contradictory to the ethos of the funnel plot and the result of this variation on 
interpretation of the data has not been formally assessed. 
1.3.2 Funnel plots and institutional or surgeon’s performance 
1.3.2.1 Performance indicators 
Traditionally, there has been hesitation at publicly reporting comparative surgical 
outcome data, probably reflecting concerns over the impact of its 
misinterpretation. In contrast to league tables already discussed, funnel plots draw 
attention only to those units that lie outside the control limits rather than the (often 
spurious) ranking of each of them. On the basis of their performance data, units of 
interest can be split into three groups: those whose performance is as expected, 
those who are performing unexpectedly well and those whose performance is 
unexpectedly poor. 
 
 
 
9
1
 
 
F
ig
u
re
 1
.1
0
 
S
im
u
la
te
d
 d
at
a 
u
se
d
 t
o
 d
em
o
n
st
ra
te
 a
 s
ym
m
et
ri
ca
l 
fu
n
n
el
 p
lo
t 
 92 
The most recent and most publicly transparent surgical outcome data in the UK 
started as a result of the collaboration between the Healthcare Commission and 
the Society for Cardiothoracic Surgery in Great Britain and Ireland 123.  For the 
first time, cardiac surgery survival data for both institutions and individual 
surgeons is available via the World Wide Web. Although there is no direct 
adjustment of the data, an expected survival rate range (confidence intervals of the 
expected survival rate) is indicated alongside each of the observed survival rates. 
Using a caterpillar plot, assessment of performance of cardiac surgical units 
nationally shows that 12 institutions with a standardised mortality ratio (SMR) 
greater than 100 could be labelled as ‘poor performers’ if the confidence intervals 
were not displayed or their meaning not understood ( Figure 1.11). Representation 
of the data as a funnel plot plausibly changes the interpretation ( Figure 1.12). The 
majority of Trust rates were consistent with common cause variation. Trust X was 
ranked as the worst performer on the caterpillar plot, when in fact its rate was 
consistent with common cause variation as indicated by the funnel plot and 
therefore had acceptable performance. Only Trust Y fell outside of the 99.8% 
control limits and appeared to be truly divergent. Although anonymous and not 
publicly advertised, the Vascular Society of Great Britain and Ireland has also 
used funnel plots to perform preliminary institutional comparison of mortality 
data following aortic aneurysm repair 128. 
These advantages of funnel plots over ranking systems has possibly facilitated 
individual units in having the confidence to academically publish their 
performance results, although the effect of external influences, such as public 
demand for increased transparency, cannot be ignored. Both funnel plots and 
cumulative funnel plots have been used to present in-hospital outcome data for 
percutaneous coronary intervention of five consultant cardiologists. Funnel plots 
display summaries of overall performance for each operator and cumulative 
funnel plots display individual operator’s performance on a case series basis 129. 
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Figure 1.11 Caterpillar plot of in-hospital standardised mortality rates following coronary artery 
bypass grafting in 28 acute NHS Trusts in England, 2004-2005. 95% confidence intervals are 
plotted. Source data from the Healthcare Commission’s 2004/2005 NHS Performance Ratings130 
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1.3.2.2 Need for Adjustment  
Funnel plot methodology will ‘tolerate’ factors that result in ‘random’ variation 
between units of interest, but will not compensate for frankly heterogeneous data. 
Practically useful performance indicators should reflect healthcare processes or 
outputs that are common to all units of interest and ideally be adjusted for aspects 
such as the treated population’s case-mix, or use a relatively homogenous patient 
population. This issue was highlighted by Mason et al. who used an administrative 
dataset to compare outcomes in urology 98. They concluded that two measures, 
30-day emergency re-admission rates after day-case care and after elective 
admissions for a therapeutic endoscopic procedure on the outlet of the male 
bladder or prostate, were of most use because of the reasonable homogeneity of 
the populations represented (any patients with a cancer diagnosis were removed 
from analysis). Standard funnel plots were constructed using 95% and 99% 
control limits. Of the measures indicated above, only eight and seven hospitals 
respectively were outside of the 99% control limits. By chance alone, this figure 
would be expected to be two hospitals (200 hospitals analysed). This suggests that 
there is very little variation in outcome across the NHS as assessed by the 
measures outlined above, but it does rely on reasonable matching of case-mix. 
The same group identified that in the absence of homogeneity there existed no 
measure of mortality that could be practically used to compare the performance of 
gynaecological units 131. However, again the emergency readmission rates after 
day-case and elective abdominal hysterectomy could be used as indirect indices. 
Under these circumstances the funnel plot, although more meaningful than a 
ranking histogram, must be interpreted with caution. 
An existing limitation in the UK as compared with the US of comparing surgical 
outcomes has been the relatively poor quality of speciality-specific data 
collection. Recent improvements in adjustment of nationally collated 
administrative databases for patient co-morbidity now potentially allows for great 
expansion in risk-adjusted analysis 
87
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1.3.2.3 Sequential monitoring with funnel plots 
As for histograms, funnel plots are used typically to provide a ‘snapshot’ analysis 
and are therefore subject to variation over time through chance alone. Sequential 
monitoring of performance can be achieved by the construction of cumulative sum 
(CUSUM) charts, which plot a cumulative number of events against time. The 
events, such as 30-day mortality following an operation, can be directly observed 
and then compared with a predicted value (observed-expected statistic), or 
adjusted for pre-operative risk factors (risk-adjusted CUSUM) 132 133. Further 
methodological modifications allow for specific charts to be applied depending on 
the context of performance assessment. All however recognise the importance of 
adjusting for individual patient risk 134. Funnel plot methodology can also be 
adapted to identify performance changes over time; a rate ratio (change in 
performance indicators observed at two points in time) assesses the relative 
change in performance and is particularly useful when looking at the impact of a 
change in healthcare delivery or performance against ‘time-fixed targets’ ( Figure 
1.13). 
 
 
9
7
 
 
F
ig
u
re
 1
.1
3
 
R
at
io
 o
f 
%
 o
f 
p
eo
p
le
 w
ai
ti
n
g
 g
re
at
er
 t
h
an
 6
 w
ee
k
s 
fo
r 
an
 e
le
ct
iv
e 
co
lo
n
o
sc
o
p
y
 i
n
 F
eb
ru
ar
y
 2
0
0
6
 t
o
 t
h
o
se
 i
n
 F
eb
ru
ar
y
 2
0
0
7
 i
n
 1
5
0
 a
cu
te
 T
ru
st
s 
in
 E
n
g
la
n
d
. 
N
in
e 
T
ru
st
s 
w
it
h
 m
is
si
n
g
 d
at
a 
w
er
e 
ex
cl
u
d
ed
. 
T
h
e 
co
n
tr
o
l 
li
m
it
s 
ar
e 
ca
lc
u
la
te
d
 a
ss
u
m
in
g
 a
 r
at
e 
ra
ti
o
 =
 1
 (
n
o
 c
h
an
g
e 
in
 r
at
es
 o
v
er
 t
h
e 
ti
m
e 
p
er
io
d
).
 N
o
 T
ru
st
 a
p
p
ea
rs
 t
o
 b
e 
fa
il
in
g
 i
n
 i
ts
 e
ff
o
rt
s 
to
 r
ed
u
ci
n
g
 w
ai
ti
n
g
 t
im
es
 f
o
r 
co
lo
n
o
sc
o
p
y
 a
s 
p
ar
t 
o
f 
th
e 
g
o
v
er
n
m
en
ta
l 
in
it
ia
ti
v
e 
en
su
ri
n
g
 t
h
at
 t
h
e 
N
H
S
 i
s 
p
ro
g
re
ss
in
g
 a
s 
p
la
n
n
ed
 t
o
w
ar
d
s 
ac
h
ie
v
in
g
 a
n
 
1
8
 w
ee
k
 p
at
ie
n
t 
p
at
h
w
a
y.
 S
o
u
rc
e 
d
at
a 
fr
o
m
 H
o
sp
it
al
 A
ct
iv
it
y
 S
ta
ti
st
ic
s 
–
 D
ia
g
n
o
st
ic
 S
ta
ti
st
ic
s1
3
5
 
 98 
1.3.3 Over-dispersion and how to deal with it 
When assessing potential indicators of performance we may see the majority of 
data points sitting outside of the control limits (over-dispersion). This is in itself 
counter-intuitive and could either reflect insufficient adjustment of the data or an 
uncontrolled underlying process. If the goal of the analysis is simply to describe 
the variation between units, then no modification is required. However, if the goal 
is to detect units with divergent performance, one can adjust the data using robust 
statistics and bring the process back under ‘control’. These methods for dealing 
with over-dispersion are well covered in the review by Spielgelhalter 
136
, but in 
summary include clustering, where data points (institutions) are stratified into 
homogenous groups to improve the comparison of like with like; comparing data 
points with a ‘normal range’ instead of a precise target; and inflation of the 
control limits, either by the incorporation of an over-dispersion factor or by using 
a random effects model. A view is held by some that the presence of considerable 
over-dispersion is indicative of the poor discriminatory value of a performance 
indicator and its use should be withheld. 
1.3.4 Volume-outcome relationship 
Funnel plots are ideally suited to exploring the volume-outcome relationship in 
surgery by plotting an observed event rate against a volume of cases. It has long 
been believed that institutions, or indeed surgeons, that undertake greater numbers 
of particular operations achieve improved surgical outcomes over ‘low-volume’ 
institutions 137. This has precipitated service reconfiguration in the UK, with 
centralisation of specialist services and similarly in the US, selective referral to 
high-volume institutions driven by proponent groups such as Leapfrog 42. The 
Leapfrog group has placed emphasis on a point cut-off for volume of procedures, 
such as oesophagectomy, coronary artery bypass grafting and elective abdominal 
aortic repair that should be undertaken by an institution with the aim of reducing 
the annual death rate for patients undergoing these procedures 138. Birkmeyer et al. 
looked at the potential benefits of adherence to more recent Leapfrog group 
standards and suggest that the annual death could be reduced by as much as a third 
139. This study plotted the average adjusted mortality rates for institutions 
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categorised into high or low volume groups based on a cut-off volume threshold, 
for five different procedures. Although the mortality data was adjusted for age, 
gender, race, admission acuity and co-existing diseases, there were limited further 
adjustments to allow for institutional, and indeed surgeon factors, that will 
influence the patient outcome (mortality) and the greater variability of outcomes 
that will exist for the lower volume institutions due to sample size constraints. For 
each of the five procedures, the low-volume institutions are shown to have 
statistically significant higher mortality rates, although the lack of adjustment for 
important influential factors and statistical methods chosen will have affected the 
results. By plotting standardised mortality ratio against volume of cases, one can 
assess for a volume-outcome relationship whilst still allowing for common cause 
variation and simultaneously identify truly divergent institutions, be they high or 
low volume. This approach was used in the national enquiry into paediatric 
cardiac surgery mortality at UK hospitals 140. It was clear that there existed an 
inverse relationship between mortality following paediatric cardiac surgery in 
under 1’s and annual caseload. It was also evident that one of the 12 hospitals had 
a truly divergent performance sitting outside of the upper 99.8% control limit. All 
other variation between hospitals was consistent with common cause variation 
( Figure 1.14) 
89
. 
While there is a large amount of research corroborating the positive correlation 
between volume and outcome, there are numerous studies to suggest no 
correlation. Of interest we see that when simple scatter graphs are used to plot 
adjusted mortality, e.g. observed versus expected mortality, as an indication of 
true mortality, against volume, correlations are not so apparent 141. Moreover, 
recent papers have explored the methodological limitations of existing techniques 
of representing volume-outcome relationships. They highlight that the greater 
variability of outcomes from centres performing low volumes of cases must be 
considered, but there is no suggestion for the use of funnel plots as an alternative 
to displaying the data 88. Funnel plots would be ideal in this setting with their 
easily understood axis. They provide an initial indication of potential volume-
outcome relationships, which can then be formally tested using a regression model 
89. It is important to emphasize that observed outcome rates are more variable in  
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low-volume centres because of their small sample size. For example, with five 
cases and a real (underlying) death rate of 20%, observed death rates of 0% to 
100% will be much more common than in centres with 50 or 500 cases, and 
control charts allow for this size-dependent sampling variation. 
The inherent adjustment for common cause variation allows for the variation in 
institutional processes of care that have yet not been fully identified and/or 
measured. The presence of truly divergent institutions as identified by the funnel 
plot, either as good or bad performers, will provide us with the best opportunity to 
understand the underlying factors driving quality of care. This can have important 
implications for policy change as identification of absolute cut-off values for 
volume threshold may not be optimal. 
1.3.5 Assessment of publication bias in the literature and funnel plots  
The assimilation of published data and subsequent interpretation forms an 
important component of practising evidence-based surgery. One of the most 
frequent uses of the funnel plot to date is in assessing the quality of aggregated 
data in meta-analysis 142. By plotting a measure of study precision (vertical axis) 
against treatment effects, for each of the studies within a meta-analysis, the 
resultant symmetry or indeed asymmetry can give an indication of the presence of 
publication bias. Publication bias describes the phenomenon whereby systematic 
reviews and meta-analysis do not necessarily include all available studies of 
interest. This occurs because the likelihood of finding studies during systematic 
searches is related to the results of those studies 143, such that smaller studies 
without statistically significant results are less likely to be published 
144
. In the 
absence of publication bias, a symmetrical inverted funnel (hence the name funnel 
plot) is generated because the treatment effect estimates from smaller studies 
scatter more widely at the base of the graph with those of larger studies narrowing 
towards the apex ( Figure 1.10). If a meta-analysis is overrepresented by larger 
studies with more significant results, and therefore smaller studies are not 
included, asymmetry of the ‘funnel’ such as that seen in  Figure 1.15 occurs. The 
problem of publication bias in the literature is not insignificant; previous research 
suggests that as many as half of meta-analyses may be subject to some level of  
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publication bias 145. Furthermore, the absence of these ‘missing’ studies as a result 
of publication bias could result in about 5-10% of meta-analyses being interpreted 
incorrectly 145. Publication bias can be grouped with location bias under a heading 
of selection bias when categorising causes of funnel plot asymmetry. Location 
bias describes factors such as the checking of reference lists of other studies and 
reviews increasing the likelihood of locating ‘supportive’ studies (citation bias), 
only incorporating studies reported in English language (language bias), studies 
published in journals not indexed in one of the major databases may not be 
included (database bias), and multiple publications originating from single studies 
results 142. Other categories, and therefore causes of asymmetry, include poor 
methodological quality of smaller studies, true heterogeneity because of study size 
differences, chance, and artefact as a result of the selected measure of study 
precision and/or treatment effect 146. Asymmetry of funnel plots cannot therefore 
be automatically attributed to ‘bias’ and other explanations need to be considered. 
Funnel plot construction requires a measure of study precision plotted against 
treatment effect. If inappropriate measures are selected, funnel plots can lose their 
ability to detect publication bias. Tang et al 147 studied a group of published meta-
analyses with asymmetrical funnel plots suggestive of selection bias. In over 85% 
of the meta-analyses studied, a change in the definitions of study precision and /or 
treatment effect used to construct the funnel plot resulted in the funnel plot 
becoming symmetrical. This raises an issue about the certainty with which 
conclusions can be made concerning the influences of bias for asymmetrical 
funnel plots. In order to try and improve the standardisation of axis choice, Sterne 
et al. 148 presented guidelines that could be applied to funnel plots of meta-
analyses with binary outcomes. They concluded that in most cases standard error 
is the most preferable measure of study precision, although precision, variance 
and the inverse of variance are also valid. A log ratio measure (log odds ratio or 
log risk ratio) is best used as a measure of treatment effect; a measure’s 
consistency across trials and its ease of interpretation is an important 
consideration 148. 
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Methods used to detect publication bias, of which funnel plots are one example, 
should themselves be subject to an evidence base. This will help to reduce costs to 
patients and society through incorrect treatment decisions being made based on 
misleading methodological processes 149. 
1.3.6 Public health issues related to surgery and application of funnel plots  
Presentation of healthcare data is an important aspect of patient education both in 
terms of health behaviour modification and public accountability. These data must 
be easily interpretable, requiring minimum background understanding and account 
for as many confounding factors as possible, so as not to be grossly 
misinterpreted. It is therefore common to see ‘high level’ data presented, often 
with graphical summation. Such comparative healthcare data commonly appear in 
the public domain via the internet, newspapers or national news broadcasts and 
the lay person draws conclusions at face value. Funnel plots have been used to 
display indicators of public health across the English Regions as commissioned by 
the Chief Medical Officer in 2003 150. 
Ranking of data can allow for variation in outcomes by chance alone, through the 
addition of confidence intervals or Bayesian ranking. These methods are not 
always readily understood, both by healthcare professionals and the public, and 
there remains a natural tendency to focus on the rank of the organisation. This has 
the danger of generating a two-tier healthcare system as one group of patients 
travel to obtain perceived optimum healthcare, whilst others, unable or unwilling 
to travel will persist with local healthcare. We may see division of healthcare 
provision across social class, which contradicts the ethos of equality of healthcare. 
Certain institutions may not be able to manage the increased workload generated 
by a favourable rating. League tables can themselves result in inequalities through 
generation of unequal demand. This, in combination with initiatives such as pay 
for performance, could lead to financial disadvantages for institutions that in truth 
are not underperforming. A sudden fall in income may then result in failure of 
healthcare services for all. 
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One area of interest in the study of inequalities in healthcare has focused on 
geographical/institutional differences in access to healthcare services. Several 
government initiated service delivery targets such as operative waiting lists 151, 
MRSA infection rates 152, referral to treatment times for cancers 153 have been 
implemented to reduce existent inequalities. Not surprisingly, differences in local 
infrastructure and population and disease demographics have inhibited a complete 
abolition of inequality. The continued identification of inequalities is therefore 
important to enable targeting of areas where further and greatest impact can be 
made. Funnel plot methodology, as for performance assessment, has been used to 
identify where inequalities exist, although the potential for more widespread use 
exists. 
MRSA infection of hospitalised patients causes significant morbidity and 
mortality and financial burden to hospitals. A government target announced in 
2004 of halving the MRSA bacteraemia rates over a three year period to 2008 has 
made this a key issue for NHS Trusts and the National Patient Safety Agency 154 , 
and it remained a performance indicator assessed by the Healthcare Commission 
155 and now by the Care Quality Commission 156. It is inevitable that a degree of 
variation between Trusts in rates of reported MRSA bacteraemia will ultimately 
be caused by the treated patient population, variability in community MRSA rates 
of the Trust’s catchment population, MRSA prevalence of inter-hospital transfers 
and chance alone. Whilst there has been some adjustment to the data publicly 
released, the figures have not included the above significantly weighted factors. 
As a result, hospitals have been spuriously ranked and the public misinformed. 
Some of the limitations can be overcome using the funnel plot methodology. For 
clinicians, epidemiologists and public health doctors, this non-specific data 
adjustment may severely limit the usefulness of the funnel plot; however, for the 
non-statistically minded public it will reduce the misdirected criticism of 
institutions that are in fact performing entirely within acceptable limits.  Figure 
1.16 is a funnel plot of MRSA cases per 1000 bed days against the number of bed 
days. Each acute, non-specialist Trust is represented as a data point. It is not 
uncommon for the scatter of results to be considerable when assessing 
performance.  
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The funnel plot, however, demonstrates that 13 Trusts are clearly outside of three 
standard deviations above the mean. Equally however, there are 17 Trusts that fall 
outside of three standard deviations below the national mean MRSA rate. The 
divergence of these Trusts potentially indicates that this special cause variation is 
beneficial to reducing MRSA infection rates. The processes within these better 
performing Trusts can be assessed to determine transferability nationally to reduce 
MRSA rates. 
There exist a number of problems when measuring changes in rates of an outcome 
over a time period, such as chance variability, regression to the mean and a low 
power to detect true underlying changes 157. These are worsened when handling 
low event numbers, such as MRSA bacteraemia cases at individual hospitals. 
Furthermore, infectious disease cases demonstrate a ‘clustering’ phenomenon, 
resulting in over-dispersion 157. All of these factors will complicate distinguishing 
between changes in underlying risk and an observed (estimated) change in rate. 
Funnel plots have been used to demonstrate these described difficulties with 
monitoring rate changes and also to demonstrate the uselessness of ranking under 
these circumstances 157. However, monitoring rate changes for outcomes like 
MRSA bacteraemia is likely to continue and recommendations for future 
improvements, such as analysing changes in MRSA rates over at least three-year 
periods, will help to improve the robustness of the interpretation 157. 
The Association of Public Health Observatories facilitates joint working across a 
network of 12 Public Health Observatories to produce information, data and 
intelligence on peoples’ health and healthcare for practitioners, policy makers and 
the wider community 158. To truly understand the health needs of the population, 
one needs not only to measure incidence and prevalence of disease, but also 
identify regional differences in these and the outcomes of patients treated with 
those diseases. Inequalities should trigger review into the underlying causative 
factors and lead to corrective measures aiming to improve the overall health of the 
studied population. 
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Figure 1.17 Funnel plots of a) standardised incidence ratios and b) standardised mortality ratios 
for female breast cancer during the period 2001-2003 for Primary Care Trusts (PCTs) in South 
West Region, Hampshire and Isle of Wight. Figures reproduced from website of South West 
Public Health Observatory159 
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 Figure 1.17, whilst we see a number of PCTs with an SIR above the upper control 
limit, all PCTs show common cause variation with respect to their SMR. There 
may be important differences in the disease case-mix between PCTs. Equally it 
might be that PCTs with higher SIRs, despite the demand upon the screening, 
referral and treatment pathways, are efficient and effective enough to maintain a 
relatively low mortality. 
Local examination of the processes of care will confirm or refute this claim, but 
there is the potential to disseminate the experiences within this PCT to improve 
the health of the entire region. By assessing outcomes, which may include 
mortality rates, across several disease groups, one can identify within a region if 
inequality exists and if too many resources are being directed at a select few 
disease groups at the expense of others. 
1.3.7 Conclusions 
The application of funnel plots within healthcare and more specifically surgery is 
increasing but is still to be established as the norm. They are relatively simple to 
construct, easy to interpret and overcome the limitations of ranking. When 
assessing performance, they make adjustment for a degree of variation between 
the units of interest (surgeons, institutions etc.) that result from factors not directly 
influential or measurable. Funnel plots should not be used as a way to overcome 
fundamental inadequacies in data quality. Funnel plots can be widely applied 
acting as a screening tool which, for indicators of performance, outcome or 
inequality, seeks to identify those areas worthy of further investigation either as 
areas of potential good practice or areas of concern. 
Funnel plots are also important for evaluating evidence emerging from aggregated 
data such as in meta-analysis, which could influence the practice of evidence-
based surgery. Crucial though is the selection of measures used to construct the 
funnel plot, as this can greatly influence any conclusions made.  
Funnel plots should play an increasingly important role as a quality control tool in 
future surgical performance assessment. 
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1.3.8 Key points for funnel plots and their emerging application in surgery 
• Funnel plots are good for identifying which processes are not yet in 
control. 
• They are practical tools, easy to use, and offer the opportunity to 
statistically define control limits around measurable outcomes. 
• Funnel plots are suited to exploring the volume-outcome relationship in 
surgery by plotting an observed event rate against a volume of cases. 
• Funnel plot methodology avoids the spurious ranking of healthcare 
providers based on performance and outcomes. 
• This alternative performance display may help future quality improvement 
initiatives to engage healthcare providers in improving transparency of 
outcomes data.  
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Chapter 2  
ASSESSING THE QUALITY OF THE 
VOLUME-OUTCOME RELATIONSHIP 
IN URO-ONCOLOGY 
 
 
 
 
 
 
 
 
 
The following chapter was published as: 
Mayer EK, Purkayastha S, Athanasiou T, Darzi A, Vale JA. Assessing the 
quality of the volume-outcome relationship in uro-oncology. BJU Int. 
2009;103(3):341-9. 
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2.1 Introduction 
The introduction has highlighted how over the last decade there has been 
increasing focus on the assessment of the volume-outcome relationship for 
complex surgery. Proponents for selective referral to high-volume institutions 
such as the Leapfrog group 42 have based their views on  a number of studies 
suggesting that there exists a positive correlation between volume and outcome. 
Centralisation of specified services, such as oncological surgery, could therefore 
in principle improve patient outcomes and so reduce postoperative morbidity and 
mortality. More recently however, the methodological limitations of existing 
measures of the volume-outcome relationship have been highlighted by several 
investigators 
88 96
. This has led to careful reconsideration to determine for which 
operations a volume-outcome relationship truly exists. To facilitate this, the IOM 
proposed a scoring system against which the methodological quality of published 
studies could be determined 
160
.  
The development and application of this relevant scoring system to assess the 
strength of the current best available evidence (methodological quality of volume-
outcome relationship studies) may have significant implications in clinical 
practice and policy setting. Also it is important to note that the volume-outcome 
literature within urology has never been systematically assessed in this way. 
Within England and Wales, there is evident organisational change for the delivery 
of oncological surgery as a result of the IOG. IOG is a component of the current 
UK government’s health policy, and identifies mechanisms for continually 
improving the treatment of cancer patients 
161
. These changes as applicable to 
urology have been based on the principle that for urological cancers (including 
those of the prostate, bladder, & kidney), patients who receive their surgery and 
post-operative care in hospitals treating larger numbers of patients, are likely to 
experience better outcomes. The latest guidance for radical urological pelvic 
cancer surgery dictates that a specialist urology team should have a total 
catchment population of at least one million and perform at least 50 combined 
total procedures 161. It is estimated that this population will produce well over the 
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minimum cut-off of 50 combined total numbers of prostatectomies and/or 
cystectomies. There is also guidance as to which patients with renal carcinoma 
should be managed by a specialist urological cancer team at a cancer centre 161. 
The aim of this study, by using a previously validated scoring system, is to 
systematically quantify the methodological quality of published studies reporting 
on the volume-outcome relationship for the three major and common uro-
oncological surgical procedures; cystectomy, prostatectomy and nephrectomy. 
This would also allow for correlation of study quality scores and reported 
outcomes, further understanding of the significance of the reported volume-
outcome relationships and facilitation of evidence based clinical and policy 
decisions. Quality scoring the urological literature to date identifies how future 
research in this field can be improved and establishes this readily useable scoring 
system within urology, allowing for future benchmarking. 
2.2 Materials and Methods 
2.2.1 Study Selection 
Multiple searches were performed of electronic databases including: PubMed, 
EMBASE & Cochrane collaboration. The last search was performed on the 1st 
May 2007. Articles published in English language literature were searched for 
using the keywords “outcome”, “volume”, “urology”, “mortality”, “morbidity”, 
“cystectomy”, “nephrectomy” and “prostatectomy”. The bibliographies of 
included articles were reviewed for further relevant citations and searches were 
performed for specific authors known to have multiple publications in this area. 
2.2.2 Primary inclusion criteria 
Studies were included if they met the following criteria:  
• Patient cohort treated from 1980 onwards 
• Relevant data referring solely to operations for malignant disease 
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• Health outcome(s) assessed as dependent variables 
• When at least hospital and/or surgeon volume was an independent 
variable  
These inclusion criteria are similar to those used by Halm et al. 85; it was decided 
to include studies from 1980 onwards such that changes in methodological quality 
and indeed the magnitude of the volume-outcome relationship would be observed 
if present. As highlighted by Halm et al. 96 clinical and surgical care prior to 1980 
were considerably different because of available treatments and surgical 
techniques, limiting the relevance to modern day outcomes. 
When articles examined more than one procedure, the data for each procedure 
were considered and analysed as a separate study. 
2.2.3 Other considerations  
When multiple studies evaluated data derived from the same dataset with any 
overlap in the studied time period for the same procedure, the following rules 
were applied: 
a. Where studies examined more than one outcome measure, the data for 
each outcome measure were considered and analysed separately 
b. For articles assessing the same procedure, with the same outcome 
measures and using extracted data from the same database, the study 
with the lower quality score was excluded. If studies had equal quality 
scores, the one incorporating the greater time period was included. 
2.2.4 Data Extraction  
Two authors (EM & TA) independently assessed articles for inclusion/exclusion 
and quality scored the studies. Any disagreement was resolved by consensus 
opinion.  
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2.2.4.1 Outcome measures 
All reported postoperative outcomes were considered in the extracted studies. A 
summary of the assessed outcomes is provided in  Table 2.1. Variation in the 
definition of the outcome measures was present. This heterogeneity only became 
important for the purpose of the random effects analysis, which was used for 
mortality. Mortality was defined by studies as either in-hospital mortality only or 
alternatively as, in-hospital or within 30 days of the index procedure. In order to 
perform the random effects analysis, mortality odds ratios for different volume 
providers were used. Frequency of reporting meant that this was only possible at 
the level of the institution. The highest volume group was maintained as the 
reference group for each study, such that the mortality odds ratio reflected the 
ratio of the odds of mortality in a low volume hospital compared to the odds in a 
high volume hospital. On each occasion, adjusted odds ratios were used, although 
there was variation between studies in the factors used for adjustment. A summary 
of the variables by which the extracted odds ratios were adjusted is displayed in 
 Table 2.2. Similarly, variation was found in the categorisation of institutional 
volumes,  Table 2.2. 
2.2.4.2 Quality assessment of studies 
Extracted studies were assessed quantitatively for quality using the pre-defined 
scoring system tailored to measure the degree to which the study design is more 
likely to reveal more accurate information about the magnitude and nature of the 
relationship between volume and outcome 85. Question 10 of this scoring system 
( Table 2.3) was slightly modified in order to incorporate studies which assessed 
outcomes other than mortality. 
 
 
1
1
6
 
O
u
tc
o
m
e
 M
e
a
su
re
s
 
U
n
it
 o
f 
a
n
a
ly
si
s
 
 
O
v
er
al
l 
S
u
rv
iv
al
  
L
o
n
g
te
rm
 
m
o
rb
id
it
y
  
D
x
T
/ 
h
o
rm
o
n
e 
re
q
u
ir
em
en
t
 
P
o
si
ti
v
e 
S
u
rg
ic
al
 
M
ar
g
in
 
P
ro
ce
ss
es
 
o
f 
ca
re
  
R
e-
ad
m
is
si
o
n
 
ra
te
s
  
L
en
g
th
 
o
f 
S
ta
y
  
C
o
m
p
li
ca
ti
o
n
s
  
M
o
rt
al
it
y
  
S
u
rg
eo
n
 
V
o
lu
m
e
 
In
st
it
u
ti
o
n
 
V
o
lu
m
e
 
S
tu
d
y
  
  
  
  
  
  
  
  
  
  
 
 
C
y
st
e
c
to
m
y
 
  
  
  
  
  
  
  
  

  

 

 
B
ir
k
m
e
y
er
 e
t 
al
. 
(2
0
0
3
) 
9
9
 
  
  
  
  
  

  

  
  
  
 

 
G
o
o
d
n
ey
 e
t 
al
. 
(2
0
0
3
) 
9
7
 
  
  
  
  
  
  
  

  

  
 

 
E
lt
in
g
 e
t 
al
. 
(2
0
0
5
) 
1
0
8
 
  
  
  
  
  
  

  
  

  
 

 
H
o
ll
en
b
ec
k
 e
t 
al
. 
(2
0
0
7
) 
1
2
0
 
  
  
 
 

  
  
  
  

  
 

 
H
o
ll
en
b
ec
k
 e
t 
al
. 
(2
0
0
7
) 
1
0
7
 
  
  
  
  
  
  
  

  
  
 

 
K
o
n
et
y
 e
t 
al
. 
(2
0
0
6
) 
1
1
8
 
  
  
  
  
  
  

  
  

  

 

 
K
o
n
et
y
 e
t 
al
. 
(2
0
0
5
) 
1
0
5
 
  
  
  
  
  
  

  
  

  
 

 
M
cC
ab
e 
et
 a
l.
 
(2
0
0
5
) 
1
0
6
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
P
r
o
st
a
te
c
to
m
y
  
  

  
  
  
  
  
  

  

  

 

 
B
eg
g
 e
t 
al
. 
(2
0
0
2
) 
9
3
 
  
  
  
  
  
  

  
  
  
 

 
E
ll
is
o
n
 e
t 
al
. 
(2
0
0
0
) 
1
6
2
 
  

  
  
  
  
  

  

  

  

 

 
H
u
 e
t 
al
. 
 
(2
0
0
3
) 
1
1
3
 

  
  
  
  
  
  
  
  

  

 
 
K
ar
ak
ie
w
ic
z 
et
 a
l.
 
(1
9
9
8
) 
1
6
3
 
 
  
  
  
  
  
  
  
 
 
 
 
 
1
1
7
 
  
  
  
  
  

  

  
  
  
 

 
Y
ao
 e
t 
al
. 
 
(1
9
9
9
) 
1
1
2
 
  
  
  

  
  
  
  
  
  

 
 
C
h
u
n
 e
t 
al
. 
 
(2
0
0
6
) 
1
1
9
 
  
  
  

  
  
  
  
  
  

 
 
E
as
th
am
 e
t 
al
. 
(2
0
0
3
) 
1
1
1
 
  
  

  
  
  
  
  
  
  
 

 
E
ll
is
o
n
 e
t 
al
. 
(2
0
0
5
) 
1
1
0
 
  
  
  
  
  
  

  
  

  
 

 
H
o
ll
en
b
ec
k
 e
t 
al
. 
(2
0
0
7
) 
1
6
4
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
N
e
p
h
r
e
c
to
m
y
  
  
  
  
  
  
  
  
  

  
 

 
B
ir
k
m
e
y
er
 e
t 
al
. 
(2
0
0
2
) 
1
6
5
 
  
  
  
  
  

  

  
  
  
 

 
G
o
o
d
n
ey
 e
t 
al
. 
(2
0
0
3
) 
9
7
 
  
  
  
  
  
  
  

  

  
 

 
D
av
en
p
o
rt
 e
t 
al
. 
(2
0
0
6
) 
1
1
4
 
  
  
  
  
  
  
  
  

  
 

 
K
o
n
et
y
 e
t 
al
. 
(2
0
0
6
) 
1
1
6
 
  
  
  
  
  
  

  
  

  
 

 
T
au
b
 e
t 
al
. 
 
(2
0
0
4
) 
1
1
5
 
T
ab
le
 2
.1
 
A
 s
u
m
m
ar
y
 o
f 
o
u
tc
o
m
es
 m
ea
su
re
d
 a
n
d
 u
n
it
 o
f 
v
o
lu
m
e 
an
al
y
si
s 
at
 a
 s
tu
d
y
 l
ev
el
 
 
1
1
8
  
A
d
ju
st
m
e
n
t 
V
a
r
ia
b
le
s
 
V
o
lu
m
e
 
C
a
te
g
o
r
is
a
ti
o
n
 
(a
n
n
u
a
l 
o
p
e
r
a
ti
o
n
 
n
u
m
b
e
r
)
 
 
H
o
sp
it
al
 F
ac
to
rs
 
(e
.g
. 
o
w
n
er
sh
ip
, 
lo
ca
ti
o
n
, 
te
ac
h
in
g
 
st
at
u
s,
 b
ed
 
n
u
m
b
er
s 
et
c.
)
  
C
an
ce
r 
g
ra
d
e 
/o
r 
st
ag
e
 
M
ea
su
re
s 
o
f 
so
ci
al
 
d
ep
ri
v
at
io
n
/ 
so
ci
o
-e
co
n
o
m
ic
 
st
at
u
s
  
A
d
m
is
si
o
n
 
ty
p
e 
(e
le
ct
iv
e/
 
n
o
n
-e
le
ct
iv
e
 
C
o
-e
x
is
ti
n
g
 
co
n
d
it
io
n
s
  
Y
ea
r 
o
f 
p
ro
ce
d
u
re
  
R
ac
e
  
S
ex
  
A
g
e
  
H
ig
h
es
t 
V
o
lu
m
e 
In
st
it
u
ti
o
n
 
L
o
w
es
t 
V
o
lu
m
e 
In
st
it
u
ti
o
n
 
S
tu
d
y
  
  
  
  
  
  
  
  
  
  
 
 
C
y
st
e
c
to
m
y
 

  
  

  

  

  

  

  

  

  
>
1
0
 
<
4
 
B
ir
k
m
e
y
er
 e
t 
al
. 
(2
0
0
3
) 
9
9
 

  
  

  
  

  
  

  

  

  
>
1
0
 
≤
3
 
E
lt
in
g
 e
t 
al
. 
(2
0
0
5
) 
1
0
8
 

  
  

  
  

  
  

  

  

  
≥
2
.7
5
 
<
1
.5
 
K
o
n
et
y
 e
t 
al
. 
(2
0
0
5
) 
1
0
5
 
  
  

 

 

  
  

  

  

  
≥
2
0
 
1
 -
 5
 
H
o
ll
en
b
ec
k
 e
t 
al
. 
(2
0
0
7
) 
1
2
0
 
  

  

  

  

  

  

  

  

  
≥
6
.1
 
0
.2
6
 -
 2
.1
1
 
H
o
ll
en
b
ec
k
 e
t 
al
. 
(2
0
0
7
) 
1
0
7
 
  
  
  
  
  
  
  
  
  
  
  
  
  
 
N
e
p
h
r
e
c
to
m
y
  
  
  

  

  

  

  

  

  

  
>
3
1
 
<
7
 
B
ir
k
m
e
y
er
 e
t 
al
. 
(2
0
0
2
) 
1
6
5
 

  
  

  
  

  

  
  

  

  
>
8
 
≤
3
 
K
o
n
et
y
 e
t 
al
. 
(2
0
0
6
) 
1
1
6
 
  
  
  

  

  
  

  

  

  
≥
3
4
 
1
 -
 1
4
 
T
au
b
 e
t 
al
. 
 
(2
0
0
4
) 
1
1
5
 
T
ab
le
 2
.2
 
D
is
p
la
y
 o
f 
v
ar
ia
ti
o
n
 b
et
w
ee
n
 s
tu
d
ie
s 
fo
r 
in
st
it
u
ti
o
n
al
 v
o
lu
m
e 
ca
te
g
o
ri
sa
ti
o
n
 a
n
d
 f
ac
to
rs
 f
o
r 
w
h
ic
h
 m
o
rt
al
it
y 
w
as
 a
d
ju
st
ed
 
 119 
2.2.5 Endpoints 
The primary endpoint of this study was to determine the methodological quality 
scores for studies exploring the volume-outcome relationship in cystectomy, 
prostatectomy and nephrectomy. The secondary endpoint was to establish 
correlation between study quality scores and the magnitude of the reported 
volume-outcome relationship within each of the three operative categories. 
2.2.6 Statistical Analysis 
For ratio measures of treatment effect, the data were transformed to logarithms 
(for example as a log odds ratio and the standard error of the log odds ratio). 
Identical outcomes across studies were combined in logarithmic scales using the 
generic inverse variance method to determine a pooled effects estimate. The 
inverse variance method is so named because the weight given to each study is 
chosen to be the inverse of the variance of the effect estimate (i.e. one over the 
square of its standard error). A variation on the inverse variance method is to 
incorporate an assumption that the different studies are estimating different, yet 
related, treatment effects. This produces a random effects meta-analysis, and the 
simplest version is known as the DerSimonian and Laird method. To undertake a 
random effects meta-analysis, the standard errors of the study-specific estimates 
are adjusted to incorporate a measure of the extent of variation, or heterogeneity, 
among the treatment effects observed in different studies. The size of this 
adjustment can be estimated from the treatment effects and standard errors of the 
studies included in the meta-analysis. 
Treatment effects were extracted as ratio measures in the form of an odds ratio 
(OR) and were therefore converted to natural logarithms. Logarithm standard 
errors were calculated using the Cochrane Collaborative formula 166. 
Because patients operated on in different institutions have varying risk profiles 
and selection criteria for each surgical technique vary, random effect models were 
used in this study.  
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Question 
 
Characteristic Score 
1. Representativeness of sample:  
Not Representative 
Representative 
 
0 
1 
2. Number of hospitals or Surgeons 
Hospitals < 20 and Surgeons < 50 
Hospitals ≥ 20 or Surgeons ≥ 50 
Hospitals ≥ 20 and Surgeons ≥ 50 
 
0 
1 
2 
3. Total sample size (cases) 
< 1000 
≥ 1000 
 
0 
1 
4. No. of Adverse Events  
<20 
21-100 
>100 
 
0 
1 
2 
5. Unit of analysis 
Hospital or Surgeon 
Both Separately 
Both Together 
Both Together + further component 
 
0 
1 
2 
3 
6. Appropriateness of patient selection 
Not measured 
Measured separately 
Measured and analysed 
 
0 
1 
2 
7. Volume 
Two categories 
Multiple categories 
 
0 
1 
8. Risk adjustment 
None  
Administrative data only  
Clinical data only  
Clinical data + C >.75 and H/L test positive 
 
0 
1 
2 
3 
9. Clinical processes of care 
Not measured 
One 
≥ 2 
 
0 
1 
2 
10. Outcomes† 
Single outcome measured 
≥ 2 outcomes measured 
 
0 
1 
Table 2.3 Scoring system used to determine study ‘quality’. 
†Minimally adapted from original scoring system 85 so as to include studies that assessed 
outcomes other than mortality. 
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In the tabulation of our results, squares indicate point estimates of treatment effect 
(logarithm of odds ratio), with 95% confidence intervals indicated by horizontal 
bars. The diamond represents the summary logarithm odds ratio from the pooled 
studies with 95% confidence intervals. Analysis was conducted using the 
statistical software Review Manager Version 4.2 (The Cochrane Collaboration, 
Software Update, Oxford). 
2.3 Results 
A total of 25 articles fulfilled the initial inclusion criteria. Five articles reported on 
more than one of the three operations of interest. Because the data for each 
procedure was considered and analysed as a separate study, the 25 articles 
provided data for 31 studies. Application of the secondary exclusion criteria, to 
stratify studies using the same datasets to evaluate the same outcomes for the 
same operations, excluded nine studies, leaving a total of 22 studies for final 
analysis. The studies were of the following origin; 18 American, two UK, one 
Canadian and one German. Year of publication ranged from 1998 to 2007, with 
19 of the 22 studies being published in the last five years. 
The final 22 studies consisted of eight cystectomy, nine prostatectomy and five 
nephrectomy series. All studies used administrative databases as their data source 
except for two studies (one single institution prospectively collected dataset and 
one speciality society prospectively collated database). All but one study had a 
total sample size greater than 1000 cases. Although nearly all of the studies used 
administrative databases as their source of data, in only about half of these were 
the databases representative of the general population. The reason for this 
originates from many US studies using administrative databases only holding data 
on patients greater than 65 years of age.  
The frequent use of administrative databases is also the explanation for studies 
persistently scoring poorly for certain data adjustments. In particular, only 18% 
and 14% of studies respectively addressed, to any degree, clinical processes of 
care or clinical data risk adjustment. No study explored the appropriateness of 
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patient selection. 15/22 and 3/22 studies solely used the institution or surgeon as 
the volume measure respectively. Only four studies appropriately explored the 
impact of both the institution and surgeon volume on the outcome measures. 
15/22 studies assessed at least two outcome measures. In the main, studies 
assessed mortality (inpatient and/or 30-day) or length of stay as their outcome 
measures. Frequencies of outcomes measured at a study level are summarised in 
 Figure 2.1. 
Across all of the studies the total quality scores ranged from 4 to 11 out of a 
maximum possible score of 18. The median total quality scores within each of the 
operation types were 8.5, 9 and 8 for cystectomy, prostatectomy and nephrectomy 
respectively.  Table 2.4,  Table 2.5,  Table 2.6.  
2.3.1 Results of the random effects model 
Six studies measured mortality as an outcome following cystectomy. The odds 
ratio (OR) of mortality between high and low volume providers, including a 
measure of uncertainty, was extractable from five of these six studies. Overall, 
mortality was almost twice as high in institutions categorised as low-volume 
providers (OR=1.88, 95%CI 1.54-2.29) ( Figure 2.2). Similarly for nephrectomy 
mortality was higher in institutions categorised as low-volume providers with an 
aggregated OR of 1.28, 95% CI 1.10-1.49 ( Figure 2.3). Mortality outcome data 
was extractable from only one of the four prostatectomy studies that assessed it, 
preventing an analysis of aggregated results. There was insufficient consistency of 
reporting to allow for random effects analysis to be performed for the remaining 
outcome measures. 
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Figure 2.1 Summary of reported outcomes across extracted studies 
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2.4 Discussion 
There has been considerable volume-outcome research within the surgical 
specialities and the relationship remains controversial. Within urology, there is 
even evidence to suggest that a high-volume surgeon can perform poorly in a 
high-volume hospital, and a low-volume surgeon can perform well in a low-
volume hospital 167. Previous authors have identified that the methodological 
quality of reported studies is not as good as might be expected 91 96. This study has 
specifically examined and quantified, using a previously validated scoring system, 
the methodological quality of volume-outcome research in the field of 
cystectomy, prostatectomy and nephrectomy. Similar to research in other surgical 
specialities we have shown that for these index procedures in uro-oncology, the 
methodological quality of the best available evidence was only modest at best. 
Studies most frequently did not adjust for appropriateness of patient selection and 
varying clinical processes of care as they rely on administrative databases which 
do not routinely record such variables.  
For cystectomy and nephrectomy it was possible to perform a random effects 
analysis which showed that for the extracted and quality scored studies, 
postoperative mortality was higher in low-volume institutions than high-volume 
institutions. The magnitude of this volume-outcome relationship is greater for the 
more technically difficult cystectomy than nephrectomy, which is in keeping with 
previous evidence that has also supported the theory that the magnitude of the 
relationship is greater with more complex surgery 165. Similar analysis could not 
be repeated for mortality following prostatectomy as it was not possible to extract 
the required data.  
Although we could have performed a pooled analysis for length of stay, it was not 
considered a valid option due to the fact that an insufficient number of studies 
provided ‘adjusted’ length of stay as an outcome, making analysis meaningless. In 
addition, length of stay can vary for reasons other than quality of care such as, for 
example, funding mechanisms and organisation of care. Random effects analysis 
was also not possible for the other remaining outcome measures, due to their 
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infrequent reporting. This point is of most concern as there is a strong argument 
that for operations such as prostatectomy and nephrectomy, where mortality is 
infrequent, other outcome measures are more appropriate to help discern 
differences between providers. For example, positive surgical margin (PSM) rates 
and postoperative PSA failure rates would be more relevant as measures of cancer 
control following radical prostatectomy, and morbidity measures such as urinary 
continence and erectile dysfunction are important from a quality of life 
perspective. Of the two papers that examined PSM rates and surgeon volume 
following radical prostatectomy, Eastham et al. demonstrated a significant trend 
towards higher surgical volume and lower PSM rates, although absolute 
differences were small. More interestingly, even after adjusting for disease case-
mix, surgical date and surgical volume, the individual surgeon remained an 
independent risk factor for positive margins 111. Chun et al. demonstrated that 
surgical volume was a statistically significant predictor of PSM, although when 
they removed the bias of the one surgeon who contributed over half of the total 
studied patient cohort, the relationship was not evident 
119
. Similarly, relevant 
outcomes following radical nephrectomy are very different to those following 
partial ‘nephron sparing’ nephrectomy and nephroureterectomy. It is important to 
mention that the pooled effects analysis of mortality following nephrectomy was 
performed without distinguishing between the different surgical approaches. This 
was necessitated by the fact that the extracted studies either did not define exactly 
what they had classified as nephrectomy 
165
, or analysed their data after having 
aggregated the different surgical approaches 115 116. Similarly it was not possible to 
subanalyse extracted studies reporting on radical cystectomy depending on 
whether the patient had undergone continent or incontinent urinary diversion. 
The secondary endpoint of correlating study quality scores and the magnitude of 
the reported volume-outcome relationship across the three operative categories 
was not achievable due to the low number of studies from which relevant data 
could be extracted and outcome heterogeneity. 
The vast majority of studies included had chosen only to explore the relationship 
of either surgeon or institution volume with outcome. A surgeon’s volume may be 
 131 
indicative of his or her technical skill and case selection, whereas an institution’s 
volume will encompass the perioperative processes and multidisciplinary 
personnel that will all impact on a patient’s quality of care, some of which the 
surgeon will not be able to directly influence. It is important that the relationship 
of the institution and surgeon with outcome is assessed as a bare minimum, and 
ideally multilevel modelling performed to understand the predominant underlying 
factors ( Figure 1.6). The degree of influence of the institution and surgeon will 
change dependent on the operation; those that require more technical skill such as 
partial nephrectomy may be more dependent on the surgeon volume than 
operations which rely more heavily on pre and postoperative input from 
associated specialities and allied healthcare professionals, such as in cystectomy.  
Multilevel modelling takes into account that patients are ‘nested’ within surgeons 
and surgeons are ‘nested’ within institutions, forming a three-level hierarchical 
structure. The power of multilevel modelling comes from the distributional 
assumptions that it makes, which allows the simultaneous estimation of between 
institution variance and institution level predictors, a process which can be 
repeated for surgeons. These issues cannot be addressed by simplistic statistical 
models that ignore the structure of the data. Multilevel modelling allows for the 
influence of each ‘level’ to be determined independent of others. Only four studies 
of the 22 combined in some form the influence of the institution and surgeon 
volume, but only one study explicitly used multilevel modelling. This study 
demonstrated that the proportion of effect of surgeon volume attributable to 
hospital volume and conversely hospital volume attributable to surgeon volume, 
on the odds of operative death between low and high volume providers, were 46% 
and 39% respectively, reinforcing the importance of a multilevel modelling 
approach to outcome analysis. 
This study incorporates previously designed and validated methodology for 
quality scoring volume-outcome research, but is unique in its specific focus on 
uro-oncology. With over 80% of our final cohort of studies having been published 
in the last five years and 50% since the most recent systematic reviews in the 
same field 168 169, it highlights the requirement for this contemporary examination 
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of the volume-outcome relationship. Most studies however, continue to focus on 
mortality and length of stay as the outcome of interest. 
The use of an almost identical scoring system to assess the methodological quality 
of the studies as used previously by Halm et al. 85 and Killeen et al. 91 allows us to 
draw some comparisons. Killeen et al. performed a systematic review of published 
volume–outcome data relating specifically to surgery for cancer up to 2004 91. 
They determined that the median quality score for cystectomy, prostatectomy and 
nephrectomy respectively was 10, 9 and 8. This was however limited by a small 
number of included studies. Halm et al. 85 reviewed the volume-outcome literature 
across all of healthcare and established that the median quality score across all 
articles up to 1999 was only 8, less than 50% of the available 18 points. Our study 
demonstrated an overall median quality score of 8.5. This encompasses our 
strategy of excluding the study with the lower quality score if two studies assessed 
the same procedure, with the same outcome measures and used extracted data 
from the same database. In addition we minimally modified the scoring system to 
allow for inclusion of studies looking at outcomes other than mortality. This 
would, if anything, serve to slightly raise the quality score assigned to a study. 
Despite these considerations, more recent volume-outcome research has therefore 
not improved, in terms of methodological quality, as compared to previous years. 
This continues to limit the transferability of the reported correlations to clinical 
practice. More importantly, it also raises the question whether much of the 
volume-outcome relationship will be voided by more methodologically robust 
research? Volume-outcome research has enormous potential to impact on current 
and future policy initiatives. It should therefore conform to an agreed and 
accepted methodological and statistical validity before it is ‘translated’ to 
healthcare reform.  
The application of this quality scoring system within uro-oncology allows for 
future research to be benchmarked and can be applied to the development of a 
quality framework within uro-oncology. It is readily useable and can be 
interpreted by people who may not have an in-depth knowledge of the area, by 
incorporating many methodological shortcomings common across studies. It 
 133 
therefore goes further than a previous study which scored uro-oncology volume-
outcome research only for case-mix adjustment 
168
. In this study, the authors 
performed a systematic review of the literature to investigate if patients 
undergoing radical prostatectomy, cystectomy or nephrectomy have improved 
health outcomes if treated at high volume hospitals or by high volume surgeons. 
They concluded that this was true for cystectomy and prostatectomy, but 
simultaneously described limitations in data adjustment that could potentially 
invalidate their conclusion 168. 
Although our study only used 22 studies for the final analysis, the decision to use 
strict inclusion/exclusion criteria means that the included studies have used data 
from either a different dataset or a different time period to assess the outcome of 
interest. This ensures no duplication of the patient populations studied. Previous 
reviews have excluded studies reporting only from single centres on the basis of 
potential bias. Single or few centre studies however can provide greater detail 
with regard to patient and pathological variables that should be adjusted for. 
Equally, they could allow for measurement of appropriateness of patient selection 
and specific processes of care, all valuable insight for shaping future research. 
Two of the final 22 included studies were single or few centre studies; both 
studies exploring the relationship between surgeon volume and PSM rates 
following radical prostatectomy adjusting for pathological data 111 119.  
The majority of the studies originated from the US which may limit the 
transferability of the conclusions to a European, and in particular the English, 
healthcare system, because of the inherent ‘structural’ differences in the 
healthcare systems. This is particularly relevant with regard to the organisational 
change resulting from IOG in England and Wales with only two UK studies 
meeting inclusion criteria. Furthermore, these studies each achieved a low 
methodological quality score of eight and four respectively 106 114 (see  Table 2.4 & 
 Table 2.6). 
The benchmarking of future research utilising a validated scoring system such as 
that used in this study will help to confirm adherence to a quality framework and 
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validate the strength of it’s conclusions and translation to changing healthcare 
policy and clinical practice.  
2.5 Conclusions 
Centralisation of radical urological pelvic cancer surgery forms an important 
component of IOG in urology. Service reconfiguration relies on the translation of 
robust health service research to support and enable it. This study has 
demonstrated, by using a previously validated quality scoring system, that the 
methodological quality of volume-outcome research as applied to cystectomy 
prostatectomy and nephrectomy is only modest at best. It can also be said, by 
comparison to previous similar studies, that despite the continued expansion of 
research in this area, study ‘quality’ has remained relatively static. There is a 
paucity of data applicable to the English healthcare system. The following two 
studies of this thesis will explore the impact of improved statistical techniques on 
volume-outcome research as related to radical cystectomy in England. Radical 
cystectomy was chosen because of the greater magnitude of volume-outcome 
relationship demonstrated by the random effects analysis. Radical cystectomy 
fulfils the criteria as an index procedure for assessing the volume-outcome 
relationship in that it is performed with sufficient frequency and has mortality and 
morbidity rates sufficient, in principle, to be able discern differences between 
providers of varying volume. 
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2.6 Key points arising from study one 
• The methodological quality of existing volume-outcome research is only 
modest at best 
• Recommendations made by the Institute of Medicine in 2000 for 
improving the quality of volume-outcome research appear to have had 
limited impact 
• The majority of volume-outcome research has been conducted in the US, 
which limits transferability to the English healthcare system 
• Random effects analysis of pooled data shows that for both cystectomy 
and nephrectomy, postoperative mortality was higher in low-volume 
institutions than high-volume institutions 
• The magnitude of the volume-outcome relationship appears to be greater 
for the more morbid cystectomy operation as compared to radical 
nephrectomy 
• The incorporation of more robust methodology when analysing existing 
administrative datasets could improve the validity and usefulness of 
volume-outcome research. 
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Chapter 3  
THE VOLUME-MORTALITY 
RELATIONSHIP FOR RADICAL 
CYSTECTOMY IN ENGLAND 
 
 
 
 
 
 
 
 
 
The following chapter was published as: 
Mayer EK, Bottle A, Darzi AW, Athanasiou T, Vale JA. The volume-mortality 
relation for radical cystectomy in England: retrospective analysis of hospital 
episode statistics. BMJ 2010 Mar 19;340:c1128. doi: 10.1136/bmj.c1128.  
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3.1 Introduction 
The previous study has quantified the methodological limitations of existing 
volume-outcome research. To incorporate all of the IOM recommendations for 
improving the quality of volume-outcome research, future research would need to 
incorporate data that has been prospectively collected specifically for this purpose. 
Some of the methodological shortcomings of the existing studies arise from the 
fact that they have used administrative datasets and these cannot be improved 
upon. It is also evident however, that some of the methodological shortcomings, 
such as multilevel modelling, are not limited by the use of administrative datasets. 
It is also feasible that by the novel manipulation of, and by combining 
contemporary administrative datasets, data can be appropriately adjusted for 
structural and process of care confounders. 
The IOM methodological scoring system 85 highlighted several important 
statistical and methodological considerations: the hierarchical structure of the 
institutional and surgeon influences (multi-level modelling), appropriate handling 
of the provider volume variable, need for adjustment of structural/process of care 
measures, and measuring outcomes other than mortality. The aim of this study is 
to create an improved statistical/methodological framework, taking these issues 
into account and use it to investigate the institutional and surgeon volume-
mortality relationship for radical cystectomy in England. The subsequent chapter 
then further examines the volume-outcome relationships by expanding the model 
to include outcomes other than mortality  
3.2 Methods 
3.2.1 Data extraction 
Data for inpatient elective cystectomies (ADMIMETH=11, 12 or 13 with the 
OPCS4 code M34 occurring in any procedure field in any episode) were taken 
from Hospital Episode Statistics (HES) for the six financial years 2000/1 to 
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2005/6 and from the Secondary Users Service for 2006/7. HES is the national 
statistical administrative database for England of the care provided by NHS 
hospitals. Each record in HES constitutes a finished consultant episode, which 
covers the continuous period during which a patient, admitted to a hospital, is 
under the care of the same consultant, whose General Medical Council (GMC) 
code is recorded (a unique identification code used by the doctor’s regulatory 
body, the GMC). Each record therefore has an identifiable consultant, as an 
individual, responsible for that patient’s care episode; it does not assume the 
operating surgeon. However, radical cystectomy is of such complexity that it will 
at the very least be a consultant supervised operation. Episodes were linked into 
admissions using the patient’s date of birth, sex and postcode, the hospital and 
date of admission, and admissions were linked together if the patient was 
transferred to another Trust. A Hospital Trust provides secondary healthcare 
services within the NHS, which can either be planned specialist medical care or 
surgery or emergency care. A Trust may comprise several hospital sites.  
Admissions were excluded if they were emergencies, had invalid age, sex or 
length of stay, were day cases or did not have a primary diagnosis of cancer 
(ICD10 C66, C67, C68, D090).  
Twenty four patients at the patient ID level had a total of 26 duplicate records. It 
was decided not to remove them on the basis that it was not possible to determine 
which was the ‘real’ record and the duplicates only made up 0.3% of the total case 
number. None of these records had a death recorded. 
3.2.2 Assignment of institutional and surgeon volume bands 
The number of cystectomies was counted by year and each of consultant code and 
Trust. To account for Trust mergers, Trust codes were unified to reflect their 
status as of April 2007. Trusts (institutions) were excluded due to very low 
volume if they either had fewer than three years of data or had an annual 
cystectomy rate of less than two. This was to try to capture institutions with 
genuine activity (i.e. not due to coding errors). If a provider had less than three 
years of data, it was considered unlikely that they were performing cystectomy 
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regularly during the time period analysed. This had to be balanced against not 
excluding providers (at the surgeon level) that either retired or were newly 
appointed during the analysed period and may therefore only appear for three or 
fewer years. We felt that this three year cut-off, in combination with an annual 
cystectomy rate of two, would identify cases more likely appearing as a result of 
coding error, while not inappropriately removing large numbers of low-volume 
providers, i.e. regularly performing between two and 10 operations per year at the 
institution level, or between one and five operations per year at the surgeon level. 
Thirteen institutions providing 41 cases (0.5% of total cases) were excluded on 
this basis. The remainder were put into three volume bands of roughly equal total 
operation numbers ( Table 3.1). 
Allocation of consultants to volume bands was performed in a similar fashion, 
although because a surgeon could operate at more than one institution, and hence 
more than one institutional volume band, this had to be performed in two stages. 
After excluding a single record with a missing consultant code, the surgeon’s 
average annual cystectomy rate was calculated. Consultants were excluded if their 
average cystectomy rate was less than or equal to two cases per year and they had 
fewer than three years of data. Exclusion was performed without summating 
caseload of consultants operating at multiple institutions because coding errors 
occur at the level of the institution. One hundred and eighty nine consultants 
providing 313 operations (3.6% of total cases) were excluded. Following 
exclusion, the annual cystectomy rate for those surgeons operating at more than 
one institution was recalculated using the maximum number of years practised 
from whichever provider and total summation of operations. Consultants were 
then divided into three volume bands of roughly equal total operation numbers 
( Table 3.1). 
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 Institutional volume band 
(Annual cystectomy rate) 
Year 
Low 
(>2 and < 10) 
Medium 
(≥10 and < 16) 
High 
(≥16) 
2000/1 453 331 346 
2001/2 437 383 359 
2002/3 495 370 378 
2003/4 461 392 398 
2004/5 431 387 416 
2005/6 375 425 463 
2006/7 384 488 424 
Total operations in volume 
band 
3036 2776 2784 
Number of institutions in 
volume band 
84 31 19 
    
 Surgeon volume band 
(Annual cystectomy rate) 
Year 
Low 
(≥1 and < 5) 
Medium 
(≥5 and ≤8) 
High 
(>8) 
2000/1 485 315 264 
2001/2 511 306 303 
2002/3 506 357 356 
2003/4 480 388 359 
2004/5 419 366 413 
2005/6 334 405 490 
2006/7 314 423 529 
Total operations in volume 
band 
3049 2560 2714 
Number of surgeons in 
volume band 
228 78 40 
Table 3.1 Breakdown of number of operations for each institutional and surgeon volume 
bands generated prior to regression modelling 
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3.2.3 Model development 
The data had a three-level structure that needed to be taken into account to avoid 
potentially biased estimates: surgeons treat a number of patients and each hospital 
has more than one surgeon (and some surgeons operate at more than one hospital).  
The final complex model was constructed in four stages. The first stage simply 
used logistic regression and the two volume variables (surgeon volume and 
institutional volume), with no adjustment for case-mix and ignoring the 
"clustering" (of patients within surgeons and surgeons within hospitals) (model 
one). The second added the case-mix variables (model two). The third took into 
account the clustering (model three) and the final model (model four) included the 
structural and process variables.  
Volume-mortality relationships were presented as odds ratios using the low 
volume band as the reference group. The interaction effects between institutional 
and surgeon volumes were assessed. 
3.2.3.1 Case-mix adjustment 
Adjusted was made for gender, age, Carstairs deprivation quintile, Charlson 
comorbidity score 170 and year of operation. Carstairs deprivation scores for every 
output area (about 500 residents on average) in England were converted into 
quintiles with equal population in each and assigned to every record via the 
postcode using a look-up file from ONS Gridlink.171 A sixth quintile was assigned 
to records with missing or invalid postcodes. These are the main case-mix 
variables available in HES for elective patients. 
3.2.3.2 Multi-level modelling & adjustment for institutional volume and 
surgeon volume 
The "clustering" was handled by fitting multilevel models with random effects for 
surgeons and hospitals, a very commonly used approach.92  Both two- and three-
level models were fitted. The two-level model recognises that some surgeons 
(around 5% in the sample) work at more than one hospital (surgeons and hospitals 
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are said to be “cross-classified”). The three-level model asserts that this 
proportion is small enough to ignore and, with continuing centralisation of 
services, is likely to decrease further in the future. Only 18 consultants of a total 
of 346 worked at more than one institution and at most two. The exact cross-
classification of each surgeon with their respective hospital(s) in the models was 
not specified, but it is believed that this would not give different results from 
either the two- or the three-level approaches that were tried. 
In practice, both sets of models gave very similar results (odds ratio point 
estimates typically differed by 0.05 at most and often by much less) and only the 
three-level model results are presented. Goodness of fit was assessed using the 
ratio of the generalised chi-square statistic to the degrees of freedom and was 
found to be close to 1 (i.e. very good fit) in all models. 
3.2.3.3 Structural and process of care adjustment 
Information for the following factors was obtained from The Information Centre 
for health and social care and Hospital Activity Statistics: average occupied acute 
bed rate, ratio of number of nurses to occupied bed count, ratio of number of 
critical care beds to total beds, ratio of registrars (all specialities) to occupied bed 
number, ratio of urology registrars to total urology episodes, and readmission rate 
following operation cancellation (percentage of patients not readmitted within 28 
days following last minute cancellation). Total urology episodes and operation 
waiting times (period between operation booking date to operation date) were 
derived from HES. Trust (institutional) teaching status was derived from 
information available on the National Patient Safety Agency website: see 
Appendix A for further details. Selection of these variables was influenced by the 
existing volume-outcome literature, and therefore included staffing characteristics, 
teaching status and hospital capacity characteristics. The availability of data 
routinely collected within England did have some impact on the final variable 
definitions chosen. (Appendix A) 
There were significant differences in the structural and process of care variables 
across the institutional volume groups  Table 3.2. 
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3.2.4 Outcome measure 
All-cause mortality within 30 days of the procedure (or admission if the procedure 
date was missing) was assessed in two ways: in-hospital mortality and mortality 
either in or out of hospital (total mortality). The latter was calculated using a date 
of death linked to HES by the Office of National Statistics. This was unavailable 
for 2006/7, but to avoid losing a year’s records and to maintain statistical power, it 
was assumed that there were no out-of-hospital deaths in 2006/7; a sensitivity 
analysis was performed on the small shortfall. 
3.2.5 Statistical Analysis 
Within- and between-volume group variations in case-mix variables were assessed 
using Chi-squared tests. All logistic regression and other statistical analysis except 
for multi-level modelling (which was done using PROC GLIMMIX in SAS 
version 9.2, North Carolina, USA) were performed using the SPSS package 
version 14 for windows (SPSS, Inc., Chicago, IL).  
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Low volume Medium volume High volume 
Overall 
mean 
One-way 
ANOVA 
Ratio of number of nurses 
to occupied bed count 
1.59 
(1.12 to 2.60) 
1.73 
(1.31 to 2.76) 
1.75 
(1.36 to 2.14) 
1.69 <0.01 
Ratio of urology 
registrars to total urology 
episodes (x10,000) 
4.1 
(0.34 to 21) 
4.3 
(0.2 to 12) 
6.3 
(0.9 to 15) 
4.9 <0.01 
Operation waiting time 
31.7 
(1 to 394) 
32.6 
(1 to 339) 
30.3 
(1 to 251) 
31.5 <0.01 
Ratio of number of 
critical care beds to total 
beds 
0.021 
(0.01 to 0.062) 
0.024 
(0.009 to 0.055) 
0.026 
(0.013 to 0.048) 
0.023 <0.01 
Ratio of registrars (all 
specialities) to occupied 
bed number 
0.09 
(0.02 to 0.35) 
0.13 
(0.06 to 0.47) 
0.15 
(0.04 to 0.28) 
0.12 <0.01 
Trust teaching status (% 
within volume group) 
9.7 19.1 41.2 
22.9 
(overall 
%) 
<0.01* 
Average occupied acute 
bed rate 
0.85 
(0.73 to 0.94) 
0.84 
(0.76 to 0.92) 
0.85 
(0.79 to 0.94) 
0.85 <0.01 
Readmission rate 
following operation 
cancellation 
0.11 
(0.00 to 0.42) 
0.10 
(0.00 to 0.35) 
0.13 
(0.01 to 0.33) 
0.11 <0.01 
Total beds, all sectors,  
available 
5372 
(2143 to 
10441) 
7356 
(1686 to 16745) 
9783 
(1651 to 18044) 
7441 <0.01 
Total acute beds available 
4056 
(1723 to 8730) 
5822 
(1686 to 14285) 
7942 
(1651 to 13506) 
5884 <0.01 
Total urology episodes 
25978 
(8688 to 
63818) 
39640 
(5132 to 83112) 
49855 
(3402 to 89385) 
38123 <0.01 
Table 3.2 Variation in the structural and process of care measures between the institutional 
volume groups. Minimum/maximum in parentheses 
* Chi squared p value 
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3.3 Results 
The number of radical cystectomies performed each year increased steadily from 
1130 in 2000/01 to 1296 in 2006/2007 (p = 0.005 for linear trend),  Figure 3.1. 
 Table 3.1 shows the distribution by institutional/surgeon volume bands. There was 
a significant downward trend in the total mortality rate from 3.5% in 2000/01 to 
2.1% in 2005/06 (out-of-hospital deaths not available for 2006/07),  Table 3.3. 
 Figure 3.2 and  Figure 3.3 show observed (crude) mortality rates by 
institutional/surgeon volume tertiles. 
3.3.1 Patient demographics and institutional characteristics  
The proportion of treated patients aged 75 years and over increased from 19.8% in 
2000/01 to 22.7% in 2006/07 (p = 0.03). There was a significantly greater 
proportion of males in 2000/01 and 2003/04 (p = 0.03). The proportion of patients 
in the highest Charlson category (six+) varied significantly year on year, but with 
no linear trend across the years. The median Charlson score and Carstairs quintile 
were two and three respectively for every year ( Table 3.5). 
Medium-volume institutions treated proportionally fewer patients in the most 
deprived Carstairs quintile (five) and a greater percentage of patients older than 75 
years (p<0.01,  Table 3.6). There was a statistically significant increase in the 
number of institutions with teaching status from the low-volume group through to 
the high-volume group (p<0.01). Medium and high-volume surgeons treated a 
greater proportion of males and fewer patients in the most deprived Carstairs 
quintile (p<0.01). Medium- and high-volume surgeons more frequently worked in 
institutions with teaching status than low-volume surgeons. 
In the multi-level model, the ‘ratio of number of critical care beds to total beds’ 
was the only structural variable significantly (p<0.05) and independently related 
to both mortality outcome measures. 
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Figure 3.1 Number of radical cystectomies performed each year in England between 2000/01 
and 2006/07 inclusive. 
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Financial year 
In-hospital mortality 
(30 days)  
n (%) 
Total mortality  
(30 days)  
n (%) 
Proportion of  
in-hospital to total 
mortality 
2000/1 32 (2.8) 39 (3.5) 0.82 
2001/2 38 (3.2) 40 (3.4) 0.95 
2002/3 34 (2.7) 36 (2.9) 0.94 
2003/4 25 (2.0) 33 (2.6) 0.76 
2004/5 40 (3.2) 42 (3.4) 0.95 
2005/6 24 (1.9) 26 (2.1) 0.92 
2006/7 30 (2.3) 30 (2.3) 1.00† 
p value for linear 
trend across years 
0.13 0.03 - 
Table 3.3 Summary of mortality outcome measures by year for radical cystectomy (unadjusted 
data) 
† 2006/7 uses Secondary User Survey to extract data. This does not include out of hospital mortality meaning 
in-patient hospital death rate equals total death rate. 
 
 In-hospital mortality 
(30 days) 
(n) 
Total mortality 
(30 days) 
(n) 
Institutional volume band   
Low 85 90 
Medium 82 90 
High 56 66 
   
Surgeon volume band   
Low 86 92 
Medium 74 81 
High 52 62 
Table 3.4 Observed numbers of in-hospital and total mortality stratified by 
institutional/surgeon volume bands 
 148 
 
Figure 3.2 Crude mortality rates (%) stratified by institutional volume tertiles. 
 
Figure 3.3 Crude mortality rates (%) stratified by surgeon volume tertiles  
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Financial year Percentage 
of males 
Charlson Score  
 
Percentage in 
category 6+ 
Age 
 
Percentage  
> 75 years 
Carstairs Score 
 
Percentage in 
category 5 
2000/1 78.0 1.9 19.8 15.7 
2001/2 74.2 1.2 18.0 14.3 
2002/3 75.2 1.7 19.2 16.3 
2003/4 79.3 1.4 20 13.2 
2004/5 75.9 2.3 20.7 14.5 
2005/6 74.5 2.9 22.6 13.9 
2006/7 75.2 1.9 22.7 13.0 
Mean across 
years 
76.0 1.9 20.5 14.4 
Chi squared 
p value 
0.03 0.05 0.03 0.2 
Table 3.5 Patient demographics across each of the years analysed 
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Provider Percentage 
of males 
Charlson 
Score  
 
Percentage 
in 
category 
6+ 
Age 
 
Percentage 
> 75 years 
Carstairs 
Score 
 
Percentage 
in 
category 5 
Teaching 
status 
 
Percentage 
within 
volume 
group 
Institution      
Low volume 75.3 1.6 17.8 15.2 9.7 
Medium 
volume 
76.3 1.9 23.0 12.4 19.1 
High volume 76.5 2.1 20.9 15.5 41.2 
Chi squared  
p value 
0.47 0.45 <0.01 <0.01 <0.01 
      
Surgeon      
Low volume 74.2 1.6 19.4 16.0 19.4 
Medium 
volume 
76.3 2.0 21.2 13.9 25.4 
High volume 78.2 2.3 21.0 12.6 24.2 
Chi squared  
p value 
<0.01 0.12 0.19 <0.01 <0.01 
Table 3.6 Differences in patient/institution characteristics by provider volume group 
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3.3.1.2 Volume-mortality relationship 
For in-hospital mortality, the OR for medium-volume institutions in model three 
was 1.16, but rose to 1.72 (1.00 to 2.98, p=0.05) in model four (which adjusted for 
the structural/process of care variables). Adjusting for the ratio of the number of 
nurses to occupied beds increased the OR to 1.31; this became 1.52 after adjusting 
for the ratio of urology registrars to total urology episodes and 1.62 after including 
operation waiting times. Adding the remaining structural/process of care variables 
led to the model four OR of 1.72. A similar pattern was seen for total mortality 
(model four OR=1.82, 1.08 to 3.06, p=0.02), ( Table 3.7). There was no 
statistically significant difference seen using models one, two or three. The only 
significant result for high-volume institutions was a lower odds of in-hospital 
mortality in model two (OR 0.67 (0.47 to 0.97, p=0.03)) ( Figure 3.4). 
High-volume surgeons had a statistically significant lower odds of in-hospital 
mortality for models one and two (OR 0.67 (0.48 to 0.95, p=0.03) and OR 0.64 
(0.44 to 0.91, p=0.01) respectively), but this became non-significant at the 5% 
level in models three and four. No statistically significant differences were seen 
for total mortality ( Figure 3.5). 
 Table 3.8 displays the crude and adjusted odds ratios for in-hospital and total 
mortality across both institution and surgeon volume tertiles. 
 Figure 3.6 shows a summary of the adjusted probabilities for in-hospital and total 
mortality across both the institutional and surgeon volume bands. Adjusted 
probabilities were calculated using model four. 
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3.3.2 Sensitivity analysis for total mortality 
On average, there were four out-of-hospital deaths per year and 23 in total. For the 
sensitivity analysis, four surviving patients were randomly allocated to have a 
“total 30-day death”: two in the low-volume and two in the high-volume 
institution groups. In clinical trials with mortality as an end-point, it is usual in 
sensitivity analyses to assume higher death rates in the drop-outs rather than 
assume that the deaths are missing at random. This allocation was chosen because 
of the finding that it was the medium-volume group that had the highest odds ratio 
from model four. The resulting odds ratio was a little lower at 1.66 (1.00 to 2.76, 
p=0.049). 
3.3.2.1 Interaction effect 
Testing for an interaction between the two volume variables resulted in a 
significant interaction term (p=0.035) but non-significant main effects (p>0.1), 
suggesting no evidence for a convincing interaction effect. 
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3.4 Discussion 
Principal findings 
When compared with low-volume institutions, patients undergoing radical 
cystectomy in medium-volume institutions had 72% and 82% greater odds of 30-
day in-hospital and total mortality respectively. This increased risk in mortality 
was only seen after adjustment for institutional structural and process variables. 
The nursing and urology registrar staffing levels appeared to have the greatest 
influence, in keeping with previous studies 108 120.  
Although not significant at the 5% level, there was weak evidence of reduced 
odds of in-hospital mortality (by 35%) for the high-volume surgeon. Surgeon 
volume also appeared to have some protective effect on in-hospital mortality at 
the institutional level. After patient case-mix adjustment alone, high-volume 
institutions displayed statistically significantly lower odds of in-hospital mortality. 
This effect disappeared after adjusting for surgeon volume. 
There was relatively little difference in the crude OR and case-mix adjusted OR of 
mortality at both the institutional and surgeon level. This is interesting in itself, as 
surgeons often use case-mix variation to explain differences in performance. It 
may be that case-mix adjustment, using variables as incorporated in this study, is 
not always necessary for analysis of effects at a highly aggregated level, as 
opposed to risk prediction at an individual patient level. Hollenbeck et al.
107
 also 
reported minimal difference in the unadjusted and adjusted (for patient 
demographics) OR of mortality for cystectomy between low-volume and high-
volume institutions. 
Strengths and weaknesses of the study 
As described earlier in study one, the median IOM quality score for previous 
studies appraising the volume-outcome relationship for cystectomy was modest at 
8.5 (range 8-11). Using the same scoring criteria, this current study would achieve 
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a higher score of 13 out of a possible 18. One mark is lost because, in this chapter, 
only the volume-mortality relationship is described. As outcomes other than 
mortality are presented in the next chapter, overall this improved methodology 
would score 14 out of 18. Four marks were not achievable because an 
administrative database was used and the appropriateness of patient selection for 
cystectomy could not therefore be determined and clinical data for risk-adjustment 
could not be used. Methods to circumvent this limitation could include linkage of 
administrative datasets with local or speciality society datasets, which would 
simultaneously serve to confirm coding accuracy. The need to centrally support 
such initiatives across the multiple available datasets has been acknowledged 172. 
Although it was not possible to adjust data for cancer stage and grade, when this 
has been possible it appeared to have little impact on the reported findings 107 173. 
Sub-analysis of mortality risk for patients who had either an ileal conduit 
diversion or continent diversion was not achievable because of under-reporting of 
continent diversions. 79% of patients were recorded as undergoing ileal conduit 
diversion, 0.5% as continent diversion and for 20% of patients it could not be 
determined. Similar difficulties have also been experienced with US 
administrative databases 108. The reliability of coding within HES has been 
questioned by clinicians for some time. In England, training of coding staff, 
regular monitoring of data quality, and a commissioning system which financially 
reimburses healthcare providers according to case-mix adjusted activity has 
improved the quality of data completeness and accuracy since the early years of 
HES 174 175. If institutional resources for coding are proportional to the overall 
workload of that institution, it is possible that miscoding rates are not 
systematically different by volume of hospital. This will have biased the estimated 
ORs towards 1 and therefore underestimated any volume-mortality relationship. 
The mortality outcome definition only used a 30-day follow-up, as is usual 173. 
Overall 90-day mortality is known to be higher than 30-day mortality following 
cystectomy 176, but whether this differs across providers is unclear; work on this, 
and longer-term cancer specific survival, should consider postoperative structural 
and process of care factors such as oncological ancillary services 120. The only 
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previous study which used HES to assess mortality following cystectomy only 
included in-hospital mortality 
106
.  
It was assumed that in 2006/7 there were no out-of-hospital deaths, rather than the 
four on average for the other years. Although this assumption is not expected to 
have been true in reality, the sensitivity analysis showed this was unlikely to have 
biased the results for this outcome. 
The finding that medium-volume institutions have higher odds of mortality is 
surprising. Without further evaluation of potential causative factors, this is 
difficult to fully explain. This study has not assessed the relative contribution of 
the institution and surgeon to the volume-mortality relationship. It has also not 
attempted to define causal pathways of influence of the structural and process of 
care variables on mortality. Previous studies have demonstrated, for instance, that 
for colorectal resections medium-volume surgeons can achieve similar inpatient 
mortality results to high-volume surgeons when operating in medium- or high-
volume hospitals but not low-volume hospitals 102. Similarly, the contribution of 
individual institutional structural variables can be important. When low-volume 
institutions have as many residents/interns and registered nurses per 100 beds as 
high-volume institutions, overall mortality rates for paediatric heart surgery and 
heart transplants appeared equivalent 
44
. 
From the summary of adjusted probabilities ( Figure 3.6), medium-volume 
institutions do appear to have worse in-hospital and total mortality than high-
volume institutions, which is consistent with previous studies. What is not clear is 
why low-volume institutions appear to have comparable outcomes to high-volume 
institutions. While it would be impossible to refute this finding, it may be 
artefactual. The division of volumes into tertiles does not assume a linear relation 
between volume and mortality, but rather allows for a non-linear one such as the 
middle volume having lower or higher mortality rates than the other two tertiles. It 
is possible that the volume cut-offs may not be optimal and that more complex 
functional forms (e.g. quadratics, splines) may perform better. The plotting of 
unit-level mortality rates against unit volume for the raw dataset did not reveal 
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any obvious relationships ( Figure 3.7), and tertiles were chosen because of 
statistical power and because such an approach is commonly used. Large numbers 
of very low volume providers were not excluded which may have contaminated 
the low volume tertile if it contained patient-level records present only through 
coding errors.  
Some of the structural and process of care factors used in the model may 
themselves be acting as proxies for volume. A number of the variables, such as 
staffing levels, critical care facilities and hospital capacity do increase across the 
institutional volume bands ( Table 3.2). In extreme cases, this can lead to 
“collinearity”, with multiple variables trying to describe the same quantity, but 
inspection of the standard errors showed no convincing evidence of this. 
However, the noticeable increase in the width of the confidence interval for the 
institution volume group with the addition of the structural and process variables 
suggests that the model is at the limit of acceptability regarding the number of 
variables included. 
The use of an incremental modelling approach for volume-outcome research is in 
itself important for helping to decide whether volume should be defined at the 
institutional or surgeon level or both. Using the institution allows for the 
importance of overall teamwork on outcomes by factoring in institutional factors 
which cannot always be measured. It has been acknowledged that existing studies 
have rarely considered the relative effects of the unit of analysis and their possible 
interactions 
177
. 
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Figure 3.7 Scatter plot of Institutional crude mortality rate against institutional annual 
cystectomy rate (volume) 
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As defined earlier, each record in HES constitutes a finished consultant episode, 
which covers the continuous period during which a patient is under the care of the 
same consultant (identified by a consultant code defined by their General Medical 
Council code). This consultant code cannot in the strictest sense therefore be 
assumed to dictate who the lead operating surgeon was, and this is a limitation in 
definition of the surgeon level analysis. Radical cystectomy, however, has been 
and increasingly continues to be either a purely consultant performed operation, or 
at the very least an operation directly supervised by the consultant. Defining 
surgeon volume using the HES consultant code is therefore not unreasonable for 
this index procedure. 
Comparisons with other studies 
McCabe et al.106 used only two volume categories in their HES-based analysis and 
defined an ‘optimum’ annual institutional caseload of 11 cases/year. When they 
shifted the case volume threshold to 16 cases/year, and therefore included more 
centres with optimum mortality outcomes in the group below the threshold (<16 
cases/year), no significant difference in mortality rate between the groups was 
demonstrated. 
The systematic review, using a random-effects analysis, described in study one 
found an 88% higher odds of mortality in low-volume than in higher-volume 
institutions for cystectomy. Only five studies could be included and their 
methodological quality was assessed as only modest at best. That the magnitude 
of difference was greater than in this current study can be partly explained by the 
limitation of meta-analysis when studies use different volume cut-off categories, 
adjustment methods, and amalgamate studies from different healthcare settings. 
US studies using the Health Care Utilization Project have demonstrated 3.2 times 
and 1.96 times the case-mix adjusted risk of dying postoperatively in low-volume 
institutions as compared with high-volume institutions (cystectomy rate 1-5/year 
versus ≥20/year 120 and cystectomy rate <1.5/year versus ≥2.75/year 105 
respectively). The direction of effect is consistent with the results of this current 
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study when only considering the case-mix adjusted odds ratios, although their 
magnitude of effect was greater. 
It could be suggested that there are only marginal differences in the annual 
caseloads between surgeon volume categories defined in this study. As compared 
with other studies however, the cut-offs are relatively far apart. Birkmeyer et al.
99
 
demonstrated that the adjusted odds ratio for operative death for patients with a 
low-volume surgeon (<2 cases/year) versus those with a high-volume surgeon 
(>3.5 cases/year) was 1.83 (CI 1.37 to 2.45). Conversely, Konety et al.105 
demonstrated no overall differences in in-hospital mortality across surgeon 
volume, but using only marginal volume cut-offs (low volume ≤ 1case/year and 
high volume > 1.5cases/year). 
Few studies have investigated the effects of institutional structural variables and 
processes of care in the cystectomy treatment pathway. Some evidence from the 
US suggests that adjusting for processes of care before, during, and after radical 
cystectomy accounts for 23% of the volume-mortality effect 107. Institutional 
structural variables can attenuate the volume-mortality relationship by up to 59% 
120.  
3.5 Conclusions 
Interpretation of the institutional volume-mortality relationship reported in this 
study was only possible after adjustment for institutional structural and process of 
care variables. Adjusting for these confounders, in addition to case-mix, must be 
performed before considering the use of volume-outcome data to support 
centralisation of care to a few high-volume centres specialising in radical 
cystectomy for bladder cancer. This study has made no effort to determine causal 
relationships between individual structural and process of care measures and 
mortality following radical cystectomy. Mortality is only one of a number of 
outcomes that need to be examined when trying to improve the quality of care for 
patients and the volume-outcome relationship for outcomes other than mortality 
needs to be explored. Longer-term outcomes, including functional morbidity and 
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disease recurrence, may ultimately influence towards centralising care and so help 
inform future service design and reconfiguration. 
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3.6 Key points arising from study two 
• A volume-outcome relationship for mortality following radical cystectomy 
exists at the institutional level, and to a lesser degree at the surgeon level 
• Appropriate interpretation of the volume-mortality relationship was only 
possible after adjusting for institutional and surgeon volumes and 
structural and process of care confounders 
• For radical cystectomy, centralising care to a few institutions should only 
be considered once the relationship between caseload volume and outcome 
(including outcomes other than mortality) has been properly adjusted for 
structural and process of care variables such as staffing levels of nurses 
and junior doctors, as well as case-mix. 
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Chapter 4  
THE VOLUME-OUTCOME 
RELATIONSHIP FOR RADICAL 
CYSTECTOMY IN ENGLAND: THE 
IMPACT OF EXAMINING 
OUTCOMES OTHER THAN 
MORTALITY 
 
 
 
 
 
 
 
The following chapter has been submitted as: 
Mayer EK, Bottle A, Aylin P, Darzi AW, Athanasiou T, Vale JA. The volume-
outcome relationship for radical cystectomy in England: An analysis of outcomes 
other than mortality. Submitted 2010. 
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4.1 Introduction 
The previous study has presented the results of volume-mortality analysis for 
radical cystectomy in England. As discussed, mortality may not always be the 
most appropriate outcome measure to demonstrate differences in care between 
volume providers if the number of events is small. Mortality is a ‘blunt’ endpoint 
and can be the result of numerous other measurable outcomes in a patient’s 
pathway of care.  
Study two has demonstrated the importance of adjusting for structural and process 
of care confounders when examining the volume-mortality relationship. It can be 
postulated that some of these same confounders, such as staffing levels, may have 
an even greater effect on outcomes in the more immediate postoperative period 
such as complications and re-intervention rates.  
The aim of this study is to expand the model developed in the previous study to 
include other outcome measures and so fully explore the volume-outcome 
relationship for radical cystectomy in England. 
4.2 Methods 
The data extraction, assignment of institutional and surgeon volume bands and 
model development is as previously described in study two, section 3.2.  
4.2.1 Outcome measures 
The additional outcome measures examined were postoperative re-intervention, 
postoperative complications and emergency readmission within 28 days for any 
reason to any hospital. Length of stay was also extracted from the dataset. 
Two re-intervention variables were created by inspecting the list of procedures 
(coded using OPCS4) occurring within 30 days of the cystectomy: re-intervention 
within 14 days (i.e. between days 1 and 13 inclusive after the cystectomy) and re-
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intervention within 30 days (i.e. between 1 and 29 days inclusive), even if 
performed following transfer or discharge from the institution at which the 
cystectomy had been performed (Appendix B). The secondary diagnosis fields 
were inspected for a list of potential postoperative complications as listed in 
Appendix B. This provided the outcome measure “complications”. We also 
subdivided “complications” into procedure-specific (those deemed to be directly 
attributable to the cystectomy) and non-procedure specific (those that could occur 
after any type of surgery). Similarly, re-interventions were categorised into those 
related to managing a complication arising directly from the operation itself 
(operation-specific re-interventions) and those needed for other reasons (non-
operation specific re-interventions). Categorisation of complications and re-
interventions was performed independently by EM and JV without having 
knowledge of the volume data to avoid causing potential study bias. Any 
disagreement was resolved by consensus opinion. Complications and re-
intervention within 14 days and 30 days were combined to give a further outcome 
measure (“any event”). 
The median length of stay was noted for each year but not included in the volume-
outcome modelling. Length of stay was calculated in days (strictly speaking, in-
patient nights) using the HES entry fields date of discharge minus date of 
admission. 
4.3 Results 
Re-intervention rates at 14 & 30 days and the outcome any event showed non-
linear trends across the years ( Table 4.1). There was also a significant, but small, 
decrease in average LOS (0.09 day each year). 
Both medium and high-volume institutions have a higher unadjusted rate of re-
interventions and any event. High-volume institutions have a greater rate of 
complications than both medium and low-volume institutions,  Figure 4.1. 
Similarly at the surgeon level, medium and high-volume surgeons have a higher 
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unadjusted rate of re-interventions within 30 days, complications and any event, 
 Figure 4.2. Absolute numbers of events are presented in  Table 4.2. 
For both institutions and surgeons there was little difference in the crude 
readmission rates across volume tertiles. 
Statistically significant associations were seen between re-intervention and some 
of the structural confounders,  Table 4.3. 
4.3.1 Volume-outcome relationship 
4.3.1.1 Re-intervention 
Medium-volume institutions had statistically significant greater odds of re-
intervention both within 14 and 30 days for all models. For model four, there was 
a 63% and 52% greater odds for re-intervention within 14 and 30 days 
respectively (OR 1.63 (1.15 to 2.32, p=0.01) and OR 1.52 (1.13 to 2.04, p=0.01)) 
( Figure 4.3). There were similar findings for high-volume institutions using 
models one, two and three, but for model four, the higher odds of re-intervention 
within 14 and 30 days decreased and became non-significant at the 5% level (OR 
1.33 (0.86 to 2.04, p=0.20) and OR 1.26 (0.87 to 1.81, p=0.22) respectively) 
( Figure 4.3). After categorising re-interventions, medium-volume institutions 
continued to show a statistically significant greater odds of non-operation specific 
re-intervention (OR 1.46 (1.13 to 1.89, p<0.01)) and a trend towards higher odds 
of operation-specific re-intervention (OR 1.25 (0.96 to 1.63, p=0.10)) for model 
four ( Figure 4.4). 
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Figure 4.1 Crude outcome rates (%) stratified by institutional volume tertiles 
 
Figure 4.2 Crude outcome rates (%) stratified by surgeon volume tertiles 
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In contrast, high-volume surgeons had a statistically significant lower odds of re-
intervention within 14 days for models three and four (OR 0.73 (0.55 to 0.96, 
p=0.02)) (OR 0.68 (0.51 to 0.91, p=0.01)) which was not apparent using models 
one and two ( Figure 4.5). For re-intervention within 30 days, a statistically 
significant higher odds for models one and two (OR 1.22 (1.06 to 1.40, p<0.01) 
and OR 1.17 (1.01 to 1.34, p=0.04)) became non-significant at the 5% level for 
models three and four ( Figure 4.5). There was no significant relationship between 
surgeon volume and operation-specific and non-operation specific re-interventions 
( Figure 4.6). 
4.3.1.2 Complications 
Both high-volume institutions and high-volume surgeons had higher odds of 
complications for models one and two. Model two gave an OR of 1.22 (1.06 to 
1.39, p<0.01) and an OR of 1.34 (1.17 to 1.54, p<0.01) for institutions and 
surgeons respectively. These results became non-significant at the 5% level for 
models three and four. No significant differences were seen for medium-volume 
institutions or surgeons ( Figure 4.7 &  Figure 4.8). There was no statistically 
significant relationship between institutional or surgeon volume and procedure-
specific and non-procedure specific complications. ( Figure 4.7 &  Figure 4.8) 
4.3.1.3 Readmission 
No statistically significant difference in odds of readmission within 28 days was 
seen across institutional or surgeon volume bands although for medium-volume 
surgeons a lower odds of readmission approached significance for model three 
(OR 0.86 (0.72-1.03, p=0.09)). ( Figure 4.9 &  Figure 4.10) 
A summary of the adjusted probabilities for each outcome across both the 
institutional and surgeon volume bands is displayed in  Figure 4.11. Adjusted 
probabilities were calculated using model four. 
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 Table 4.4,  Table 4.5 and  Table 4.6 display the crude odds ratios and adjusted odds 
ratios for models two to four for each outcome assessed across both institution 
and surgeon volume tertiles. 
4.3.2 Interaction effect 
Only re-intervention within 14 days had a statistically significant relationship for 
both institutional and surgeon volume. This therefore allowed for testing of 
interaction effect between the two volume variables but this was not statistically 
significant (p=0.67). 
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4.4 Discussion 
4.4.1 Principal findings 
The odds of re-intervention within 14 and 30 days of operation, for patients 
undergoing radical cystectomy in medium-volume institutions when compared 
with low-volume institutions, were found to be 63% and 52% higher respectively. 
This did not translate to a correspondingly higher readmission rate; this could be 
due to the fact that re-intervention may have itself reduced readmission rates, the 
complication having become manifest before discharge. Patients had 46% greater 
odds of non-operation specific re-interventions using the final complex model. 
Adjustment for the same variables had no effect on operation-specific re-
intervention rates. This suggests that the structural and process of care factors had 
an important protective role at the medium-volume institutional level on non-
operation specific re-interventions. 
High-volume surgeons (but not medium volume) were associated with a reduced 
odds (32%) of early re-intervention (within 14 days) compared with low-volume 
surgeons. Operation-specific re-interventions are generally needed within a 
shorter timeframe following the index procedure and this could explain why the 
lower odds of overall re-intervention seen for high-volume surgeons within 14 
days is no longer present at 30 days due to dilution by non-operation specific re-
interventions, which occur later. Categorisation of re-interventions within a 30-
day period into operation specific and non-operation specific re-interventions, 
however, did not reveal any noticeable relationships with surgeon volume. 
There was no statistically significant relationship between volume and the risk of 
complications at either the institutional or surgeon level. Recording of 
complications will vary between institutions and the finding may be artefactual. 
An argument against this is that a statistically significant higher rate of 
complications was seen for both high-volume surgeons and institutions after case-
mix adjustment, and this only became non-significant after adjusting for 
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clustering. The implication may be that complications can be directly influenced 
by both the surgeon and institution (some more surgically related such as 
anastomotic leaks, wound haematomas and some more medically related to post-
operative care, such as deep vein thrombosis and chest infection). The results did 
not reveal any definitive patterns after categorisation of complications into 
procedure-specific and non-procedure specific. 
As seen for mortality, there was relatively little difference in the crude OR and 
case-mix adjusted OR of each outcome at both the institutional and surgeon level. 
This provides further supporting evidence that case-mix adjustment may not be 
necessary for high level performance analysis, such as used in this study. 
4.4.2 Strengths and weaknesses of the study  
As highlighted in the previous study, it was not possible to perform sub-analysis 
of outcomes on the basis of whether an ileal conduit diversion or continent 
diversion had been performed. This limitation was probably less important when 
examining mortality, but differentiating between continent and incontinent 
diversion will have more of an impact on complication and re-intervention rates 
and indeed even possibly readmission rates.  
Mortality is a definitive endpoint and avoids some of the concerns of coding 
errors in administrative databases for outcomes such as re-interventions and 
complications, which require a greater degree of subjectivity when interpreting 
clinical notes for the purpose of coding. A coding audit carried out by the Audit 
Commission identified that the vast majority of errors of diagnostic and procedure 
codes were caused by coders rather than non-coders because of suboptimal 
standards of source documentation 178. Procedure (re-intervention) coding was 
demonstrated to be more accurate than diagnosis (complication) coding 174. The 
Payment by Results national benchmarker has been introduced to target areas for 
clinical coding audits as part of an assurance framework to further improve data 
quality at the local level 178. The average clinical coding error rate of 16.5% across 
primary and secondary diagnosis and procedure coding in 2007/08 improved in 
2008/09 to 12.8% with a reduction also seen in the interquartile ranges for both 
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procedure and diagnosis coding across acute NHS Trusts in England 174. If the 
recording of complications/re-interventions in HES is very dependent on volume, 
there is the possibility that differences seen across volume bands could be at least 
partly due to artefact, but it is impossible to prove this one way or the other with 
the available data. 
This study has adjusted for both institutional and surgeon volume simultaneously 
to begin to assess the influence of each across a number of outcomes. It can be 
difficult to distinguish the independent effects of the institution/surgeon on 
outcomes because high-volume surgeons operate at high-volume institutions and 
vice versa. This study demonstrated a non-significant interaction effect for 
institution/surgeon volume on re-intervention rates within 14 days, although 
statistical power to detect an interaction effect was limited. Of those operations 
performed in a high-volume institution, 16%, 32% and 50% were performed by 
low, medium and high-volume surgeons respectively. The 2% of operations that 
did not have an attributable surgeon volume arose because these surgeons were 
excluded from the surgeon level analysis for performing, on average, ≤2 
cystectomies per year and having fewer than three years of data. 
The variable ‘re-intervention’ rather than return to theatre was used as an outcome 
measure because contemporary approaches to the management of post-operative 
complications are more conservative and often include radiological techniques. As 
a result, transfusion episodes were incorporated as a re-intervention. However, the 
method by which the re-intervention was generated means that only transfusions 
given in the days following cystectomy, and not therefore required intra-
operatively, were included and as such reflect a ‘true’ re-intervention. It was not 
possible to determine the number of units transfused for each patient.  
The outcome measure ‘any event’ was created to explore the impact of assessing 
the volume-outcome relationship using a composite outcome measure as opposed 
to more granular measures, i.e. re-intervention and complications separately. In 
the final complex model, neither at the institutional level or surgeon level was 
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there a volume-any event relationship when one existed for one of its component 
elements, re-intervention.  
The previous study discussed the issue of overfitting of the model (collinearity), 
such that if the variables used in our final complex model were highly correlated 
with volume this would have the effect of widening the confidence intervals and 
reducing the statistical significance of any differences seen; there would not be 
any biasing of the results. The noticeable increase in the width of the confidence 
interval seen for the institution volume group with the addition of the structural 
and process variables when examining mortality was not convincingly repeated 
for the other outcomes. There is therefore no convincing evidence of overfitting of 
the model. Including 11 outcomes in the analysis affords more opportunity for 
false positives than if only a single outcome measure was used, but the finding 
that five of these outcomes had significant (at the conventional 5% level and in 
fact with p<0.02) volume relations is more than would be expected by chance. 
4.4.3 Comparisons with other studies 
The volume-complications relationship following cystectomy has been 
infrequently considered. Elting et al.108 demonstrated that the risk of developing a 
complication was 47% lower if the patient was treated in a high-volume hospital 
(>10 cases/year). In contrast Konety et al.118 only showed a statistically significant 
lower risk in high-volume hospitals (> 3 cases/year) for primary complications 
(directly attributable to cystectomy), OR 0.81 (0.66–0.99); no differences were 
seen for their list of secondary complications, OR 0.96 (0.75–1.24). This current 
study did not corroborate the finding of a lower risk of primary complications, but 
this is not surprising as Konety et al. defined high-volume as > 3 cases per year as 
compared to > 16 cases per year (low-volume > 2 < 10 cases per year) used in this 
study. Although a higher case-mix adjusted risk of complications for both high-
volume institutions and surgeons was demonstrated, the loss of this relationship 
after adjusting for clustering and categorisation of complications indicates the 
importance of this analysis approach. Another study reported no significant 
association between hospital volume and complications 179. It has also been shown 
that there can be volume-complication relationships for specific complications, 
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where none exists for composite complications measures 121. Absolute differences 
in the risk of complications for high-volume hospitals in this study as compared 
with the others described could be explained by the different volume cut-offs 
used. No study has specifically evaluated the re-intervention rates following 
cystectomy, although inevitably some of the complications reported will require 
surgical intervention. Re-intervention, like mortality, forms ‘hard’ measurable 
endpoints and can be associated with significant morbidity for the patient.  
There was no relationship between volume and readmission rates. Measuring 
readmission rates has been shown to be useful as a performance measure when 
assessing a relatively homogenous patient population with respect to case-mix, 
and the severity of the condition of interest displays little variance, such as in the 
day surgery setting 98. 
The only other urological study to investigate complications and readmission rates 
using the HES database assessed these outcomes in relation to radical 
prostatectomy 121. They reported that there was an inverse relationship between 
in-hospital complications within 30 days and hospital volume. This association 
however disappeared after case-mix adjustment. They did confirm that 
readmission rates within a year were lower in higher volume institutions but again 
after case-mix adjustment, there was a non-statistical difference across 
institutional volume of an order similar to our study. Other studies have shown no 
relationship between volume and 30-day readmission rate following cystectomy 
97
. There appears, therefore, to be little additional benefit in measuring 
readmission beyond 30 days. 
4.5 Conclusions 
This study, in combination with the evidence from study two, implies that when 
using currently available administrative data for risk-adjustment, measures of 
mortality, complications and re-intervention rates can be used as outcome 
measures to discern differences across institutional or surgeon volume providers 
when analysed independently of each other. However, when the institutional and 
 194 
surgeon volume are co-examined and adjustment for structural and process of care 
variables performed, volume-outcome relationships become less clear, although 
mortality and re-intervention rates continue to demonstrate differences. 
Institutions and surgeons are not mutually exclusive and treatment outcomes are 
dependent on the interaction between them. Mortality is a definitive endpoint and 
avoids some of the concerns of coding errors in administrative databases for 
outcomes such as re-interventions and complications, which require a greater 
degree of subjectivity when interpreting clinical notes for the purpose of coding. 
While this study has suggested correlation between individual structural and 
process of care measures and outcomes of radical cystectomy, it has made no 
effort to determine causal relationships and this will need to be the subject of 
further research to help inform future service design and reconfiguration. The 
influence of the surgeon, on-call surgical and nursing cover and availability of 
ancillary services such as interventional radiology can all influence the detection 
and management of complications that may lead to re-intervention and/or death; 
all of these factors need to be measured and considered together. 
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4.6 Key points arising from study three 
• A volume-outcome relationship for re-intervention after radical 
cystectomy existed at the institutional and surgeon level. 
• Re-intervention rates can be used as outcome measures to discern 
differences across institutional or surgeon volume providers when the 
institutional and surgeon volume are co-examined and adjustment for 
structural and process of care confounders performed. 
• The surgeon volume-re-intervention relationship only became apparent 
after adjusting for the influence of the institution and provided the 
strongest evidence for the influence that the surgeon/institution interaction 
can have on patient outcomes. 
• The absence of a volume-outcome relationship for the outcome measure 
‘any event’ when one was present for re-intervention, demonstrated the 
importance of not using composite outcome measures. 
• Further understanding of the interplay between the volume-complication, 
re-intervention and mortality relationships will help to determine the 
causal relationships that may exist between structural and process of care 
confounders and patient outcomes. 
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Chapter 5  
RISK-ADJUSTED FUNNEL PLOT 
ANALYSIS OF RADICAL 
CYSTECTOMY OUTCOMES ACROSS 
ENGLISH NHS TRUSTS 
 
 
 
 
 
 
 
 
 
The following chapter has been submitted as: 
Mayer EK, Bottle A, Aylin P, Darzi AW, Vale JA, Athanasiou T. What is the 
role of risk-adjusted funnel plots in the analysis of radical cystectomy volume-
outcome relationships? Submitted 2010. 
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5.1 Introduction 
As highlighted in the introductory chapter, ranking in surgical performance has 
significant limitations, risks and implications which can be addressed by the use 
of statistical control charts. CUSUM are ideal for prospective assessment once 
‘control’ has been confirmed. Funnel plots are good for identifying which 
processes are not yet in control and are practical tools, easy to use, and offer the 
opportunity to statistically define control limits around measurable outcomes and 
allow for adjustment of unmeasured factors, but should not be used to overcome 
significant inadequacies in data quality. Displaying performance data using funnel 
plots has advantages over conventional bar graphs and caterpillar plots 89. 
The incremental model developed in studies two and three demonstrated the 
benefits of adjusting volume-outcome relationship data for structural and process 
of care factors and considering the hierarchical nature by co-examining 
institutional and surgeon volume. For this aggregated, ‘high-level’ analysis, there 
appeared to be little impact of case-mix adjustment using currently available 
variables from administrative data.  
Risk-adjusted funnel plots can be produced for each step of the incremental 
statistical model and display risk-adjusted outcomes for each provider unit. 
Analysis at a more granular level might reveal volume-outcome relationships 
which are obscured by aggregated data analysis and consequently forms an 
important component of a broader methodological framework for volume-
outcome relationship analysis. 
The first aim of this study was to identify whether risk-adjusted funnel plots were 
useful as an addition to aggregated cross-sectional volume-outcome data analysis. 
The second aim was to increase the understanding, at the institutional level, of the 
impact of analysing volume-outcome data by combining funnel plots with an 
incremental statistical model approach. 
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5.2 Methods 
5.2.1 Data extraction and model development 
The data extraction, assignment of institutional volume bands, model 
development and outcome definitions are as previously described in studies two 
and three, sections 3.2 and 4.2. 
Risk-adjusted funnel plots were produced for mortality and re-intervention rate as 
these two outcomes were shown, in studies two and three, to have a statistically 
significant institutional volume-outcome relationship following radical 
cystectomy. The definitions for total mortality and re-intervention within 30 days, 
as previously described, were used. 
5.2.2 Creating risk-adjusted funnel plots 
Funnel plots were produced in Excel using templates, freely available from the 
Eastern Region Public Health Observatory 180. These funnel plots for proportions 
use exact binomial limits (based on the F-distribution). The templates were 
adapted to create risk-adjusted funnel plots and so that each Trust was assigned a 
different colour data point depending on whether it was low-, medium- or high-
volume. A single funnel plot was created for each of models one to four, using the 
corresponding Trust-level crude outcome rates for model one or predicted 
probabilities for the other models. 
The adjusted outcome rates, at the Trust level, were calculated by the formula: 
(observed number of events for the Trust / total predicted probability for the 
Trust) x (total observed number of events in England / total number of operations 
in England) 
Predicted probabilities at the patient level for model two were calculated using 
logistic regression in SPSS version 16. Predicted probabilities for models three 
and four were derived from three-level models in SAS v9.2 that allowed for the 
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clustering of patients within surgeons and of surgeons within hospitals. Predicted 
probabilities at the patient level were aggregated for each model to give the total 
predicted probability for each outcome by Trust. 
Using Trust-level crude mortality rates, a bar graph and caterpillar plot were 
created to allow direct comparison of data presentation with an unadjusted funnel 
plot. 95% confidence intervals for the caterpillar plot were calculated in the 
standard fashion using the normal approximation: 
95% CI = mortality rate +/- (1.96 x standard error) 
Calculating the mean predicted probabilities by volume tertile for total mortality 
confirmed that these mean rates reflected the trends of the odds ratios derived 
from study two. Medium volume Trusts demonstrated a higher mean predicted 
probability as compared to low-volume Trusts and high-volume Trusts. A similar 
correlation of trends was seen between the predicted probabilities and odds ratios 
for re-intervention within 30 days,  Table 5.1. 
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5.3 Results 
5.3.1 Bar graph and Caterpillar plot analysis 
Conventional performance data display as in  Figure 5.1 does not consider volume 
of procedures performed and spuriously ranks Trusts against one another. Trusts 
82 to 134 had a mortality rate greater than the average of 2.9%.  Figure 5.2 is 
similar to  Figure 5.1 in its ranking of Trusts but in addition plots the 95% 
confidence intervals. Trust A and Trust B are the only two that have their lower 
confidence interval above the average and so it can be stated that their observed 
mortality rate was greater than the national average. Two Trusts were observed to 
have lower than average rates (Trusts 41 and 46). 
5.3.2 Funnel plot analysis 
Using the same crude mortality rates,  Figure 5.3 (model one), is an unadjusted 
funnel plot that demonstrates that no Trusts had truly divergent high mortality 
rates (outside the 3 standard deviation control limits). Trust A and Trust B, can be 
seen to be lying between the upper 2 standard deviation and upper 3 standard 
deviation control limits. Compared with medium and high-volume Trusts, 
considerably more low-volume Trusts had a recorded mortality rate of zero. 
Comparing model one with model two ( Figure 5.3), there appeared to be 
relatively little impact at the individual Trust level of adjusting for case-mix. 
Adjusting for the influence of the surgeon (model three,  Figure 5.4), 
demonstrated, in particular for Trusts A and B, that there was a considerable 
decrease in the adjusted mortality rates. In the final complex model, which 
adjusted for structural and process of care confounders, all Trusts, apart from two 
high-volume providers who recorded zero mortalities, simply show the natural 
variation inherent in any stable process (or, in SPC terminology, ‘common cause 
variation’ as opposed to ‘special-cause variation’). 
For re-intervention within 30 days of operation, the unadjusted data identified a 
single high-volume Trust (Trust C) that had a truly divergent high rate of re-
intervention,  Figure 5.5, model one. A single medium-volume Trust was lying on 
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the upper 3 standard deviation control limit and a number of low-, medium- and 
high-volume Trusts lie between the upper 2 and 3 standard deviation control 
limits. As for mortality, there appeared to be relatively little influence of case-mix 
adjustment at the individual Trust level when comparing model one’s funnel plot 
with that of model two,  Figure 5.5. Adjusting for the influence of the surgeon 
caused the adjusted re-intervention rate of Trust C to return to sit within the 
control limits.  Figure 5.6. In the final complex model all Trusts, apart from three 
low-volume Trusts who recorded zero re-intervention rates, were acting under 
common cause variation. For several medium-volume Trusts, however, adjusting 
for structural and process of care confounders did cause an increase in the 
adjusted re-intervention rate and a single Trust came to lie between the upper 2 
and 3 standard deviation control limits. 
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Figure 5.2 Caterpillar plot of crude mortality within 30 days of radical cystectomy for NHS 
Trusts in England. 95% confidence intervals are plotted and compared with the overall proportion 
of 2.9% 
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5.4 Discussion 
5.4.1 Principal findings 
Ranking Trusts based on their mortality rates using a conventional technique 
identified that over a third of Trusts had a rate that was worse than the national 
average and which could be construed, in particular by the lay person, to have 
poor (divergent) performance when in reality this was not true. The addition of 
95% confidence intervals as seen in the caterpillar plot did correctly identify that 
for all except two of these Trusts, the observed rate cannot be said, with any 
statistical certainty, to be different from the mean. Plotting the same data using 
unadjusted funnel plot methodology demonstrated that no Trust had truly 
divergently high mortality rates, although the same two Trusts highlighted by the 
caterpillar plot did lie between the upper two and three standard deviation control 
limits which might warrant further investigation.  
No Trust in the final complex model risk-adjusted funnel plots exhibited special-
cause variation with abnormally high mortality or re-intervention rates. Special-
cause (non-random) variation signals the effects of external factors upon a process 
which requires further investigation. It was reported in studies two and three that 
when compared with low-volume Trusts, medium-volume Trusts had 82% greater 
odds of 30-day total mortality and 52% greater odds of re-intervention within 30 
days. There were no outliers at the individual Trust level which satisfactorily 
explained this higher aggregated mortality odds ratio for medium-volume Trusts. 
Two high-volume Trusts in the final complex model, each having performed more 
than 100 cases, had a recorded zero mortality rate and were acting under special-
cause variation with a truly divergent low mortality rate. Further investigation 
could well identify important lessons to be learnt. 
For both mortality and re-intervention rate, adjusting for influence of the surgeon 
had the greatest impact. This was particularly true for re-intervention rates, where 
a single high-volume Trust that displayed special-cause variation with a high re-
intervention rate was brought back ‘under statistical control’ (i.e. within the 
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control limits). This control was maintained when adjusting for structural and 
process of care confounders and confirms that further investigation at the surgeon 
level could identify important issues. A similar trend was seen for a single 
medium-volume and high-volume Trust with respect to mortality, although their 
performance was not truly divergent before adjusting for the surgeon influence.  
5.4.2 Strengths and weaknesses of the study 
Funnel plot methodology has the advantage of allowing for the simultaneous 
interpretation of performance with volume of procedures performed, a 
considerable advantage over methods such as caterpillar plots. As previously 
described, funnel plots can be used for the initial assessment of any volume-
outcome relationship 89. They cannot, however, overcome basic inadequacies in 
data quality such as ‘coding errors’. For the volume tertiles generated in studies 
two and three, large numbers of very low-volume providers were not excluded 
which may have contaminated the low-volume tertile if it contained patient-level 
records present only through coding errors. It can be seen from the mortality 
funnel plots that a relatively large proportion of low-volume Trusts, as compared 
to medium and high-volume Trusts, have a mortality rate recorded as zero. It is 
impossible to say if this is from miscoding or is a ‘true’ zero reflecting the low 
overall operation count. This proportion of ‘zero Trusts’ would have influenced 
the aggregated odds ratios generated in study two thereby diluting any potential 
volume-outcome relationship. It is not possible to say anything more about these 
low-volume Trusts in terms of their mortality rates from the current data, but 
further investigation could look to see if they are really carrying out these 
procedures. The plotting of individual provider level data for funnel plots, 
therefore, has advantages when interpreted alongside the more traditional 
aggregated volume-outcome relationship research. 
Plotting risk-adjusted funnel plots as an adjunct to aggregated volume-outcome 
analysis also allows for a degree of model development validation. As can be seen 
from this study, colour coding the Trusts in each volume tertile demonstrated that 
the annual cystectomy rate cut-offs used for the volume tertiles correlated well 
with overall number of procedures performed. This means that at the Trust level, 
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volume categorisation was reflective of both total procedures performed and an 
annual rate of procedures performed. This is maybe not surprising at the Trust 
level, but may not hold true at the surgeon level, where newly appointed 
consultants and those retiring during the time period analysed will influence the 
correlation between experience gained from having performed a certain total 
number of procedures and a critical number of procedures performed on an 
ongoing basis to maintain performance levels. The importance of overall number 
of procedures performed and quality of training on ongoing performance in uro-
oncological surgery has been previously highlighted 181 182. 
Funnel plot control limits can be generated to ask a number of different questions, 
but this study has only used them to assess which Trusts’ rates are not compatible 
with the overall average. As no Trust in the funnel plot using the final complex 
model for risk-adjustment, for both mortality and re-intervention, can be 
confidently said to have a performance worse than the national average, 
constructing different control limits to further explore which Trusts are probably 
extraordinary performers was not necessary 
183
. 
5.4.3 Comparison with other studies 
To the best of my knowledge, no study has previously published or made publicly 
available a similar funnel plot analysis of outcomes for radical cystectomy either 
in England or elsewhere. Direct comparison with other studies is therefore not 
possible. The advantages of funnel plots as a graphical aid for comparing 
institutional performance and avoiding spurious ranking of institutions into 
‘league tables’ has been reported 
89
. The case for a more widespread application 
of funnel plots in surgery in order to help to overcome some of the existing 
difficulties in assessing and reporting performance was made in chapter 1, section 
1.3. The use of funnel plot methodology in combination with a more statistically 
robust methodological framework for volume-outcome relationship assessment 
has not been previously reported. 
From studies two and three, it was concluded that medium-volume Trusts had a 
statistically higher odds of mortality and re-intervention within 30 days of radical 
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cystectomy as compared with low-volume Trusts. High-volume Trusts had 
statistically no difference in odds as compared with low-volume Trusts. Although 
this incremental funnel plots analysis cannot refute this finding, it has provided 
additional information as to potential reasons for this finding. It was stated in 
study two that compared with low-volume Trusts, patients undergoing radical 
cystectomy in medium-volume Trusts had 82% greater odds of total mortality 
following their radical cystectomy. From  Figure 5.4 (model four), it is difficult to 
see such a clear difference in performance between low-volume and medium- 
volume Trusts that cannot be attributed to common-cause variation alone. 
Furthermore, the greater odds of total mortality for medium-volume Trusts only 
became apparent after adjustment for structural and process of care confounders, 
i.e. model four vs. model three. By comparing the mortality funnel plots for 
models three and four ( Figure 5.4) it can be seen that although there is relatively 
little difference in their appearance, two medium-volume Trusts of relatively 
higher volume (> 100 total cases) increase their mortality rates from 3.6% to 6.0% 
and 4.0% to 5.6%. This change, in two relatively high-volume Trusts within the 
medium-volume tertile, may have been instrumental in determining the 
statistically significant higher odds ratios calculated for medium-volume Trusts in 
the final complex model (study 2). The benefits of both visualising provider-level 
performance data and displaying them in combination with volume are therefore 
clearly evident. In study three, it was demonstrated that the magnitude of the 
greater odds of re-intervention in medium-volume Trusts compared with low-
volume Trusts was similar for all models. By comparing the re-intervention rate 
funnel plots for models two and three ( Figure 5.5 and  Figure 5.6), it can be seen, 
however, that there was considerable impact of adjusting for the influence of the 
surgeon on the individual Trust level outcomes. 
From the aggregated data analysis, it was postulated that case-mix adjustment, 
using variables as incorporated in studies two and three, was not always necessary 
for analysis of effects at a highly aggregated level. This appears to have been 
confirmed by the funnel plot analysis, which does not identify any significant 
changes, at the individual Trust level, between models one and two for either 
mortality or re-intervention rates.  
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5.5 Conclusions 
Unadjusted and risk adjusted funnel plots as produced in this study do have a 
useful role to play as a component of a methodological framework for 
investigating the volume-outcome relationship at the institutional level. They help 
with model validation by displaying disaggregated outcomes at the provider level 
and account for unmeasured confounders, so reducing the opportunity for spurious 
labelling of outliers. They have the advantage over conventional bar graphs and 
caterpillar plots of accounting for volume. 
Although funnel plots show something about the distribution of outcomes by 
volume of cases and should theoretically be able to demonstrate a volume-
outcome effect, in this analysis, the aggregated volume-mortality and volume-re-
intervention relationships previously reported in studies two and three are not 
obvious graphically. The interpretation of risk-adjusted funnel plots alongside 
more conventional aggregated volume-outcome relationship data can identify 
important areas for further evaluation and a combined approach to this question is 
therefore recommended. 
There is a need for funnel plots to play a more dynamic role as quality control 
tools in future surgical performance assessment and expand their use as an adjunct 
within a methodological framework for investigating the volume-outcome 
relationship which could influence future healthcare delivery. 
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5.6 Key points arising from study four 
• In the final complex model, no Trust in England demonstrated a truly 
divergent high rate of mortality or re-intervention within 30 days 
following radical cystectomy. 
• Risk-adjusted funnel plots do have a useful role to play as a component of 
a methodological framework for investigating the volume-outcome 
relationship. 
• Analysing volume-outcome data using risk-adjusted funnel plots can 
potentially influence the overall conclusions made from aggregated data 
analysis alone and therefore act as a useful adjunct for assessing the 
volume-outcome relationship. 
• Applying risk-adjusted funnel plots to an incremental statistical model can 
help direct further investigation of confounding factors at the individual 
Trust level.  
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Chapter 6  
PROVISION OF RADICAL PELVIC 
UROLOGICAL SURGERY IN 
ENGLAND AND COMPLIANCE WITH 
IMPROVING OUTCOMES GUIDANCE 
 
 
 
 
 
 
 
 
The following chapter was published as: 
Mayer EK, Bottle A, Darzi AW, Athanasiou T, Vale JA. Provision of radical 
pelvic urological surgery in England, and compliance with improving outcomes 
guidance. BJU Int. 2009;104(10):1446-51.  
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6.1 Introduction 
The importance of the volume-outcome relationship as a means to improve the 
quality of care that patients receive has been acknowledged in England and Wales 
with health policy centralising oncological services across a number of specialities 
43. Two hypotheses have been used traditionally to explain higher volume-better 
outcome relationships reported by numerous studies 96: “practice makes perfect” 
and the “selective-referral” hypothesis. The latter describes the phenomenon by 
which institutions or surgeons that display better outcomes receive more referrals 
and as a result treat greater volumes of patients 82. Several volume-outcome 
studies have suggested a minimum number of operations that should be achieved 
to improve patient outcomes. Pertinent to England, McCabe et al. suggested that a 
volume of 11 cystectomies per year was associated with the lowest mortality rates 
106. Judge et al. demonstrated a ‘U-shaped’ association between 30-day in-hospital 
mortality and the mean annual volume of prostatectomies categorised into 
quintiles (1-14 through to 46-93) 121. 
In 2002, NICE published IOG for urological cancer services, which was one 
supporting element for the implementation of the NHS cancer plan 
153
 and 
therefore served to improve treatment for cancer patients. Importance was placed 
on a regionalised multidisciplinary approach for the management of a number of 
urological cancers including radical pelvic surgery which considered radical 
cystectomy and radical prostatectomy in combination. The latest guidance for 
radical pelvic urological surgery indicated that a service should serve a catchment 
population of at least one million and consequently provide a minimum of 50 
radical cystectomy/prostatectomy procedures in total per annum 161. Although the 
idea of a catchment population has been introduced more recently, the minimum 
standard of 50 cases per annum had been a feature since the original guidelines.  
This study had three aims: firstly to ascertain the compliance of institutions to 
IOG guidelines for radical pelvic surgery, secondly to explore, in more detail, the 
pattern of service provision for radical cystectomy and radical prostatectomy both 
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before and after the introduction of IOG, and thirdly to investigate the referral 
patterns between Trusts for radical cystectomy service provision. 
6.2 Methods 
6.2.1 Data extraction 
Data extraction follows the principles described in section 3.2.1, but is again 
summarised here. 
Data for inpatient elective cystectomies (OPCS4 code M34 occurring in any 
procedure field in any episode) were taken from Hospital Episode Statistics (HES) 
for the six financial years 2000/1 to 2005/6 and from the Secondary Users Service 
for 2006/7. This was repeated using the OPCS4 code M61 to extract elective 
prostatectomy. HES covers all inpatient and day case admissions in NHS hospitals 
in England. Each record in HES constitutes a finished consultant episode, which 
covers the continuous period during which a patient is under the care of the same 
consultant, whose GMC code is recorded. Episodes were linked into admissions 
using the patient’s hospital number, the Trust and date of admission, and 
admissions were linked together if the patient was transferred to another Trust. 
Admissions were excluded if they were emergencies, had invalid age, sex or 
length of stay or were day cases or did not have a primary diagnosis of cancer 
(ICD10 C66, C67, C68, D090 for cystectomy, and C61 for prostatectomy). The 
proportion of cystectomies and prostatectomies that had such a diagnosis was 
calculated for each year. 
6.2.2 Assignment of radical cystectomy and radical prostatectomy volume 
bands 
The assignment of Trusts into volume bands for radical cystectomy and radical 
prostatectomy was necessarily independent of each other, although the approach 
and exclusion criteria used were identical. The numbers of radical cystectomies 
/radical prostatectomies were counted by year and by NHS hospital Trust. To 
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account for Trust mergers, Trust codes were unified to reflect their status as of 
April 2007. Trusts were excluded due to very low volume if they either had fewer 
than three years of data or had an annual rate of less than two radical 
cystectomies/radical prostatectomies per year. There is no agreed technique for 
dealing with Trusts which have low numbers of radical cystectomies/radical 
prostatectomies recorded, either as a result of coding errors or not, and the 
exclusion criteria were based on an assumption that less than three years’ data 
entry and mean annual radical cystectomy/radical prostatectomy rate less than two 
is unlikely to reflect true activity. Thirteen Trusts contributing 41 records from the 
radical cystectomy dataset and 17 Trusts contributing 73 records from the radical 
prostatectomy dataset were excluded on this basis. These excluded cases made up 
only 0.5% and 0.4% of the original datasets respectively. The remaining Trusts 
were put into ascending order of annual radical cystectomy/radical prostatectomy 
rate and divided into three groups of roughly equal volumes. The Trust volume 
bands defined for both radical cystectomy and radical prostatectomy are 
summarised in  Table 6.1. 
6.2.3 Assignment of IOG volume bands 
After exclusion of very low volume Trusts as described above, the numbers of 
radical cystectomy and radical prostatectomy performed by each Trust were 
combined for each year to give a total annual IOG activity per Trust. Where there 
was no recorded activity for either radical cystectomy or radical prostatectomy 
within a Trust in any one year, a figure of zero was assumed and the IOG activity 
for that year was calculated using only the number of either radical cystectomy or 
radical prostatectomy performed (whichever was present). Trusts were then 
categorised into three groups of unequal size according to their IOG activity for 
each year: Group 1 = <25 procedures, Group 2 = 25-50 procedures, Group 3 = 
>50 procedures. 
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6.2.4 IOG catchment populations 
Each radical cystectomy and radical prostatectomy spell was attributed to a 
Middle Layer Super Output Area (MSOA) via the patient postcode. MSOAs are 
geographical units with a minimum population of 5000. A Trust catchment 
population for radical cystectomy and radical prostatectomy was then calculated 
using the proportionate flow method. This is described in more detail elsewhere 
184. In brief, the same proportion of the population within each area (MSOA) is 
assigned to a Trust provider as the proportion of operative spells (radical 
cystectomy and radical prostatectomy) that originated from that area. The 
assigned populations from each area are then added together to give an overall 
catchment population specific for the operation(s) of interest. 
6.2.5 Radical cystectomy referral patterns 
In order to explore the referral activity of patients for radical cystectomy, patient 
IDs of those who had undergone radical cystectomy were used to identify records 
for preceding endoscopic extirpation of lesion of bladder (M42) or diagnostic 
endoscopic examination of bladder with biopsy of lesion of bladder (M45.1, 
M45.8, M45.9) as an indication of where the diagnosis and decision for RC had 
been made - “final endoscopic bladder procedure”. For each patient, the OPCS4 
episode occurring immediately prior to radical cystectomy was identified and the 
time period between date of admission for this final endoscopic bladder procedure 
and radical cystectomy noted. Differences in the recorded provider codes for 
radical cystectomy and preceding endoscopic bladder procedure were also 
identified.  
6.2.6 Data validation 
In the radical cystectomy dataset 24 patient IDs (combinations of date of birth, sex 
and postcode) had a total of 26 duplicate records. It was decided not to remove 
them as it was not always possible to determine which was the ‘real’ record and 
the duplicates only made up 0.3% of the total case number. In the radical 
prostatectomy dataset there were 120 patients each with a single duplicate record 
making up 0.7% of the total prostatectomy number. 
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Seven hundred and two patients (8.2%) in the radical cystectomy dataset did not 
have an identifiable, linkable record prior to their radical cystectomy admission 
record, and these were excluded from the referral pattern analysis only. 
Some of the patient records did not have an assigned postcode which precluded 
them from the catchment population analysis. Missing postcodes made up 0.9% of 
the radical cystectomy dataset and 0.6% of the radical prostatectomy dataset. 
Statistical analysis was performed using Statistical Package for Social Scientists 
(SPSS, version 16, Chicago, USA). Chi-square tests, logistic regression, linear 
regression and analysis of variance were used with significance defined at the 5% 
level. 
6.3 Results 
6.3.1 Improving Outcome Guidance adherence 
When combining, at the Trust level, the number of radical cystectomies and 
radical prostatectomies performed each year, it can be seen that those Trusts 
performing less than 25 procedures per annum (Group 1) decreased over the 
studied period and the decrease was occurring prior to the introduction of 
Improving Outcomes Guidance. The number of Trusts performing greater than 50 
procedures per year (Group 3) increased and, similarly, seems to have occurred 
irrespective of Improving Outcomes Guidance. The greatest effect of Improving 
Outcomes Guidance seems to have been on those Trusts performing 25 to 50 
procedures per annum (Group 2) where numbers have fallen after 2004/05 ( Figure 
6.1). Group 1 had higher numbers than expected in 2000/01, but within the 
expected range for all other years; group 3 had lower than expected counts in 
2000/01 and then higher in 2005/06 and 2006/07. 
The absolute number of Trusts achieving the guidance of 50 or greater procedures 
per year increased from eight in 2000/01 to 39 in 2006/2007. This means that 
34.2% of Trusts in 2006/07 were adhering to Improving Outcomes Guidance; this 
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compares with only 13.4% in 2002/03 – the year Improving Outcomes Guidance 
was introduced. There was a significant increase, during the time period analysed, 
in the percentage of Trusts achieving the recommended minimal case volume 
(36% rise in odds per year, P<0.0005 (OR 1.36, CI 1.24 to 1.50)) ( Figure 6.2). 
In 2006/07, only a single Trust achieved the recommended Improving Outcomes 
Guidance catchment population of greater than 1 million. The other 38 Trusts that 
achieved the cut-off of 50 cases per annum had a mean catchment population of 
472,577 (range 336,714 to 920,464),  Figure 6.3. 
6.3.2 Pattern of service provision for radical cystectomy and radical 
prostatectomy 
8596 records of cystectomy performed for cancer were extracted for the time 
period analysed. The number of cystectomies performed each year increased 
steadily from 1366 in 2000/01 to 1564 in 2006/07. The proportion of these 
assigned a diagnosis of cancer (mean 83.3%) did not vary significantly across the 
years (Chi square p value = 0.63). The number of prostatectomy operations 
performed for cancer over the time period studied increased significantly from 
1,601 to 3,083 (p value of trend across years <0.01); in total 18338 radical 
prostatectomy records were extracted. The proportion of radical prostatectomies 
to overall prostatectomy numbers similarly increased, 79.4% in 2000/01 to 90% in 
2006/07.  
The percentage of patients undergoing radical cystectomy under 65 years of age 
was relatively unchanged year on year with a mean of 36.9% ( Figure 6.4). The 
mean percentage of patients who underwent radical prostatectomy under the age 
of 65 was 59.4%,  Figure 6.5. 
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Figure 6.1 Histogram showing the variation in number of Trusts by IOG volume category over 
the time period studied 
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Figure 6.2 Figure demonstrating percentage of Trusts performing greater than 50 radical 
cystectomies and radical prostatectomies per year and therefore achieving IOG compliance 
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Figure 6.3 Scatter plot of catchment population versus annual number of combined 
cystectomies and prostatectomies at the Trust level. The horizontal intercept line indicates the cut-
off of 50 cases per year and the vertical intercept line indicates the recommended one million 
catchment population per Trust 
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During the studied period, 30 Trusts were involved in a merger resulting in a 
change of their provider code, accounting for 575 operations (6.7% of total). No 
mergers took place after 2003. Mergers resulted in 12 providers (as defined by 
2007 codes) changing volume band during the seven-year period (five Trusts 
moved from volume band two to three and five Trusts moved from volume band 
one to two; two Trusts would have been excluded).  
The total number of Trusts performing radical cystectomy significantly decreased 
over the years (linear regression p value = 0.03), whereas the total number of 
Trusts performing radical prostatectomy did not significantly decrease over the 
years (linear regression p value = 0.6) ( Figure 6.6). When categorised into volume 
groups, it is the low-volume Trusts both for radical cystectomy and radical 
prostatectomy that decreased in number over the years, although the decrease was 
not more than expected by chance. The numbers of medium- and high-volume 
Trusts remained static. The proportion of radical cystectomies performed by low-
volume Trusts was less than expected in 2005/06 and 2006/2007. The proportion 
performed by high-volume and medium-volume Trusts was more than expected in 
2005/06 and 2006/07 respectively ( Table 6.2). For radical prostatectomy, the 
proportion of operations performed by low-volume Trusts was lower than 
expected in 2005/06 and 2006/07 having been more than expected from 2002/03 
to 2004/05. Medium-volume Trusts performed more than expected procedures in 
2005/06 and 2006/07 ( Table 6.2). 
Only 47% of Trusts that were high volume for radical cystectomy were also high-
volume providers for radical prostatectomy,  Table 6.3. 50% of radical 
prostatectomy high-volume providers were also high-volume radical cystectomy 
providers (data not shown). The R-squared linear regression coefficient for 
correlation between annual cystectomy rate and annual prostatectomy rate is 0.4, 
( Figure 6.7). 
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Figure 6.4 Percentage of patients, who underwent radical cystectomy, who are over or under 
the age of 65 years. 
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Figure 6.5 Percentage of patients, who underwent radical prostatectomy, who are over or under 
the age of 65 years 
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Figure 6.7 Correlation between annual cystectomy rate and annual prostatectomy rate at the 
Trust level. 
 
 233 
6.3.3 Referral patterns for radical cystectomy 
7081 patients (82.4%) underwent the “final endoscopic bladder procedure” at the 
same Trust as the radical cystectomy. 813 (9.5%) patients were referred to another 
Trust for their radical cystectomy. Of these, 61% were transferred to a high-
volume radical cystectomy provider from a lower-volume Trust or a provider that 
had no volume band assigned (either a Trust that had been excluded during the 
assignment of volume bands process or a provider that was not recorded as 
performing radical cystectomy),  Table 6.4. 
Over the years there was a significant increase in the percentage of patients 
referred to another provider for their radical cystectomy, from 5.5% in 2000/01 to 
19.6% in 2006/07 – 28% rise in odds per year, P<0.0005 (OR 1.28, CI 1.23 to 
1.33). There were less than expected patients referred in the years 2000/01 to 
2003/04 and more than expected in 2005/06 and 2006/07. For the 267 records 
referred from Trusts in the ‘no volume band assigned group’, 171 (64%) were 
from small acute Trusts, 27 from medium acute Trusts, 25 from a single large 
acute Trust, six from a single acute teaching Trust and one from an acute 
specialist Trust. 32 records were recorded as being referred from a Primary Care 
Trust (12%) and five from mental health Trusts.  
The average time between admission for final endoscopic bladder procedure and 
radical cystectomy was significantly longer for patients who had different 
providers for the two procedures compared with those who did not (157 days 
versus 114 days, ANOVA p<0.0005). This difference remained across the time 
period assessed (Linear regression p<0.0005). To confirm significance of the 
difference in lag times between the two groups, trim points were generated for the 
5th and 95th percentile to exclude lag time outliers (775 records excluded) which 
could have arisen from limitations of the methods used or date coding errors (the 
endoscopic procedure being repeated on day of cystectomy (62 records) or 
apparent extremely long waits). The mean lag times were reduced to 110 days and 
91 days for those referred and those not referred respectively (also p<0.0005). 
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6.4 Discussion 
6.4.1 Principal findings 
Improving Outcomes Guidance appears to have had a positive effect on the 
centralisation of radical pelvic surgery. The decrease in low-volume providers 
prior to Improving Outcomes Guidance implementation (approximately 20 low-
volume Trusts) is likely to have reflected the natural regional reorganisation of 
services as a result of Trust mergers. After 2003/04 (when no mergers occurred), 
there was a continual decrease in low-volume providers and furthermore a 
decrease in medium-volume providers was seen after 2004/05 when previously 
numbers had been relatively stable. Although there had been a continued increase 
in the number of Trusts performing more than 50 cases during the introduction of 
Improving Outcomes Guidance in 2002/03, there was a greater increase from 
2005/06. Correspondingly there was a greater then expected increase in the 
number of patients referred to another provider for their radical cystectomy during 
2005/06 and 2006/07 and this is therefore likely to have represented a true 
Improving Outcomes Guidance phenomenon.  
It is plausible that the Improving Outcomes Guidance took time to take effect and 
as such studying change over a wider time period was necessary to reflect this. Of 
those Trusts compliant with Improving Outcomes Guidance in 2006/07, all but 
one did not have a catchment population greater than one million and the majority 
had a population less than half a million.  
The subject of volume-outcome relationships in surgery is a contentious one and 
this may explain in part the relatively slow uptake of Improving Outcomes 
Guidance and the number of Trusts that remained non-compliant in 2006/07. This 
may reflect sufficient doubt of clinicians as to the quality of existing evidence 
upon which Improving Outcomes Guidance has been built and therefore a 
reluctance to change local service arrangements. It was acknowledged in the 
Improving Outcomes Guidance for Urological Cancers research evidence 185 that  
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 “Most of the published research on urological cancers focuses on clinical 
evaluation of treatment; relatively little direct research has been carried out on the 
organisation and delivery of services. In addition, for many service delivery 
issues, RCTs (categorised here as the highest quality evidence) are not feasible. 
Therefore, research designs which are regarded as of relatively poor quality for 
evaluating a clinical intervention may be the most reliable available for assessing 
the effectiveness of service delivery”.  
The authors concluded that based on US data, having acknowledged its 
limitations, for radical prostatectomy, concentration to a small number of 
professionals appeared to lead to an increase in the effectiveness of that 
intervention. Evidence from a single English study did not support a similar 
finding for bladder cancer survival. The authors also acknowledged that increased 
volume alone would not necessarily lead to an improvement in the quality of care 
offered to patients. It is therefore maybe not surprising that engagement of 
clinicians with the centralisation policy is not forthcoming. 
Other inhibiting reasons for slow uptake of Improving Outcomes Guidance could 
also include local commissioning processes, new patient-choice reforms, public 
health factors such as patient willingness to travel and existing local referral 
networks amongst clinical colleagues. 
Improving Outcomes Guidance for radical pelvic urological surgery assesses 
radical cystectomy in combination with radical prostatectomy and therefore 
considers important the impact of different, but related, procedures (non-index 
procedures) on outcomes of the procedure of interest (index procedure). Even if 
there are different surgeons performing these operations, the institutional set-up 
and processes of care will influence the patient treatment episode irrespective of 
the index procedure. This is also reflected pre-operatively in the multi-disciplinary 
team environment and making available to the patient the most appropriate, 
evidence-based, management options. Gilbert et al. demonstrated that the 
relationship between surgical volume and mortality was reduced by 20% for 
radical prostatectomy and 60% for radical cystectomy after adjusting for surgical 
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volume of ‘non-index’ operations (radical nephrectomy and radical cystectomy 
and radical nephrectomy and radical prostatectomy respectively) 
186
. This current 
study has shown that there is correlation between the numbers of radical 
cystectomies and prostatectomies performed on a yearly basis at the NHS Trust 
level, although there is a fair amount of spread, ( Figure 6.7). In study two, 
adjusting for the institutional total urology episodes, although differing 
significantly across institutional volume groups, did not affect the volume-
mortality relationship ( Table 3.7). This is in keeping with the findings of Fradet et 
al. who demonstrated that a higher hospital radical cystectomy volume appeared 
to lower the risk of complications after other common urological oncological 
procedures (radical prostatectomy and nephrectomy), but not after non-
oncological urology procedures 187. 
The finding that about 37% and 59% of patients each year, who underwent radical 
cystectomy and radical prostatectomy respectively, were under the age of 65 years 
is further evidence why translating US based data to the UK setting can have 
limitations. Some of the US databases, as a result of the insurance schemes, are 
not representative of the entire treated population by only collating data on those 
over 65 years.  
6.4.2 Strengths and weaknesses of study 
There is no agreed process for dealing with potential coding errors when handling 
HES data for studies of this nature. During the assignment of volume groups for 
radical cystectomy it was decided to exclude very low volume Trusts (fewer than 
three years of data or an annual rate of <2 cystectomies per year) on the basis that 
it was not certain if these records reflected true activity. Justification for our 
exclusion criteria is provided by the referral pattern data. Of the 13 Trusts 
excluded during volume group assignment, 11 were subsequently identified as 
routinely referring their patients to another provider for radical cystectomy, 
contributing 193 of the total 813 (24%) referred patient population. This 
substantiates that the very low-volume radical cystectomy activity identified for 
these 11 Trusts was correctly excluded as coding errors. Similarly, this finding 
provides supporting evidence for the approach taken to exclude very low volume 
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Trusts in the volume-outcome relationship model presented in studies two and 
three. 
It was not possible to track the lag time between diagnosis of prostate cancer and 
radical prostatectomy in a similar fashion to that done for radical cystectomy. This 
is because outpatient procedures, such as prostate biopsy, are generally still not 
recorded in the HES database. This could potentially be overcome by combining 
national cancer registry data with HES data but, as demonstrated by a recent 
study, discrepancies when combining datasets can result in loss of a large number 
of the study population 173. It is possible that the percentage of patients identified 
as having been referred to another Trust for their radical cystectomy is under 
estimated because some institutions may routinely repeat the “final endoscopic 
bladder procedure” prior to radical cystectomy when taking a patient from 
elsewhere. 
6.4.3 Comparison with other studies 
The most recent study that commented on Improving Outcomes Guidance for 
radical pelvic surgery looked at volume-outcome relationship for radical 
prostatectomy in England 121. Having categorised mean annual radical 
prostatectomy volumes over an eight year period into quintiles they calculated 
potential Improving Outcomes Guidance adherence by adding a mean Trust 
cystectomy rate in 2004/05 to the quintile volumes for radical prostatectomy (“on 
average Trusts do 10 radical cystectomies per year in 2004/05”). On that basis 
they suggest that about 20% of Trusts would achieve the Improving Outcomes 
Guidance 50 cases per year. This current study suggests that this figure may be 
even lower at 17.8% for 2004/05 using the technique of combining radical 
cystectomy and radical prostatectomy at the Trust level. Furthermore, there was 
significant year-on-year variation in this figure. In addition to the different 
methods used, a further possible explanation for the difference in results between 
studies is that Judge et al. included all prostatectomy cases and not just those 
performed for cancer, i.e. radical prostatectomy. Moreover, Judge et al. quoted a 
median annual hospital Trust volume of 35 in 2004/05 as compared with a median 
of only 25 from this analysis. The group code M61 incorporates procedures such 
 239 
as transvesical prostatectomy. Irrespective of the differences discussed, Judge et 
al. showed that no more than a fifth of institutions performing radical 
prostatectomy approximately two years after introduction of Improving Outcomes 
Guidance were compliant. From this current study, this figure has only risen to 
approximately one-third compliance in 2006/07. 
6.5 Conclusion 
Improving Outcomes Guidance appears to have had a positive effect on the 
centralisation of radical pelvic surgery although it took time to happen. However, 
four years after its introduction only a third of English NHS Trusts achieved the 
minimum standard of 50 procedures. All but one of these did not have a 
catchment population of one million. The impact of this centralisation on patient 
outcomes and quality of care for radical cystectomy and radical prostatectomy in 
England has yet to be fully ascertained, but could be further explored by 
longitudinal data analysis. An analysis of this sort would need to incorporate the 
methodological improvements described in studies two and three and also 
incorporate risk-adjusted statistical control charts as part of an improved 
methodological framework for assessing quality of care. 
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6.6 Key points arising from study five 
• In 2006/07, only about one third of NHS Trusts in England were 
compliant with Improving Outcomes Guidance for volume of radical 
cystectomies and radical prostatectomies performed. 
• Of those Trusts who performed more than 50 cases per annum, only a 
single Trust served the recommended catchment population of at least one 
million. 
• Improving Outcomes Guidance does appear to have had some positive 
effect on centralisation of services with a decrease in low and medium-
volume providers in recent years. 
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Chapter 7  
CONCLUSIONS & FUTURE WORK 
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7.1 Conclusions 
This thesis has evaluated methods to assess the volume-outcome relationship as 
applied to radical cystectomy in English NHS Trusts and provided justification for 
future research in this area to be conducted under the guidance of a sound 
methodological framework.  
Such a methodological quality framework was originally proposed by the IOM in 
2000. It proposed clear guidance for future volume-outcome research, having 
extensively evaluated research up to that time, and incorporates two areas specific 
to methodological quality improvement ( Table 7.1). Despite this guidance, study 
one demonstrated that the quality of existing volume-outcome research as applied 
to uro-oncology was only modest at best and this was consistent with previously 
studies reporting on similar analysis 85 91. The recommendations of the IOM 
therefore appear to have had a limited impact and yet the application of a 
validated scoring system, which is readily useable and can be interpreted by 
healthcare professionals who may not have an in-depth knowledge of the area, has 
the potential to enhance interpretation of the volume-outcome literature. This in 
turn would improve translation to clinical practice and the practice of evidence-
based surgery by addressing several fundamental questions 86.  
The paucity of volume-outcome research relevant to uro-oncology and originating 
from a UK healthcare setting was highlighted as was the potential for more 
methodological robust statistical techniques to challenge the conclusions of 
previous research with the secondary implications for existing healthcare policy, 
which has advocated centralisation of services. 
 
 
 243 
 
 
Table 7.1 Guidance as developed by the Institute of Medicine for improving the quality of 
volume-outcome research  
 
Methodological Development 
 
 Examine outcomes other than mortality (e.g., functional status, quality 
of life), including longer-term outcomes 
 Include potential intervening variables (e.g., processes and systems of 
care) in volume– outcome studies 
 Integrate social science methods (e.g., sociology, medical anthropology, 
systems analysis) into volume–outcome research 
 In studies with mortality as an end point, examine the time of death to 
help explain the cause of death 
 Develop procedure-condition-specific risk-adjustment tools. 
 
Health Services Research Data Infrastructure 
 
 Develop condition-procedure-specific, prospective, population-based 
clinical databases and registries (e.g., New York’s cardiovascular 
surgery database) 
 Develop chronic disease databases that cover both hospital and 
outpatient care 
 When clinical databases are available to serve as a “gold standard,” 
evaluate the sensitivity and specificity of volume as a quality indicator 
 Selectively add key clinical risk factors and process data into 
administrative databases 
 Include more reliable identifiers of physicians in federal and state 
administrative databases. 
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The volume-outcome relationship for radical cystectomy in the English healthcare 
setting was evaluated, using an improved statistical/methodological framework 
that considered the hierarchical structure of the institutional and surgeon 
influences (multi-level modelling), appropriate handling of the provider volume 
variable, adjustment for structural/process of care measures, and measured 
outcomes other than mortality. A volume-outcome relationship for mortality and 
re-intervention following radical cystectomy was evident across English NHS 
Trusts. At the institutional level, medium-volume institutions were found to have 
statistically significant greater odds of mortality. Appropriate interpretation of the 
volume-mortality relationship was only possible after adjusting for institutional 
and surgeon volumes and structural and process of care confounders. The finding 
that medium-volume institutions, as compared with low-volume institutions, had 
higher odds of mortality was surprising. More consistent with previous studies 
was the finding that medium-volume institutions appeared to have worse in-
hospital and total mortality than high-volume institutions. What is not clear is why 
low-volume institutions appeared to have comparable outcomes to high-volume 
institutions.  
For re-intervention, a volume-outcome relationship existed at the institutional and 
surgeon level. Again, as for mortality, the odds of re-intervention within 14 and 
30 days of operation, were found to be greater in medium-volume institutions 
when compared with low-volume institutions. High-volume surgeons (but not 
medium volume) were associated with a reduced odds of early re-intervention 
(within 14 days) compared with low-volume surgeons. The surgeon volume-re-
intervention relationship only became apparent after adjusting for the influence of 
the institution and provided the strongest evidence for the influence that the 
surgeon/institution interaction can have on patient outcomes. 
Adjustment for structural and process of care variables appeared to have the most 
impact at the medium-volume institutional level. The difficulties and dangers of 
trying to define an absolute minimum caseload are evident. More work is needed 
to define ‘medium-volume’ institutions and also the surgeon’s volume that makes 
it protective for institutional outcomes. Centralising care to specified institutions 
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without accounting for the inherent structural and process factors that result in 
optimum care is meaningless. Equally, the outcomes a surgeon can achieve are 
dependent on the support network provided at the institutional level. The relative 
contribution of all these factors needs to be considered when reconfiguring service 
delivery to improve the quality of care that a patient receives 
177
. 
Analysing the same volume-outcome data using risk-adjusted funnel plots 
potentially influences the overall conclusions made from the aggregated data 
analysis alone and therefore act as a useful adjunct for assessing the volume-
outcome relationship. Using the final complex model, no Trusts in England 
demonstrated a truly divergent high rate of mortality or re-intervention within 30 
days following radical cystectomy. It cannot be said with any certainty therefore 
that any Trust has a performance worse than the national average for these 
outcomes. As risk-adjusted funnel plots also display disaggregated provider level 
data, applying them to an incremental statistical model can help direct further 
investigation of confounding factors at the individual Trust level and compliment 
methods of data validation.  
The volumes of other related operations that may influence mortality risk for 
radical cystectomy were not included in the statistical model. The impact of 
overall uro-oncological operative volumes has been highlighted and, for 
cystectomy, adjustment for institutional volumes of nephrectomies and 
prostatectomies attenuated the institutional cystectomy volume-mortality 
relationship by 60% 
186
. This is particularly important for English healthcare and 
Improving Outcomes Guidance for urological cancer services, as the minimum 
caseload guidance for radical pelvic surgery of 50 cases/year considers 
cystectomy and prostatectomy in combination. As demonstrated in study five, 
although there was some correlation between the numbers of radical cystectomies 
and prostatectomies performed on a yearly basis at the NHS Trust level, in 
2006/07 only about one third of NHS Trusts in England were compliant with 
Improving Outcomes Guidance. There appeared to have been some positive effect 
on centralisation of services with a decrease in low and medium-volume providers 
in recent years, suggesting at least some degree of engagement, at the regional 
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level, with the volume-outcome agenda to improve quality of care. A survey of 
consultant urological surgeons in the UK suggested that most supported the 
principle of setting minimum volume thresholds for urological cancer operations, 
including radical cystectomy 188. 
Longitudinal data analysis is important for assessing causality and causal 
direction, as it indicates whether outcomes improve if annual volume of activity 
increases over time. As previously reported 189, studies which have demonstrated 
volume-outcome relationships on cross-sectional analysis have subsequently 
found no relationship between changes in volume and outcome over time. The 
absence of reliable longitudinal data in volume-outcome research has been 
highlighted as a concern when trying to predict, with any certainty, the success of 
centralising services to improve outcomes 177. 
7.2 Unanswered questions and future research 
The volume-outcome relationship investigated in this thesis is only one 
component of a much broader future quality improvement framework that must 
combine other integral factors such as adherence to process of care measures 
encompassing the entire patient treatment pathway, other outcomes of surgery 
including longer-term clinical outcomes (cancer recurrence rates and cancer-
specific survival), patient-reported measures including quality of life assessment 
and patient satisfaction/experience assessment.  
Further volume-outcome research needs to explore the relative contributions of 
each of the factors, the institution, the surgeon and individual structural and 
process of care characteristics and explore the relationship between caseload 
volume and operative outcomes other than mortality. This, in combination with 
further efforts to improve the methods used for volume-outcome research, such as 
longitudinal data analysis to help establish causality, will be important for 
informing future healthcare service changes, such as centralising care for 
relatively infrequent operations like radical cystectomy and improving the quality 
of care delivered. 
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A novel quality framework will need to address the challenges of weighting, 
standardising, and combining a number of structural, process, outcome and 
patient-reported measures to produce a composite score. The Quality 
Measurement Task Force of The Society of Thoracic Surgeons compared a 
number of statistical methodological approaches to develop such a composite 
score for 11 quality indicators across four domains for coronary artery bypass 
grafting 77 ( Table 7.2). The Task Force used nine principles to guide the selection 
of the quality indicators ( Table 7.2). This work is the most comprehensive quality 
measurement programme to date and uses a scientifically rigorous approach to 
evaluate difficulties such as combining multiple measures into a single score, 
while maintaining the ability to isolate the individual components to allow for 
performance assessment of specific areas. A detailed description of this work has 
been published 78, but in summary recommends the use of Bayesian random-
effects analyses, all or none scoring for ‘within-domain’ composite scoring and 
rescaling for combining across-domain scores. The latter two approaches avoid 
the subjective weighting of the individual quality indicators. All or none scoring 
ensures consistent directionality between ‘quality’ measures and risk-adjusted 
performance measures; the numerators of the risk-adjusted performance measures 
are defined as the number of patients who avoid the ‘non-desired’ end point.  
Larger values of the numerator are therefore favourable for the chosen ‘quality’ 
measures. Rescaling considers that ‘quality’ measures have different scales of 
measurement. The Bayesian random-effects approach accounts for small sample 
size and incorporates a risk-adjustment for performance 78. 
It is clearly impractical, in terms of time and resource, to collect and collate 
hundreds of ‘quality measures’. Using the technique of data mining with factor 
analysis or structural equation modelling, pilot studies can be used to identify 
correlation among the measures. This establishes whether any of the measures can 
be eliminated if they provide redundant rather than complementary information. 
Furthermore, to confirm that each quality indicator is contributing to, but not 
dominating, the final composite score, the individual indicator to total score 
correlation can be calculated 78.  
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Reported findings from this thesis and the approach described above by the 
Society of Thoracic Surgeons highlight the need and importance for a high-level 
quality framework to be further adapted within specific surgical specialities, and 
even named procedures, to maximise the benefit and relevance to the quality of 
care delivered for particular cohorts of patients. Quality control can only be done 
for institutions and surgeons using prospectively collected procedure-specific 
outcome measures such as cancer control data, intra- and postoperative parameters 
and complications and short, medium and long-term morbidity including quality 
of life assessment. This will be an important move away from the frequent use of 
mortality as a surrogate measure of outcome. The generation of hybrid 
administrative and clinical datasets at a Trust level may allow us to evaluate, with 
much greater complexity, underlying determinants within the volume-outcome 
relationship including structural and process differences between Trusts, 
departments and surgeons and their impact on the quality of care that our patients 
receive. The framework will need to incorporate an appropriate statistical 
methodology such as multilevel modelling to ensure that the data is handled in the 
correct manner. 
Although the public reporting of performance data stimulates quality 
improvement activity at the provider level 
4
, this does not always lead a patient to 
choose the most appropriate provider for him/herself 4. ‘Packaging’ of this 
information for the public is therefore crucial and inconsistent presentation of 
information leads to variable results 
3
. One key element relies on the ease with 
which the information can be interpreted by the public. Hibbard et al. suggest that 
it should “be immediately obvious who the top and bottom performers are, to 
stimulate quality improvement efforts” 
190
. Yet the presentation of information on 
quality can create resistance and disengagement from quality improvement 
programmes. Providers must be able to trust the data (this can be achieved by 
giving them ownership), and trust the methods of presentation, such that there is 
not spurious ranking and unfair discrimination as a result of unmeasured or 
immeasurable factors. This is particularly important when quality improvement 
programmes are evolving and datasets may not reflect true case-mix adjustment, 
for example.  
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Although funnel plots are limited to displaying only one ‘quality measure’ at a 
time, multiple plots have been used, in combination, to provide an overall 
assessment of provider performance across a range of indicators 191. The number 
of quality measures can be minimised by using techniques such as data mining, as 
described previously, to eliminate ‘redundant’ measures. This means that a 
smaller number of funnel plots can be produced displaying a bundle of variables 
providing complementary information. 
Existing initiatives of quality appraisal have been important, but there is still the 
need for a universally accepted and validated quality framework which 
incorporates a multi-dimensional approach to measuring both the clinical and 
patient-orientated measures of quality of care. The assessment tools for patient-
reported measures need to be agreed using an evidence-base and then made freely 
available through a quality forum to facilitate both national and international 
benchmarking and continuous improvements through feedback mechanisms. 
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APPENDIX A 
Structural variables 
Teaching status – Trusts were assigned a flag to say whether they had teaching 
hospital status according to the National Patient Safety Agency website. 
Data source - http://www.npsa.nhs.uk/nrls/patient-safety-incident-data/feedback-
reports/sample-reports-benchmarking/ 
 
Total available beds, all sectors – Calculated using summation of available beds, 
all sectors, across all seven years.  
Data source Hospital Activity Statistics – 
http://www.performance.doh.gov.uk/hospitalactivity/data_requests/beds_open_ov
ernight.htm 
 
Total available acute beds – Calculated using summation of available acute beds 
across all seven years.  
Data source Hospital Activity Statistics - 
http://www.performance.doh.gov.uk/hospitalactivity/data_requests/beds_open_ov
ernight.htm 
 
Total urology episodes – Calculated using summation of total urology episodes, 
defined as either the specialty code for the episode or a urology OPCS code (‘M’ 
and ‘N’ chapters). Data source – Hospital Episode Statistics 
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Average acute occupied bed rate – Calculated using total (across all seven years) 
occupied acute beds divided by total available acute beds by provider.  
Data source Hospital Activity Statistics – 
http://www.performance.doh.gov.uk/hospitalactivity/data_requests/beds_open_ov
ernight.htm 
 
Average nurse to occupied bed ratio – Calculated using summation of all nurses 
by provider across all seven years divided by total occupied beds, all sectors, by 
provider. Data source of nursing workforce – The Information Centre Workforce 
Census (obtained by request). 
 
Average critical care to total bed ratio – Calculated using total available critical 
care bed counts for six years available (2001/02 – 2006/07) divided by total 
available beds, all sectors, across corresponding six years.  
Data source Hospital Activity Statistics - 
http://www.performance.doh.gov.uk/hospitalactivity/data_requests/critical_care_b
eds.htm  
and 
http://www.performance.doh.gov.uk/hospitalactivity/data_requests/beds_open_ov
ernight.htm 
 
Average registrars (all clinicians) to occupied beds ratio – Calculated using 
summation of registrars counts, whole time equivalents, (all specialities) across all 
seven years divided by total occupied bed counts, all sectors, across all seven 
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years. A single Trust had clinician counts only available for six years and 
corresponding years for bed counts were therefore used to calculate the average.  
Data Source of registrar workforce - The Information Centre for Health and Social 
Care (obtained by request). 
 
Urology registrars to total urology episodes – Calculated using summation of 
urology registrar counts across years available and divided by total urology 
episodes across years available.   
Data Source of registrar workforce - The Information Centre for Health and Social 
Care (obtained by request). 
 
Process of care variables 
Average operation cancellation rates (Rate not admitted within 28 days following 
cancellation – Average calculated across six years for which data available 
(2001/02 – 2006/07).  
Data source Hospital Activity Statistics - 
http://www.performance.doh.gov.uk/hospitalactivity/data_requests/cancelled_ope
rations.htm 
 
Waiting times for surgery (days) – Calculated at the patient ID level using the 
HES fields “Elecdate” (booking date) minus “admidate” (admission date for 
cystectomy). Data source – Hospital Episode Statistics  
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APPENDIX B 
ICD-10 codes used to define potential complications resulting from surgery: 
Procedure-specific complications 
N328, T810, T811, K661, R571, R58X Haemorrhage/haematoma  
A40, A41, A49 Sepsis 
R31 Unspecified haematuria 
S366 Rectal Injury (+/- formation of colostomy) 
N995 Stoma complication (ischaemia, necrosis, infection, bleeding, prolapse) 
R390 Urine leakage (anastomtic breakdown) 
N393, N394, R32 Incontinence of urine 
N484 Impotency (erectile dysfunction) 
R33 Retention of urine 
S346, S348, S741, S742, S747, S748, S749, T133 Neuropraxia 
S365 Bowel injury 
S360 Splenic injury 
S361 Liver injury 
S350, S351, S352, S353, S355 Aorta/IVC injury + other major vessel injury 
S362 Pancreas injury 
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Non-procedure specific complications 
N390, T835 Urinary tract infection 
J12, J13, J14, J15, J16, J17, J18, J22 Chest infection 
I26 Pulmonary embolus 
I60, I61, I62, I63, I64 Stroke 
I801, I802, I822 Deep vein thrombosis 
I21, I22, I249, I256 Myocardial infarction 
N17, N19 Acute renal failure 
A09 Infective diarrhoea 
K920, K921, K922, K250, K252, K260, K262, K270, K272, K280, K282, K290 
Gastrointestinal bleed 
T814 Wound infection 
K560, K567 Ileus 
S273, S276 Lung/pleura injury 
S270, J938, J939 Pneumothorax 
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A list of the codes considered to be a re-intervention: 
Operation-specific re-intervention 
X339, X332, T283, T302, M478, M136, M193, T309, S424, T301, T413, G693, 
M459, T303, X338, S423, T453, T414, T462, M198, S571, G699, G731, M062, 
M498, T452, T458, T554, X333, G784, H151, M132, M195, M292, S624, T308, 
T315, X342, M162, M479, T318, T463, T468, T556, G712, G758, H159, M215, 
M418, M472, T342, T343, T418, G738, G742, G788, H335, H468, H628, M151, 
M203, P298, T253, T289, T488, G633, G698, G702, G714, G723, G728, G741, 
G743, G755, H059, H113, H152, H158, H161, H176, M022, M063, M069, 
M118, M119, M135, M138, M168, M182, M221, M258, M264, M302, M373, 
M378, M382, M388, M768, M832, T282, T288, T316, T348, T361, T374, T384, 
T451, T459, T461, T469, T549, T838  
Non-operation specific re-intervention 
L912, L913, G459, E423, G451, L911, G478, L133, T124, X408, G434, H259, 
S472, X344, X403, X501, Y903, G603, G608, H221, H289, K608, L714, E498, 
E499, G344, G521, G522, K601, L728, L951, S422, S579, T123, W901, X402, 
A559, A843, C623, E051, E315, E368, E429, E506, E594, G289, G348, G383, 
G432, G433, G435, G448, G479, G601, H012, H029, H229, H248, K491, K633, 
L161, L463, L631, L634, L722, L741, L791, L918, L938, N039, N242, N262, 
N304, N306, P092, P172, Q552, S421, S428, S429, S432, S476, S478, S578, 
S608, T121, T122, T223, T278, T393, V331, W471, X291, X318, X368, X388, 
X502, X508, X558  
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